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ABSTRACT 
 
Hop (Hsp70-Hsp90 Organizing Protein) is a co-chaperone of two major molecular 
chaperones, Hsp70 and Hsp90, and acts by transferring substrates from Hsp70 to Hsp90. 
Although under normal conditions Hop is predominantly localized within the cytosol, 
Hop has been detected in the nucleus under certain conditions including cell cycle arrest. 
A putative nuclear localization signal (NLS) has been identified within Hop, which 
overlaps with the TPR2A domain (previously shown to be critical for Hop-Hsp90 
interactions). Hop is phosphorylated in vitro by two cell cycle kinases, namely, casein 
kinase II (CKII) at S189 and cdc2-kinase at T198; both residues are found upstream of 
the putative NLS and TPR2A domain. Mimicking phosphorylation at either 
phosphorylation site appeared to affect the subcellular localization of Hop. The aim of 
this study was to characterize Hop with respect to its phosphorylation status in vivo, as 
well as its subcellular localization pattern under heat stress and determine how these 
properties affected its interaction with Hsp90 as a co-chaperone. Dephosphorylation of 
proteins under normal and heat shock conditions changed the isoform composition of 
Hop, providing strong evidence that Hop was phosphorylated in vivo. Surface plasmon 
resonance (SPR) and glutatione-S-transferase (GST) co-precipitation studies showed that 
a cdc2-kinase phosphorylated mimic of Hop disrupted Hop-Hsp90 binding. A full length 
Hop-EGFP construct, as well as substitution mutants of the predicted NLS residues 
within the Hop-EGFP construct, were transfected into baby hamster kidney (BHK)-21 
cells in order to establish the subcellular localization of Hop under heat stress and to test 
whether predicted residues were critical for nuclear localization of Hop. Under normal 
conditions, both Hop-EGFP and the NLS mutants were predominantly cytosolic, but 
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when the cells were subjected to heat stress, Hop and its NLS-mutants were localized to 
both the cytosol and the nucleus. SPR and GST co-precipitation studies showed that 
substitution of the residues within the major arm of the putative NLS abrogated Hop-
Hsp90 interactions. The data obtained from this study, showed for the first time, that Hop 
was phosphorylated in vivo and suggested that phosphorylation of Hop by cdc2-kinase 
could inhibit Hop-Hsp90 interactions. Moreover, these results suggested that the 
subcellular localization of Hop was dependent on stress levels of the cell, particularly 
heat stress. We propose that the nuclear localization of Hop may be primarily regulated 
by stress and secondarily by cell cycle arrest. The major arm of the putative NLS did not 
affect the localization of Hop directly, but was shown to be critical for Hop-Hsp90 
binding in vitro. The results of this study suggested that binding of Hop to Hsp90 
sequestered Hop within the cytosol and that Hsp90 acted as a cytosolic retention factor 
for Hop. Both phosphorylation of Hop, and its subcellular localization, appeared to be 
intimately related to its interaction with Hsp90 as a co-chaperone.  
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Two roads diverged in a yellow wood 
and sorry I could not travel both 
And be one traveller, long I stood 
and looked down one as far as I could 
to where it bent in the undergrowth; 
Then took the other, as just as fair, 
and having perhaps the better claim 
because it was grassy and wanted wear; 
though as for that, the passing there 
had worn them really about the same, 
And both that morning equally lay 
in leaves no feet had trodden black. 
Oh, I kept the first for another day! 
Yet knowing how way leads on to way, 
I doubted if I should ever come back. 
I shall be telling this with a sigh 
Somewhere ages and ages hence: 
Two roads diverged in a wood, and I -- 
I took the one less travelled by, 
and that has made all the difference 
- Robert Frost 
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CHAPTER 1 
 
INTRODUCTION 
 
 
 
 
“The pure and simple truth is rarely pure and never simple.” 
 
- Anon 
 
 
 
 
 
 
 
Chapter 1: Introduction 
 
 
2 
1.1 LITERATURE REVIEW 
1.1.1   The ‘Crowded’ Cell  
The biological cell is a membrane-bound unit composed of a concentrated aqueous 
solution of chemicals and is capable of duplicating itself through the process of cell 
division (Alberts et al., 1998). The total percentage of the volume occupied by 
macromolecules present within a cell is approximately 20-30% (i.e. within a 
concentration range of 200-300 g L-1). The steric significance of this proportion results in 
a large volume of the cell being unavailable to other molecules, and allows the interior 
environment of the cell to be designated as ‘crowded’ (as reviewed by Ellis, 2001b, 
2007). Thus most biomolecules have evolved to function within crowded environments 
and the functioning of protein machineries within the cell reflects this appropriately.  
 
Almost all the major processes that take place in a cell are driven by the assembly of a 
number of protein molecules, which interact with each other to form ‘protein 
machineries’. These protein machineries may eventually interact with other protein 
complexes such that they form networks of interactions and interwoven functions within 
the cell (reviewed in Alberts, 1998; Ellis, 2007). This is particularly fascinating, in light 
of the crowded environments that they function in. For example, in the case of a single 
cell of Escherichia coli (E. coli) the total concentration of protein and RNA is estimated 
to be in the range of 300-400 g L-1 (Zimmermann and Minton, 1991). A measurement of 
the diffusion coefficients for large molecules such as green fluorescent protein (GFP) and 
small molecules like carboxyfluorescein within the cytoplasm, have shown a three to 
tenfold reduction compared to their values in water (Kao et al., 1993; Elowitz et al., 
1999).   
 
Although crowding reduces the rate of diffusion as shown by the above-mentioned 
examples, it increases the thermodynamic activities of various biochemical reactions 
within the cell (Burg, 2000).  As a result, some biochemical effects caused by the 
crowded cellular environment include an increase in macromolecular association 
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reactions, oligomerization of various molecular components, the formation of 
multicomponent complexes within specific biological pathways and the unfolding of 
proteins induced by stress. The increased proximity of polypeptide chains during the 
process of folding and the associated increase in the thermodynamic activity of partly 
folded polypeptides, thus poses the danger of misfolding and the binding of these 
polypeptide chains to one another causing aggregation (Ellis, 2001b, 2007). Since the 
diffusion rate may be slowed down to a greater extent in the case of larger polypeptides, 
than that of small polypeptides, this may mean that the increase in aggregation may be 
more predominant in smaller polypeptide chains. Aggregation of proteins into non-
functional bodies is seen in various forms, for e.g. inclusion bodies in a bacterial system 
and plaques in human amyloid disease (Burg, 2000; Ellis, 2001b, 2007).   
 
1.1.2 Protein Folding and Molecular Chaperones 
The folding of proteins into their three-dimensional structures is fundamental for efficient 
functionality, long-term stability in crowded biological environments as well as their 
correct subcellular localization. Moreover, protein folding is a process that is coupled to 
the regulation of cellular growth, cell cycle events and differentiation (Radford and 
Dobson, 1999). Early work in this field showed that all the information required for a 
protein to fold into its basic structural elements was contained within its amino acid 
sequence. Despite the large number of total possible conformations into which a protein 
can fold, the native state most proteins usually assume is the lowest thermodynamic 
energy conformation possible under the physiological conditions. The more stable native-
like interactions between residues are preferred over non-native ones, thus achieving its 
lowest possible energy three-dimensional structure (reviewed in Dobson, 2003; Pauwels 
et al., 2007).  
 
It is believed that a smaller number of amino acid residues within the protein interact to 
form a ‘folding nucleus’ and the remainder of the structure condenses around it. The final 
structure is achieved when all the side chains become occupied in a closely packed 
arrangement and water is excluded from the core of the protein (Fersht, 2000; Cheung et 
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al., 2002; Dobson, 2003). Partially folded proteins may unavoidably expose certain 
residues, which are otherwise buried within the native structure, to the solvent and thus 
be prone to aggregation or inappropriate interactions with other molecules within the cell 
(as reviewed by Ellis, 2001a, 2007). Protein damage may not always be induced by 
environmental stress, and sometimes may be caused by some of its inherent properties 
such as mutations that disrupt its native structure. Using a Caenorhabditis elegans 
polyglutamine aggregation model, it was shown that mutation of a single protein that 
caused misfolding, disrupted the general protein homeostasis within the cellular 
environment (Gidalevitz et al., 2006).  Failure within protein folding pathways is linked 
to a wide variety of pathological conditions, including cystic fibrosis, Alzheimer’s and 
Parkinson’s disease, the spongiform encephalopathies and type II diabetes (reviewed by 
Thomas et al., 1995; Horwich, 2002; Dobson, 2003).   
 
The cell employs various strategies to counteract this problem of protein misfolding and 
aggregation. One such strategy lies in the form of a class of proteins termed ‘molecular 
chaperones’, which assists other proteins in assembling and disassembling and which 
removes itself from the final functional structure of the proteins they assist (Ellis, 2007). 
Molecular chaperones are known to interact with nascent polypeptide chains, as they 
emerge from the ribosome (co-translational), as well as assist proteins in later stages of 
folding processes (post-translational). Molecular chaperones can not only prevent the 
misfolding of proteins, but sometimes are involved in the rescue of misfolded and 
aggregated proteins, and usually require ATP for efficient functioning. A classic example 
of well-studied chaperone machinery is the bacterial GroEL/GroES system, which 
belongs to the family of chaperonins. This system operates by the sequestering of 
incompletely folded polypeptides within a cage-like structure in GroEL, so that the 
polypeptide is shielded from the complex outer environment (reviewed in Bukau and 
Horwich, 1998; Hartl and Hayer-Hartl, 2002; Ellis, 2007).  
Although chaperones increase the efficiency of protein folding, they normally do not 
increase the folding rate constants significantly. There is, however, a second strategy 
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employed by the cell to prevent the misfolding of proteins. Folding catalysts such as the 
peptidylprolyl isomerases and protein disulphide isomerases operate by speeding up 
potentially slow steps in the folding process. The former acts by increasing the rate of 
cis-trans isomerization of peptide bonds involving proline residues and the latter 
enhances the rate of formation and reorganization of disulphide bonds (Schiene and 
Fischer, 2000). Outer membrane proteins (OMP) of bacteria, such as PhoE in E.coli, 
have been shown to fold in vivo at a comparatively faster rate than other proteins (Jansen 
et al., 2000; Tamm et al., 2004). A proposed folding catalyst for such OMPs is SurA, a 
periplasmic peptidyl-prolyl isomerase whose peptidyl-prolyl activity lies in a parvulin-
like domain in the C-terminus. However, SurA also has chaperone-like activity in its N-
terminus, and it appears that both domains play a part in its protein folding activity 
(Lazar and Kolter, 1996; Behrens et al., 2001). 
A third strategy employed by the cell in combating problems arising from protein 
misfolding is in the form of the steric chaperones (Ellis, 1998). These are proteins that are 
synthesized with a prosequence, which is essential for the correct folding of the rest of 
the chain but is then proteolytically removed. Examples of proteases that fall under the 
category of steric chaperones are subtilisin and α-lytic protease. Lipase-specific foldases 
are specific for lipases, as the name obviously suggests and are active within extracellular 
medium. Fimbrial chaperones provide an otherwise missing β-strand to a folding fibrila 
subunit, which otherwise aggregates in the periplasm and are degraded by proteases (as 
reviewed in Ellis, 1998; Pauwels et al., 2007).  
 
1.1.3  Subcellular Protein Translocation 
Due to the differences in specificity of the environment offered by each subcellular 
compartment that affects the physiological and enzymatic activities of proteins as well as 
the particular localization of protein-interaction partners, many proteins are targeted 
toward specific subcellular compartments. Thus proteins are not functional until they are 
accurately transported to their destination after synthesis on ribosomes in the cytoplasm 
(Simon and Blobel, 1991). The ‘signal hypothesis’ was first put forward by Gunter 
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Blobel, who postulated the presence of ‘codes’ i.e. short peptide motifs present in the 
amino acid sequence of the proteins that directed these proteins to their various 
subcellular compartments such as the ER, nucleus, mitochondria etc. (Simon and Blobel, 
1991; Sheilds, 2001).  
 
Proteins that are destined for secretion to the extracellular environment are first 
translocated to the ER, which contains a range of molecular chaperones and folding 
catalysts (Zimmermann et al., 2006). Transport into the ER usually occurs through the 
recognition of an N-terminal cleavable signal sequence on the protein and the subsequent 
transport of the protein through a hydrophilic channel that is part of the protein 
translocation machinery. This is usually the Sec61 pathway in eukaryotes (Zimmermann 
et al., 2006). The Sec61 complex consists of three units which together form a 
heterotrimeric complex. A number of heterotrimers are strategically located around a 
central aqueous pore through which the proteins are translocated. Proteins that have a less 
hydrophobic signal sequence are transported by another membrane protein complex 
known as the Sec62/63 complex. In addition, the molecular chaperones, Hsp70 (heat 
shock protein) and its co-chaperone Hsp40 (these are discussed in sections 1.1.7-1.1.10) 
along with nucleotide exchange factors, are also involved in this protein translocatory 
process (reviewed by Osborne et al., 2005; Dudek et al., 2006; Zimmermann et al., 2006; 
Flower, 2007).  
 
Most mitochondrial proteins are synthesized in the cytosol and then transported to the 
mitochondria via translocatory protein complexes found in the inner and outer 
mitochondrial membranes (Hoogenraad et al., 2002). The receptors found on the surface 
of the outer mitochondrial membrane (Tom) including Tom20, Tom22, Tom70 and the 
channel protein Tom40, comprise the translocatory machinery at this site, whereas a suite 
of proteins comprising the Tim translocases are found on the inner mitochondrial 
membrane (Hoogenraad et al., 2002). Tom70 recognizes internal targeting signals within 
the amino acid sequences of mitochondrial proteins and is now known to possess a 
chaperone-binding region. A number of molecular chaperones such as Hsp70 and Hsp90 
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(discussed in detail in sections 1.1.7-1.1.10) are implicated along with TOM 70 in 
mitochondrial protein recognition and translocation (Young et al., 2003).  
 
A number of diseased conditions are associated with mislocalization of proteins within 
the cell. BARD1 (breast cancer-associated protein) and BRCA1 (breast and ovarian 
cancer susceptibility protein 1) are binding partners and both shuttle between the nucleus 
and cytoplasm by means of individual nuclear export signals (NES) that direct proteins 
out of the nucleus and into the cytosol. BARD1 is proapoptotic within the cytoplasm. 
Interestingly, both BARD1 and BRCA1, in binding to one another, can mask their 
respective NES, and their resulting nuclear compartmentalization can lead to cell cycle 
arrest and the promotion of breast cancer (Fabbro et al., 2002; Schüchner et al., 2005). 
Similarly, in the case of the adenomatous polyposis coli (APC), protein which is a tumor 
suppressor, the loss of a functional NES within the amino acid sequence resulted in the 
arrest of the protein within the nucleus and this phenomenon was observed in colorectal 
cancer cells (Henderson and Fagotto, 2002; Rosin-Arbesfeld et al., 2003).  
  
1.1.4           Protein Translocation into the Nucleus 
Nuclear proteins, or proteins destined to translocate to the nucleus at some point in their 
lifetime, are synthesized on free ribosomes in the cytoplasm and transported to the 
nucleus through the nuclear pore complexes (NPCs) found in the nuclear envelope 
(Lange et al., 2007). The NPC is a proteinaceous structure with a molecular mass of 
about 125 MDa in mammalian cells and about 60 MDa in yeast. It contains an aqueous 
diffusion channel that is approximately 10 nm in diameter through which molecules 
smaller than 40 kDa can passively diffuse. However, larger proteins require the importing 
transport mechanism and its recognition of intrinsic nuclear localization signals (NLSs) 
uniquely present in proteins, which are targeted, to the nucleus. NLSs are short peptide 
sequences that are necessary and sufficient for nuclear localization of their respective 
proteins (reviewed in Allen et al., 2000; Yoneda, 2000; Chook and Blobel, 2001; 
Suntharalingam and Wente, 2003; Lange et al., 2007).  
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Mutation or deletion of the NLS has been shown to lead to cytosolic localization of the 
protein in question. The NLS has also been shown to be active in nuclear targeting of a 
normally cytosolically localized carrier protein. Unlike signal sequences that target 
proteins into the ER or mitochondria, the NLS is not deleted after or during translocation, 
but remains as part of the protein molecule (reviewed in Yoneda, 1997, 2000).  The NLS 
of simian virus 40 (SV40) large T-antigen was the first example of an NLS to be 
identified at the level of its amino acid sequence and this NLS contains a basic amino 
acid cluster, which is thought to be a characteristic feature of most NLSs. Classical NLSs 
are divided into two main groups, a single basic type like that found in SV40 large T-
antigen, and a bipartite basic type, consisting of two series of basic residues separated by 
a 10 to 12 amino acid spacer such as that found in nucleoplasmin (reviewed in Dingwall 
and Laskey, 1991; Yoneda, 2000; Lange et al., 2007).  
 
Non-classical NLSs such as the M9 sequence found in hnRNP (heterogenous nuclear 
ribonucleoprotein) A1, have also been described previously, and these contain both a 
signal for nuclear import as well as one for nuclear export, both of which are mediated by 
pathways that are distinctly different from that of the classical NLSs. Another novel 
nucleocytoplasmic shuttling domain, KNS, was identified in the hnRNP K shuttling 
protein, which also confers nuclear import and export qualities to hnRNP K but its import 
pathway appears to be different from that of the M9 or classical NLSs (Michael et al., 
1995; Michael et al., 1997; Krebber and Silver, 2000).  
 
The functioning of NLSs is believed to be through recognition/ligand-receptor-like 
interactions and it has been shown to be only an entry signal having no part to play in the 
further retention of the protein within the nucleus (Lange et al., 2007). An NLS can 
however, confer specific regulatory properties associated with active transport to the 
protein carrying it, such as temperature and/or ATP dependent nuclear transport 
(Breeuwer and Goldfarb, 1990).   Nuclear transport of proteins bearing a classical NLS is 
mediated by the importin-α/β heterodimer, also known as karyopherin-α/β (Moroianu et 
al., 1995). The process of the classical NLS-mediated nuclear import of proteins is 
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composed of three stages: (a) docking at the NPC (b) translocation through the NPC and 
(c) deposition of the cargo within the nucleus.  
 
During the first stage the nuclear protein in the cytosol binds to importin-α and this 
complex is targeted to the NPC. In the second stage, translocation through the NPC 
requires the small-guanosine 5’ triphosphatase (GTPase) Ran, GTP and physiological 
temperature. Binding of the cargo protein-importin-α complex to importin-β is 
responsible for the docking of the cargo protein-importin-α complex to the NPC 
(Moroianu et al., 1995; Mattaj and Englmeier, 1998). Once the protein-importin-α 
complex is inside the nucleus, importin-β dissociates from the protein complex by 
binding to Ran loaded with GTP to form a Ran-GTP-importin complex, which then 
allows importin-α to be taken back to the cytoplasm for further nuclear protein import 
processes (reviewed in Lange et al., 2007) as shown in figure 1.1. 
 
The 3-D structure of importin-α reveals a short N-terminal binding domain for importin-
β , and a large NLS binding domain, which is comprised of 10 tandem armadillo (ARM) 
repeats. The ARM repeats form a concave binding groove containing a major binding site 
and a minor binding site for the NLS (Conti et al., 1998; Kobe, 1999; Fontes et al., 2000; 
Fontes et al., 2005). Monopartite NLS sequences can bind to both sites but only binding 
to the major site has been shown to be physiologically relevant (Conti et al., 1998; Conti 
and Kuriyan, 2000). The bipartite NLS sequence binds to both binding sites, with the 
major binding site of importin-α recognizing the major arm of the NLS and the minor 
binding site of importin-α recognizing the minor arm of the NLS (Fontes et al., 2000). 
Interestingly, the importin-β binding domain (IBB) on importin-α mimics an NLS, and 
binds to the NLS binding domain of importin-α, in the absence of importin-β (Kobe, 
1999; Fanara et al., 2000; Catimel et al., 2001). Thus the affinity of importin-α for its 
NLS bearing substrates is increased in the presence of importin-β , as depicted in figure 
1.1.  
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Figure 1.1: Affinity of importin-a for an NLS bearing protein is increased in the presence of 
importin-J3 (adapted from Lange et ai., 2007). A simple schematic showing a bipartite NLS peptide 
(pink) bound to the major and minor binding domains (yellow) of importin-a (dark green) and the 
importin-j3-binding (IBB) domain of importin-a bound to importin-j3 (red) in the cytosol. Importin-j3 
facilitates the transport of the importin-NLS complex into the nucleus, after which, its interaction 
with RanGTP releases it from the flexible IBB. The IBB competes with the NLS peptide for the 
major binding site on importin-a, which results in a low affinity of importin-a for the NLS peptide, 
and this facilitates delivery ofthe NLS-bearing protein cargo into the nucleus. 
10 
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1.1.5  Regulation of Nuclear Protein Import 
Various factors have been shown to influence the NLS function of a particular protein. 
One such factor is the position of the NLS within a protein. The general consensus is that 
an NLS has to be located on the surface of the protein to be accessible for recognition 
(Roberts et al., 1997) and studies have shown that the protein context surrounding the 
NLS can play a role in mediating interactions with importin-α (Friedrich et al., 2006).  
 
The tumour suppressor p53 is linked to DNA repair, apoptotic cell death and genomic 
stability functions within the cell, and translocates to the nucleus by means of an NLS 
found at residues 316-322. Moreover, two basic residues, Lys305 and Arg306 also 
contributed to the nuclear localization of p53, in addition to its NLS. Interestingly, a 
region of the amino acid sequence proximal to its NLS, residues 326-355, was found to 
constitute a cytoplasmic sequestration domain (CSD), which also contained an NES (340-
351). The CSD was shown to reduce the efficiency of nuclear import of p53 by 
interfering with the binding of the NLS of p53 with importin-α and this was independent 
of NES activity in the same region (Liang and Clarke, 1999a, b; Stommel et al., 1999).  
 
Intra- and intermolecular interactions of the NLS (or NLS-containing proteins) 
(Khokhlatchev et al., 1998) may further regulate nuclear localization (Kaffman and 
O'Shea, 1999). In the case of the p53 tumour suppressor, it has been suggested that the 
basic domain comprising of Lys305-Arg306, which is only nine amino acids proximal to 
its NLS, may interact with the CSD and in doing so present the NLS in a conformation 
that enhances binding of the NLS to importin α (Liang and Clarke, 1999a, b). The 
glucocorticoid receptor (GR) belongs to the steroid hormone receptor (SR) family and is 
generally inactive in the cytosol, while complexed with a number of proteins such as the 
90-kDa heat shock protein (Hsp90). In the active state, GR binds to its ligand and 
accessory proteins like Hsp90 are found to dissociate from the GR-ligand complex, 
allowing for rapid nuclear translocation and the activation of gene expression. Ligand 
withdrawal from GR is associated with the export of GR back to the cytosol (Guiochon-
Mantel et al., 1996; Kaffman and O'Shea, 1999).  
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The association of certain proteins that lack a functional NLS, with an NLS-bearing 
protein, is known as the ‘piggy-back’ effect. This association may be responsible for the 
transport of an NLS-devoid protein greater than 40 kDa, into the nucleus (Jans and 
Hubner, 1996). In the filamentous fungal system (Aspergillus nidulans), the Hap complex 
consisting of subunits B, C and E, are a class of DNA binding transcription factors. HapB 
was shown to possess an NLS at its C-terminus, outside the conserved region required for 
both DNA binding and interaction with the other subunits, HapC and HapE. Although 
HapC and HapE do not carry an NLS, they were shown to translocate to the nucleus in 
the presence of HapB, suggesting that the mechanism of nuclear entry was by 
complexing with HapB and “piggy-backing” on the NLS of HapB as a heterotrimeric 
DNA binding complex (Steidl et al., 2004; Kato, 2005).  
 
Phosphorylation is known to affect the affinity of a cargo protein for its receptor, and 
thereby influence the outcome of the subcellular localization of the cargo protein. The 
integrin-linked kinase (ILK), a major signaling integrator in mammalian cells, is 
phosphorylated by p21-activated kinase 1 (PAK1) at its threonine 173 and serine 246 
residues in vitro and in vivo. ILK is mainly localized in the cytoplasm and cytoskeleton, 
but has been detected in the nuclei under specific conditions. A functional NLS as well as 
NES motif was identified in the amino acid sequence of ILK and it was shown that the 
selective depletion of PAK1 caused an increase in nuclear accumulation of ILK. These 
results suggested that the ILK shuttles dynamically between the nucleus and cytoplasmic 
compartments of the cell, and that this subcellular translocation of ILK is regulated by 
phosphorylation by PAK1 (Chun et al., 2005; Acconcia et al., 2007). 
 
Phosphorylation sites close to the NLS have been shown to enhance or inhibit NLS 
activity of the protein through phosphorylation – mediated regulatory modules, also 
known as phosphorylation-regulated NLSs. Phosphorylation of the APC protein at a site 
immediately adjacent to the C-terminus of an NLS showed to negatively influence the 
nuclear import of the full- length protein (Zhang et al., 2000). Other studies showed that 
mimicking phosphorylation at a site adjacent to an NLS could decrease the affinity of the 
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NLS for importin α (Harreman et al., 2004). The nuclear import of the yeast transcription 
factor Swi5 is inhibited by phosphorylation of residues proximal to its two NLSs (Moll et 
al., 1991) and this was confirmed by Harreman et al. (2004). 
 
The nuclear localization of SV40 large T-antigen (T-ag) is subject to regulation by cell 
cycle-regulatory kinases, casein kinase II (CKII) and cdc2-kinase, at sites that are within 
the vicinity of the NLS, and this determines both the rate and the absolute amount of T-ag 
that accumulates in the nucleus (Jans and Hubner, 1996). Phosphorylation at the CKII site 
at S112 increases the rate of NLS-dependent nuclear import, and phosphorylation by 
cdc2-kinase at T124 inhibits nuclear import. It is understood that phosphorylation at these 
sites may modulate the recognition of the NLS by importin-α and that there is no direct 
interaction of the phosphorylated residues with the importin receptor. This regulatory 
module for T-ag nuclear transport is referred to as the ‘CcN motif’ (‘C’ for CKII, ‘c’ for 
cdc2-kinase and ‘N’ for NLS) and is also found in c-myc (human), B-myb (human) and 
p110RBI (mouse) (Fontes et al., 2003).  
 
Phosphorylation of the importin transport machinery may be involved in the regulation of 
nuclear import of proteins. Phosphatase inhibitors okadeic acid and microcystin were 
shown to inhibit transport mediated by β-importin and this inhibition was partially 
reversed by the protein kinase inhibitor staurosporine. The phosphatase inhibitors 
mentioned above, did not have any effect on substrate binding by the α/β importin 
complex, or the association of this complex with the NPC. This suggested that 
phosphorylation of a component of the nuclear transport machinery could inhibit nuclear 
transport of NLS-mediated proteins and that this may be a global mechanism utilized by 
cells to negatively regulate nucleocytoplasmic trafficking (Kehlenbach and Gerace, 
2000). The importin α/β-dependent nuclear transport can also be affected by various cell 
cycle phases in a manner that is independent of phosphorylation. A decrease in the 
efficiency of the α/β-transport machinery was observed at the early S, G2/M and M1/G1 
phases (the cell cycle phases are discussed in the next section), thereby suggesting that 
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the nuclear protein import pathways are also regulated in harmony during cell cycle 
progression (Yasuhara et al., 2004).   
 
1.1.6 The Cell Cycle Control System 
The cell cycle control system is a biochemical device comprised of a set of interacting 
proteins that induce and coordinate the processes involved in the cell cycle. A number of 
signals exist, which function to stop the cell cycle at specific checkpoints. Signals that 
arrest the cycle usually act on the G1 control point, which is referred to as the ‘G1 
checkpoint’ in higher eukaryotes, whereas in yeast this control point is referred to as 
‘start’. In a continuously cycling cell the G1 checkpoint is the point where the cell-cycle 
control system triggers the S phase and the G2 checkpoint is where it triggers the 
initiation of the M phase (reviewed in Alberts et al., 1994; King and Cidlowski, 1998; 
Schafer, 1998). 
 
Two main families of proteins participate in the cell cycle control system, namely the 
cyclin-dependent protein kinases (Cdk) and the cyclins (Kohn, 1999; Kovarova et al., 
2003). The Cdks are responsible for inducing the various downstream processes by 
phosphorylating selected proteins on serines and threonines, whereas the cyclins are a 
family of specialized Cdk-activating proteins that are known to be highly unstable and 
continuously ‘cycling’ during the cell cycle. Four major cyclins (D, E, A and B) are 
produced sequentially as the cells proceed through the cycle. Entry into mitosis requires 
the association of cyclin B, with cdc2-kinase (cell division cycle 2, also known as cdk1; 
Cdc28 in budding yeast), and this results in the activation of cdc2-kinase (also known as 
p34cdc2). In eukaryotic cells, the mitotic phase is initiated by the activation of the p34cdc2 
protein kinase, which rises to a high level at the onset of M phase and remains high 
throughout most of this process (Moreno and Nurse, 1990; Kohn, 1999; Kovarova et al., 
2003).  
 
In the eukaryotic system the G2 to M phase transition in the cell cycle is controlled by the 
M-phase promoting factor (MPF). Mitotic cyclin accumulates gradually during the G2 
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phase and binds to cdc2 to form the MPF complex. Before mitosis, cdc2-Cyclin B1 
complexes are held in an inactive state by cdc2 phosphorylation at Thr 14 and Tyr 15.  
Phosphorylation of the complex is catalyzed by Wee1, Myt1 and related protein kinases. 
Activation of the MPF complex is initiated by the dephosphorylation of Tyr 15 by cdc25 
phosphatase and inhibition of Wee1-like kinases. Other mechanisms that control the 
dephosphorylation of cdc2 exist and include the protein kinase, Plx, which 
phosphorylates cdc25 in mitosis (Jin et al., 1998; Kohn, 1999).  
 
Evidence from human cells and starfish oocytes support the possibility that initiation of 
mitosis is not only accompanied by cdc2 dephosphorylation, but also by changes in the 
subcellular localization of cyclin B1 (Jin et al., 1998; Porter and Donoghue, 2003). 
During S phase and G2, cyclin B1 accumulates in the cytoplasm. Just before mitosis, the 
majority of cdc2-cyclin B1 complexes are found in the nucleus. Since many of the key 
substrates for the cdc2-Cyclin B1 complex are found in the nucleus, this shuttling of 
cdc2-Cyclin B1 complexes between nucleus and cytoplasm may be necessary to control 
mitosis. Interestingly, Cyclin B1 does not have an NLS, but has a leucine rich NES which 
binds to an export mediator, CRM1, and enables its export from the nucleus to the 
cytosol. The NES is found within a CSD and phosphorylation of four specific serine 
residues found within the NES inhibited binding of the NES to CRM1. The mechanism of 
nuclear localization of the cyclin B1-cdc2 complex is speculated to involve a “piggy-
back” mechanism, through the interaction of the cyclin B1-cdc2 complex with cyclin F 
which translocates into the nucleus through two functional NLSs (Kong et al., 2000; 
Yang et al., 2001; Porter and Donoghue, 2003).  
 
A protein that plays a significant role in the transition of cells from the G0 phase to the G1 
phase of the cell cycle, and in the continuing passage through the early G1 phase is CKII 
(Pyerin, 1994). CKII is a widely distributed cyclic-AMP-independent protein kinase, 
which phosphorylates proteins on their serine and threonine residues (Dingwall and 
Laskey, 1991) and which is itself phosphorylated extensively in mitotic cells, as well as 
likely to be regulated by cdc2-kinase (Bosc et al., 1995). The regulation of CKII by cdc2-
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kinase may mean that CKII is regulated during cell division, and is thus, likely to mediate 
some effects of MPF (Mulner-Lorillon et al., 1990). 
 
1.1.7 The Heat Shock Response  
The challenges cells face during their life cycle include starvation, infection, changes in 
their physical or chemical condition and genotoxic damage, all of which can induce acute 
and/or chronic stress. Studies in Drosophila salivary glands showed that an increase in 
temperature of a few degrees above the physiological level caused the induction of a 
specific group of molecular chaperones termed ‘heat shock proteins’ (Hsp) and the 
protective mechanism was termed the heat shock response (Sørensen et al., 2003). Both 
prokaryotic and eukaryotic systems react to the heat shock response, which is required to 
preserve cellular function and homeostasis. Although chronic exposure of extreme stress 
is harmful to the cell, the resultant induction of Hsps is beneficial in instilling stress 
tolerance as well as providing cytoprotection against stress-induced molecular damage. 
Moreover, transient exposure to high temperatures was found to bring about a cross-
protective effect to the cell against sustained, normally lethal exposures to other forms of 
stress (as reviewed in Santoro, 2000; Pockley, 2003; Sørensen et al., 2003).  
 
Under normal non-stressful conditions the heat shock transcription factor (HSF) exists as 
a cytoplasmic, transcriptionally inactive, non-DNA binding monomer (Pirkkala et al., 
2001; Pockley, 2003). Four forms of HSF have been identified in vertebrates, of which 
only HSF1 and HSF2 are conserved, with HSF1 being the main heat shock factor 
involved in stress response, and HSF2 being selectively induced during early 
developmental stages. As shown in figure 1.2, the heat shock response stimulates the 
assembly of HSF1 into active homotrimers (oligomerization) and subsequent 
translocation into the nucleus, where they are capable of binding to the consensus heat 
shock element (HSE) located in the promoter region of the heat shock genes (Jacquier-
Sarlin et al., 1994; Hong et al., 2001; Pirkkala et al., 2001; Pockley, 2003).  
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HSF is phosphorylated further, and Hsp mRNA is transcribed and leaves the nucleus for 
the cytosol where new Hsp protein is synthesized (Kiang and Tsokos, 1998; Santoro, 
2000). A number of molecular chaperones including the heat shock proteins 70 and 90 
(discussed in further sections) play a role in modulating the activation of HSF1 by 
forming stable complexes with HSF1 and by stabilizing the monomeric conformation of 
HSF1 (Shi et al., 1998; Zou et al., 1998; Dai et al., 2003). Modulation of the transcription 
of heat shock genes is also maintained during non-stressful conditions such as during 
progression through the cell cycle, development and differentiation of the cell, or 
following exposure of the cell to molecules that regulate cell proliferation (Santoro, 2000; 
Pockley, 2003). 
 
1.1.8            Heat Shock Proteins 
Heat shock proteins are highly conserved, ubiquitous, and abundant in nearly all the 
subcellular compartments. They are divided into different families according to molecular 
size in kilodaltons (Hsp 100, Hsp 90, Hsp70, Hsp 60, etc) (Santoro, 2000). The Hsps, 
mainly Hsp70 and Hsp90 play a direct role in the autoregulation of the heat shock 
response because, as described in section 1.1.7, they are bound to the inert form of HSF 
within the cytosol under unstressed conditions. It is the stress signal, which is usually in 
the form of an influx of non-native proteins, that causes the release of HSF from the 
Hsps, and the resultant stress-induced transcription (Shi et al., 1998; Zou et al., 1998; 
Santoro, 2000; Pockley, 2003).  
 
Abrupt increases in temperature produced aggregation of non-native proteins within 
inclusion bodies in an E. coli mutant strain that was defective in the heat shock response 
(Gragerov et al., 1991). This suggested that the Hsps, among other molecular chaperones, 
were essential elements in the reduction of such intracellular aggregation processes. The 
Hsps reversibly interact with nascent chains to minimize off-pathway interactions and 
thereby increase the yield of native folded protein (Smith et al., 1998). Hsps are also 
involved in the protection of proteins from irreversible denaturation caused by heat and 
other stressors such as exposure to heavy metals or viral infections, as well as assisting 
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them in renaturation. In accordance with this conclusion, most members of the Hsp 
family were found to be over expressed under physiological as well as stressed conditions 
(as reviewed by Lindquist and Craig, 1988; Santoro, 2000; Sørensen et al., 2003). 
 
Besides their intracellular chaperoning tasks, members of specific heat shock protein 
families such as Hsp60, Hsp70 and Hsp90, are regarded as highly immunogenic to the 
host’s cellular immune system (Multhoff et al., 1998). An involvement of heat shock 
proteins in several autoimmune diseases and in anti-cancer immune responses has also 
been reported (Multhoff et al., 1998). Hsps have also been shown to protect the cell from 
injury during metabolic stress (Williams et al., 1993), inflammation (Polla et al., 1998), 
viral infection (Amici et al., 1994) and ischemia (Mestril et al., 1994). 
 
Hsps are also involved in protein translocation across various organelles such as the ER 
and the mitochondria. A number of mitochondrial proteins are encoded by nuclear genes, 
synthesized in the cytoplasm, and then transported across one or both mitochondrial 
membranes as described in section 1.1.3. Proteins are translocated across the 
mitochondria in a linear manner as unfolded chains, and both cytoplasmic as well as, 
mitochondrial heat shock proteins participate in the unfolding and refolding pathways 
(reviewed in Bursac and Lithgow, 2006; Zimmermann et al., 2006).  
 
1.1.9 Hsp70 
One of the most studied Hsp families is the 70 kDa Hsp (Hsp70), whose structure is 
widely conserved through evolution from bacteria to man, indicating an important role in 
the survival of the organism (Lindquist and Craig, 1988). In the mammalian system, the 
Hsp70 family is composed of four members: Hsc70 (heat shock cognate), which is 
constitutively expressed, the inducible Hsp70, BiP (immunoglobulin heavy-chain binding 
protein), and mtHsp70 (mitochondrial Hsp70). For the purposes of this study, ‘Hsp70’ 
will be used as a general term indicating the collective family of Hsp70 proteins 
including Hsc70. Any specific member of the Hsp70 family will be indicated by the 
appropriate description, e.g. Hsc70.  
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Figure 1.2: The mechanism of heat shock response in humans (adapted from Kiang and 
Tsokos, 1999). Heat shock factor (HSF) that resides in the cytosol under normal conditions is usually 
found bound to heat shock proteins (Hsp) and inactive. Under stress conditions, HSF separates from 
Hsp and are phosphorylated by protein kinases. They also oligomerize to form trimers in the cytosol 
that enter the nucleus and bind to heat shock elements (HSE) in the promoter region of the HSP gene. 
HSF is further phosphorylated by HSF kinase and the HSP mRNA is transcribed, which translocates 
to the cytosol and new Hsps are synthesized. HSF also translocates to the cytosol and remains bound 
to Hsp until the cell undergoes stress again.  
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The members of the Hsp70 family have been found to be compartment specific; Hsc70 
and inducible Hsp70 are localized in the cytosol, whereas BiP and mtHsp70 are found in 
the ER and mitochondrial matrix, respectively (Fink, 1999). This subcellular localization 
is essential for the coordinated action of these proteins in the translocation of 
polypeptides across membranes (Arispe and De Maio, 2000). Hsp70 is known to localize 
to the nucleus where it regulates the activity of certain nuclear DNA-binding transcription 
factors (Diehl et al., 2003). The presence of a functional NLS within the C-terminus of 
Hsp70 has been alluded to, as well as a role for Hsp70 in piggybacking proteins devoid of 
an NLS into the nucleus. The fusion of a C-terminal Hsp70 peptide and the p50 subunit 
of NF-κB, a key transcriptional regulator of inflammatory responses, allowed for the 
nuclear translocation of the NF-κB subunit, and its interaction with DNA (Fujihara and 
Nadler, 1999). Hsc70 accumulates in the nucleus and nucleolus after heat stress, and a 
functional NLS and NES have been identified in this heat shock protein. It is suggested 
that the NLS could be capable of functionally masking the NES, as a mechanism of 
nucleocytoplasmic traffic regulation of Hsc70 (Tsukahara and Maru, 2004). Hsc70 has 
also been reported to be involved in the regulation of the subcellular localization of a 
temperature sensitive p53 mutant p53Val-135. The temperature sensitive mutant 
accumulated in the nucleus at 32oC and acted like the unmutated form, but it was shown 
to be sequestered in the cytosol at 37oC. It was postulated that the association of p53Val-135 
with Hsc70 at 32oC and not 37oC inhibited its interaction with the nuclear import receptor 
(Akakura et al., 2001).  
 
Hsp70 proteins are composed of two functionally coupled domains. The N-terminal 
ATPase domain (44 kDa) binds ATP with high affinity in the presence of potassium or 
magnesium and mediates the hydrolysis of ATP. This process is responsible for the 
regulation of substrate recognition (Rudiger et al., 1997). The C-terminal domain consists 
of two functional subdomains, one of which (18 kDa) recognizes and binds substrate 
polypeptides, and the other (10 kDa) forms a lid over the peptide-binding pocket 
(Rudiger et al., 1997). The ATP-bound form of Hsp70 binds and releases substrate 
rapidly, resulting in a low overall affinity of Hsp70 for substrate, whereas the ADP-form 
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binds substrate slowly but more stably (Palleros et al., 1991). The regulatory motif, 
EEVD at the C-terminus is conserved among nearly all the eukaryotic cytosolic Hsp70s 
(Multhoff et al., 1998). Deletion or mutation of EEVD affects the ATPase activity, the 
ability to interact with substrate, and interferes with the ability of the mutant Hsp70 to 
interact with HDJ-1 in the refolding of denatured firefly luciferase (Freeman et al., 1998). 
 
Hsc70 is essentially involved in the folding and refolding of proteins, in maintaining their 
unfolded/transport state, and in the elimination of non-functional proteins through a cycle 
of ATP binding, hydrolysis and nucleotide exchange (Johnson et al., 1998). The 
inducible Hsp70, on the other hand, is expressed when cells are exposed to stress and the 
feedback regulation of inducible Hsp70 contributes to the overall Hsp70 abundance 
needed to maintain efficient chaperoning activity. The increased abundance of Hsp70 
under stress conditions helps to stabilize non-native polypeptides through the binding of 
exposed hydrophobic peptide segments on partially unfolded proteins, or newly 
synthesized proteins, as well as during protein translocation and degradation (Rudiger et 
al., 1997; Tutar et al., 2006). It has been reported that both normal and cancer cells 
require Hsc70 to be viable, and that cancer cells have an additional requirement for the 
inducible Hsp70 (Nylandsted et al., 2000; Rohde et al., 2005).  
 
The mammalian Hsp70 is believed to interact with the growing polypeptide chain as it 
emerges from the ribosome, thus facilitating its exit and preventing premature 
aggregation (Hartl and Hayer-Hartl, 2002). Hsp70, through its refolding and degradation 
activities, was shown to reduce the levels of aggregation and toxicity of α-synuclein, a 
natively unfolded protein that can self-aggregate and form oligomers, which pose a risk 
in neurons for the development of Parkinson’s disease (Klucken et al., 2004). Hsp70 was 
also shown to associate with newly synthesized Huntingtin protein and play a role in 
suppressing the aggregation of this protein, which is associated with Huntington’s disease 
(Jana et al., 2000) 
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Cell surface localization of Hsp70 related proteins is postulated to be involved in chronic 
inflammatory lesions of several experimental autoimmune diseases, however, 
contradictory findings have demonstrated that members of the Hsp70 family possess the 
ability to protect tissues from the deleterious effects of inflammation (Jacquier-Sarlin et 
al., 1994). Such protection is believed to involve prevention of DNA strand breaks 
induced by reactive oxygen species and lipid peroxidation as well as protection of 
mitochondrial structures and functions. The processing and presentation of bacterial and 
tumoural antigens, is another factor contributing to the protection offered to the immune 
system by the Hsp70 family (Multhoff et al., 1998).  
 
Evidence is also beginning to suggest a likely role for heat shock proteins, especially 
Hsp70, in cell cycle control under normal conditions. Studies conducted by Nakamura et 
al. (1999) demonstrate an interaction between Hsc70 and p27Kip1, an inhibitor of cyclin-
dependent kinase (CDK), during G1/S transition. Cell cycle transitions require the 
sequential activation of CDKs and inactivation of CDK inhibitors. Complex formation of 
Hsc70 and p27Kip1 was shown to be cell cycle dependent and maximum accumulation 
occurs at the G1/S transition where levels of p27Kip1 were found to be dramatically 
decreased (Nakamura et al., 1999).  Investigations by Diehl et al. (2003) suggest the 
association of Hsc70 with newly synthesised cyclin D1 (the regulatory subunits of the 
CDK4/6 kinase) and the direct involvement of Hsc70 with cyclin D1 in a mature, 
catalytically active cyclin D1/CDK4 holoenzyme complex.  
 
Ectopic expression of Hsc70 has been shown to increase the cyclin D1 steady state levels, 
thereby increasing its availability to activate its catalytic partner CDK4. An Hsc70 mutant 
lacking ATPase activity, Hsc70 K71E, failed to stabilize cyclin D1, confirming that 
Hsc70 chaperone function is required for cyclin D1 maturation (Diehl et al., 2003). The 
same authors also report the identification of a majority of co-purifying Hsc70 found 
where newly synthesized cyclin D1 is preferentially localized, implying that Hsc70 is 
involved in the folding of cyclin D1 prior to its assembly into complexes with CDK4. It 
has also been suggested that the necessity for coexpression of Hsc70 along with cyclin 
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D1 insinuates that Hsc70 may be a limiting factor when cyclin D1 is over-expressed 
(Diehl et al., 2003).  
 
Cdc2-kinase has been shown to interact with Hsp70-2 gene (expressed only in 
spermatogenic cells) in mouse testis cells, it was concluded that Hsp70-2 acts as a 
molecular chaperone for cdc2-kinase, and is required for its formation (Zhu et al., 1997). 
Another key molecule of the cell cycle control system is the retinoblastoma protein 
(pRB), which acts as a suppressor molecule by suppressing transcription in its 
nonphosphorylated or hypophosphorylated state, while bound to the E2F (eukaryotic) 
family of transcription factors. G1-Cdk is required to phosphorylate pRB and in this way 
activates E2F-dependent transcription of S-phase genes subsequently allowing for DNA 
synthesis (Inoue et al., 1995). Hsc70 has been shown to bind selectively to 
nonphosphorylated pRB, thereby rendering it unsusceptible to in vitro phosphorylation 
(Helmbrecht et al., 2000).   
 
Various co-chaperones modulate the ATPase activity of Hsp70 and thus influence the 
affinity of the chaperone for polypeptide substrates (Hartl, 1996). In eukaryotes, the 
Hsp70 co-chaperone, Hsp40, stimulates the hydrolysis of ATP thereby stimulating the 
ATPase activity of Hsp70. Nucleotide exchange factors such as BAG1 a (Bcl2-associated 
anthanogene) promote nucleotide exchange thereby enhancing the ATPase activity of 
Hsp70 (reviewed by Hohfeld, 1998; Hennessy et al., 2005; Bracher and Brodsky, 2006).  
In E. coli, however, this process is regulated by the ATPase-activating protein DnaJ 
(bacterial homolog of Hsp40) and a nucleotide exchange factor GrpE. Only in the 
presence of both proteins, is DnaK (bacterial homologue of Hsp70) able to undergo 
efficient cycles of ATP-binding and hydrolysis. Hip (Hsp70 interacting protein) is a 50-
kDa cytosolic protein that stimulates the assembly of the Hsp70-Hsp40-substrate 
complex. Hip has been found to interact with the ATPase domain of Hsc70 and is capable 
of stabilizing its ADP-bound conformation such that the unfolded polypeptide has more 
time to attain its proper conformation before being released from the chaperone complex 
(reviewed in Hennessy et al., 2005; Rosser and Cyr, 2006; Bracher and Brodsky, 2006). 
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Once it is released, the polypeptide either folds to its native state, or is passed on to other 
molecular chaperones, which includes the Hsp90 chaperone machinery. 
 
1.1.10 Hsp90 
The Hsp90 family of proteins is one of the most abundant cytosolic protein families in all 
eukaryotic cells (~ 2% of cytosolic proteins) and is essential for viability, in contrast to its 
eubacterial homolog HtpG, which is dispensable (Frydman, 2001). The Hsp90 chaperone 
family includes Hsp90 (90 kDa heat shock protein) of the eukaryotic cytosol, termed 
Hsp90α and β in humans (major and minor isoforms respectively), Hsp86 and Hsp84 in 
mice, Hsp83 in Drosophilia, Hsc82 and Hsp82 in yeast, and as mentioned above, HtpG in 
bacterial cytosol (Young et al., 2001). Hsp90 is associated with the folding of signal-
transducing proteins such as steroid hormone receptors and protein kinases, and is 
required for the maintenance of most proteins in vivo. It is a homodimer with both the N-
terminus and C-terminus being implicated in the binding of substrate polypeptides 
(reviewed in Pearl and Prodromou, 2006).  
 
There are two ATP binding sites within the N- and C- terminal domains of Hsp90, and 
ATP hydrolysis is crucial to the functioning of Hsp90 in vivo (Csermely and Kahn, 1991; 
Csermely et al., 1993; Panaretou et al., 1998; Young and Hartl, 2000; Söti et al., 2002; 
Johnson et al., 2007). The ATPase activity of human Hsp90 is very weak but binding of 
Hsp90 to certain client proteins like GR has been shown to increase the ATPase activity 
of Hsp90 up to 200 times (McLaughlin et al., 2002). Within the eukaryotic cytosol, 
Hsp90 is known to interact with a variety of co-chaperone proteins that assemble into a 
multichaperone complex, and these co-chaperones may or may not modulate Hsp90 
activities. The Hch1/Aha1 proteins have been identified as Hsp90 co-chaperones, 
accelerating the ATPase activity of yeast Hsp90 to 12 times its basal level (Panaretou et 
al., 2002). Cdc37 (p50) is a co-chaperone and an inhibitor of the Hsp90 ATPase activity, 
and this suppression is restored to normal levels when Cdc37/p50 is displaced by Cpr6 
(Siligardi et al., 2002). The immunophilin, FKBP59, showed little effect on the basal 
ATPase activity rate of Hsp90, but increased the client protein-stimulated rate 
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considerably. This was in contrast to p23, another Hsp90 co-chaperone involved in 
stabilizing the Hsp90-GR complexes. Both the basal and the client protein-stimulated 
ATPase activity of Hsp90 was inhibited by binding of p23, and it was further proposed 
that p23 may play an important role in arresting Hsp90 in a high-affinity state for client 
proteins (McLaughlin et al., 2002; McLaughlin et al., 2006).  
 
Crystallographic as well as biochemical studies of Hsp90 and its interactions with co-
chaperones have contributed greatly to the understanding of how its ATP hydrolysis 
contributes to its interactions with co-chaperones and substrates (Prodromou et al., 1997; 
Stebbins et al., 1997; Meyer et al., 2003; Harris et al., 2004; Ali et al., 2006; Johnson et 
al., 2007). The ADP-bound form of Hsp90 is described as ‘relaxed’ and hence ideal for 
client protein loading, whereas the ATP-bound form of Hsp90 is described as a ‘closed’ 
conformation because it is capable of tightly retaining the substrate. The efficient release 
of the substrate from Hsp90 is thus carried out by the conversion of the ATP to ADP 
state, and this regulation of the ATPase activity of Hsp90 by various co-chaperones 
allows for optimal binding and releasing of the substrate (Young and Hartl, 2000; 
McLaughlin et al., 2002; Siligardi et al., 2002; McLaughlin et al., 2004). Note that this is 
in contrast to the ATP regulated substrate-binding cycle of Hsp70 described in section 
1.1.9. The benzoquinone ansamycin antibiotic geldanamycin blocks this cycle by 
maintaining Hsp90 in an ADP-bound state, thereby acting as a specific inhibitor of Hsp90 
(Panaretou et al., 1998).  
 
Most co-chaperones bind to Hsp90 through a modular domain containing three 34 amino 
acid, helix-turn-helix tetratricopeptide repeat (TPR) motifs (Young et al., 2001). TPRs 
are protein-protein interaction modules found in varying numbers of tandem repeats and 
present in a number of proteins that are functionally unrelated (Blatch and Lässle, 1999). 
TPR motifs are associated mostly with multiprotein complexes, and have been shown to 
be vital for the functioning of chaperone, cell cycle and protein transport complexes 
(Blatch and Lässle, 1999). The specific recruitment of TPR-domain co-chaperones, which 
compete with each other for a binding site at the C-terminus of Hsp90, has been detailed 
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by crystallographic and biochemical studies of the various interactions (Young et al., 
1998; Scheufler et al., 2000).  
 
Although both Hsp70 and Hsp90 protein folding systems act independently of each other 
and on different substrates, some protein substrates are processed by Hsp70 and then 
transferred to Hsp90. This association between the two major chaperone machineries, 
Hsp70 and Hsp90 is coordinated by a number of co-chaperones, in particular, Hop - the 
Hsp70/Hsp90 Organizing Protein (reviewed by Odunuga et al., 2004). Much interest has 
been generated regarding the role of the Hsp90-Hsp70-co-chaperone heterocomplex in 
regulating various steroid receptors (SR) (reviewed in Cheung and Smith, 2000; Smith, 
2000; Pratt et al., 2004b). Different members of the SR family reside within the cytosol, 
and in the absence of their particular steroid hormone, exist in an inactive or non-
transformed state. Once the appropriate hormone diffuses into the cell, it binds to its 
receptor and results in the transformation of that receptor into an active transcription 
factor, which is capable of activating or repressing the expression of the steroid response 
genes. Binding of the SR to Hsp90 is believed to stabilize the receptor in an optimal 
conformational state that allows efficient binding of SR to the appropriate hormone 
(Picard et al., 1990; Kosano et al., 1998; McLaughlin and Jackson, 2002).  
 
The inactive forms of many SRs exist as relatively large complexes, whereas the active 
forms are homodimers with their steroid ligands tightly bound. Analysis of the purified 
inactive form of various receptors revealed the presence of the steroid-binding 
component, typically a 50-100-kDa polypeptide, a number of polypeptides between 50-
70 kDa, and Hsp 90 (Catelli et al., 1985). It is now known that a minimal system of five 
purified proteins, Hsp90, Hsp70, Hop, Hsp40 and p23, are essential for the assembly of 
the glucocorticoid receptor (GR)-Hsp 90 heterocomplex, which causes the simultaneous 
opening of the steroid binding cleft to access by the steroid (Kanelakis et al., 2002). The 
first step in this assembly is the ATP-dependent and Hsp40-dependent binding of Hsp70 
to the GR (stabilized by Hip), which primes the receptor for subsequent ATP-dependent 
activation by Hsp90, Hop and p23. This is followed by rapid binding of the primed GR-
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Hsp70 complex with Hsp90 and the rate-limiting step appears to be the ATP-dependent 
opening of the steroid binding cleft after Hsp90 binding (Kanelakis et al., 2002). p23 is 
an acidic 23 kDa protein which binds to, and stabilizes, preformed GR-Hsp90 
heterocomplexes in an ATP-independent manner. It has been postulated that p23 is not 
essential for GR folding to the hormone-binding site, but rather it stabilizes the GR-
Hsp90 heterocomplex once the ATP-dependent conformation of Hsp90 has been 
achieved (Yoshihiro et al., 1999). Other investigations by Kanelakis et al. (2002) suggest 
however that there is no difference between the ATP-bound, ADP-bound, and the 
unbound state of Hsp90 in its ability to bind to the primed GR-Hsp70 complex.  
 
According to the model of GR-Hsp90 heterocomplex assembly proposed by Pratt et al. 
(2001), the Hsp90/Hsp70 based chaperone complex (also known as a foldosome) 
converts the GR ligand-binding domain from a folded conformation (where the 
hydrophobic steroid binding cleft is closed and inaccessible to the hormone) to a partially 
unfolded conformation (in which the cleft is opened to access by steroid). Binding of p23 
stabilizes the GR-Hsp90 complex. The adaptor protein, Hop, then dissociates leaving the 
TPR acceptor site on Hsp90 open (Pratt et al., 2001).  
 
The presence of high molecular weight mammalian immunophilins (FKBP52, FKBP51 
and CyP-40) have been discovered in SR-Hsp90 heterocomplexes (Pratt and Toft, 1997). 
The major immunophilin in the GR-Hsp90 heterocomplex, FKBP52, is shown to bind to 
the free TPR acceptor site on Hsp90, after Hop dissociates from the GR-Hsp90 
heterocomplex (Pratt et al., 2001). In the final GR-Hsp90 heterocomplex, Hsp70 is 
usually absent or otherwise present at substoichiometric levels with respect to the 
receptor (Pratt et al., 2001).  
 
In unstressed cells, the localization of Hsp90 is predominantly in the cytoplasm, although 
some Hsp90 is present in the nucleus too (reviewed in Pratt and Toft, 1997; Pratt et al., 
1999; Pratt and Toft, 2003). Under stressful conditions Hsp90 translocates from the 
cytoplasm into the nucleus, a redistribution seen in some cell types but not in all (Pratt 
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and Toft, 1997; Langer et al., 2003). As mentioned in section 1.1.5, binding of Hsp90 to 
SR is known to sequester SR to the cytosol. Molybdate, which binds to Hsp90 and 
stabilizes SR-Hsp90 complexes in vivo, has been shown to trap the SRs in the cytoplasm 
of cells suggesting that in the presence of molybdate, the receptors cannot be imported 
into the nuclei (Yang and DeFranco, 1996; Pratt and Toft, 1997). On the basis of this 
experiment, Yang and DeFranco (1996) proposed that SR-Hsp90 complex formation was 
a dynamic process in which the components were constantly dissociating and being 
reformed under physiological conditions in the cell. This would be necessary to permit 
the association of SRs with the macromolecular components that participate in the 
delivery of receptors to their nuclear sites of action. Thus the stabilization of the complex 
by molybdate hinders this dynamic process, anchoring the Hsp90-SR complex to the 
cytosol and thereby suggesting a role for Hsp90 in protein movement mechanism. 
 
A second postulation regarding the role of Hsp90 in SR subcellular trafficking was made 
soon after, by Czar et al. (1997), based on experiments conducted with geldanamycin, 
which disrupts the function of Hsp90 and obstructs the steroid-dependent movement of 
GR from the cytoplasm to the nucleus. Thus it was also suggested that Hsp90 may itself 
be involved in the nuclear trafficking of SR as part of a transportosome, or it may be 
associated with the attachment of the SR to a trafficking machinery within the cell (Czar 
et al., 1997; Pratt et al., 2004a). In normal cells, the retrograde movement of particles 
toward the nucleus is known to occur along microtubules in a process that requires the 
molecular motor protein cytoplasmic dynein (Pratt, 1993). It is believed that the 
immunophilin, FKBP52, which attaches to the SR-Hsp90 heterocomplex, plays an active 
role in the transportosome function by linking the SR to cytoplasmic dynein, thereby 
generating retrograde movement toward the nucleus along microtubular tracks (Pratt et 
al., 2001). The Hsp90-chaperoned transcription factor, p53, is transported to the nucleus 
by cytoplasmic dynein. It was shown that Hsp90 binding immunophilins were 
responsible for linking p53-Hsp90 complexes to dynein. The nuclear translocation of p53 
was shown to be inhibited either when p53-Hsp90 binding was inhibited, or when 
immunophilin binding to dynein was inhibited (Galigniana et al., 2004)  
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Hsp90 is known to be heavily phosphorylated in animal cells, and in vitro studies have 
shown that the purified protein acts as a substrate for double-stranded DNA-activated 
kinase (Welch et al., 1983; Garnier et al., 2001). The phosphorylation of Hsp90 has been 
linked to its chaperoning activity with its phosphorylation appearing to be coupled with 
the release of Hsp90 from its client protein (Zhao et al., 2001). Ppt1 (a protein 
phosphatase found in the yeast system, and belonging to the PPP family of 
serine/threonine phosphatases) specifically dephosphorylates Hsp90 by directly 
interacting through its TPR domain. Deletion of the ppt1 gene results in the 
hyperphosphorylation of Hsp90 in vivo and consequently a decrease in the efficiency of 
its chaperone activity (Wandinger et al., 2006). 
 
A number of investigators have reported interactions between Hsp90 and various protein 
kinases. Studies conducted by Miyata & Yahara (1992) reported that Hsp90 co-purified 
with CKII in vitro and enhanced the activity of CKII.  Munoz and Jimenez (1999) 
demonstrated the possibility of an interaction between Hsp90 and cdc2 kinase in the 
fission yeast Schizosaccharomyces pombe, through the regulation of Wee1 by swo1, the 
gene coding for Hsp90. Wee1 encodes a tyrosine kinase that inhibits entry into mitosis by 
phosphorylation of cdc2 kinase, and swo1 acts as a suppressor of the over-expression of 
Wee1 (Munoz and Jimenez, 1999). Translocation of Hsp90α to the cell surface under 
high glucose conditions has been observed, and this has been postulated to be associated 
with phosphorylation of Hsp90α by the cAMP-dependent protein kinase A (Lei et al., 
2007).  
 
1.1.11 Hop (Hsp70-Hsp90-Organizing Protein) 
The 60-kDa scaffolding protein Hop, was first identified in the yeast system by Nicolet 
and Craig during a genetic screen for proteins that were involved in the heat shock 
response (Nicolet and Craig, 1989). The most well known function of Hop is its 
interaction with Hsp70 and Hsp90 within intermediate steroid receptor complexes and in 
this context, Hop was shown to be essential for the in vitro assembly of steroid receptors 
with Hsp90 (Smith et al., 1993; Dittmar et al., 1996). Homologues of Hop have also been 
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identified in humans (Honoré et al., 1992), mice (Blatch et al., 1997), rats (Demand et al., 
1998), insects (Adams et al., 2000), plants (Zhang et al., 2003), parasites (Webb et al., 
1997) and viruses (Cheng et al., 2002), and are classified as belonging to the stress-
inducible protein 1 (STI1) family (Nicolet and Craig, 1989). For the purposes of this 
study, the term ‘Hop’ will refer to the protein of mammalian origin. However, any 
reference to a specific species of the protein will be specified as such, for example, yeast 
Hop and mouse Hop.  
 
The various homologues of Hop are structurally characterized by the presence of nine 
TPR motifs; the TPR motifs are grouped into three domains, each comprising three TPRs. 
The N terminal TPR domain of Hop (TPR1) is required for Hsp70 binding (van der Spuy 
et al., 2000) and a central TPR motif-containing region is essential for Hsp90 binding 
(Chen et al., 1996b; Odunuga et al., 2003). In yeast Hop, it has been shown, however, 
that both TPR1 and TPR2B are required for Hsp70 interaction in vivo and that although 
TPR2A was sufficient for yeast Hop-Hsp90 interactions in vivo, an isolated TPR2A 
domain was not sufficient for Hsp90 binding unless it was combined with TPR2B (Flom 
et al., 2007). The TPR acceptor site on Hsp90 is comprised of five C-terminal residues 
MEEVD and Hsp70 is bound to TPR1 of Hop through the last eight residues of Hsp70 
(GPTIEEVD) (Scheufler et al., 2000; Brinker et al., 2002; Odunuga et al., 2003). A 
single mutation in TPR2A, R341E, was shown to disrupt the stable yeast Hop-Hsp90 
interactions (Carrigan et al., 2004; Flom et al., 2006). Furthermore, the deletion of an 
amino acid in TPR2A, A304 as well as one in TPR2B, A438, disrupted yeast Hop-Hsp90 
interaction and had a deleterious effect on yeast Hop activity in vivo (Flom et al., 2006). 
It is now accepted that there may be networks of interactions between Hop and the 
chaperones Hsp70 and Hsp90, apart from those mediated by the TPR domains, which 
allow for its functionality as a scaffolding protein (Odunuga et al., 2003; Carrigan et al., 
2005; Flom et al., 2007).  
 
For example, Hop also contains two smaller domains with characteristic DP repeat motifs 
comprising of four amino acid sequences, reflected in an arrangement that corresponds to 
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TPR1-DP1-TPR2A-TPR2B-DP2 (Prapapanich et al., 1998; Carrigan et al., 2005). 
Drosophila melanogaster Hop which lacks DP1 (dHop) can still bind to both Hsp70 and 
Hsp90 and even complement for and thereby rescue any growth defects in yeast that arise 
from a deficiency of yeast Hop, but interestingly, it cannot support GR function in yeast 
(Carrigan et al., 2005).  Moreover, the disruption of DP2 was shown to abrogate binding 
to Hsp70, suggesting that DP2 may interact with TPR 1 (Carrigan et al., 2005).  
 
Initial studies of Hop focused on its interaction with Hsp70 and Hsp90, mostly in the 
context of the assembly of this multichaperone complex in SR regulation. Hop appears to 
be regulated between a monomeric and dimeric state, interacting with the dimeric Hsp90 
as a dimer while associating with Hsp70 as a monomer (Hernandez et al., 2002). In yeast 
Hop, TPR2A was found to be necessary and sufficient for its dimerization properties in 
vitro (Flom et al., 2007). The assembly of the progesterone receptor (PR) and the 
glucocorticoid receptor (GR) requires the participation of Hsp70, which brings the 
substrate protein into contact with Hsp90 via the scaffolding function of Hop, as detailed 
in section 1.1.7. In yeast Hop, it was shown that both TPR1 and TPR2 domains had to be 
present on the same polypeptide, in order to maintain regulation of SR activation by 
Hsp70 and Hsp90 (Song and Masison, 2005).  
 
It has been suggested that yeast Hop may not be essential to mediate associations 
between Hsp70, Hsp90 and target proteins (Chang et al., 1997). Although comparisons 
between the yeast and mammalian Hsp90 chaperone complexes have shown conservation 
of many of the basic elements (Chang and Lindquist, 1994) this was in contrast to 
previous reports maintaining that mammalian Hop was necessary for efficient assembly 
of steroid receptor-Hsp90 complexes in vitro (Smith et al., 1993; Chen et al., 1996b; 
Dittmar et al., 1996). It was also shown that Hop was essential in integrating Hsp70-
Hsp90 interactions (Chen and Smith, 1998; Song and Masison, 2005). Moreover, purified 
Hsp90 and Hsp70 had not been shown to associate in a complex unless Hop was present 
(Chen et al., 1996b).  
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A conflicting report by Morishima et al. (2000), however, showed that Hop was not 
necessarily essential for GR folding by the Hsp90 chaperone machinery, but rather was 
capable of enhancing the rate of this phenomenon. Moreover, the authors showed that 
some GR activation was achievable with purified Hsp70 and Hsp90 in the absence of 
Hop. This suggested that both Hsps may interact directly with each other, but that Hop, 
being an adaptor protein, was able to bring Hsp70 and Hsp90 into better proximity with 
each other, thereby facilitating this interaction and ensuring an efficient folding 
machinery for substrate proteins (Morishima et al., 2000). This is also consistent with the 
latest published report on yeast Hop showing that certain mutations in yeast Hop caused a 
reduced recovery of Hsp70 in Hsp90 complexes in vivo (Flom et al., 2007).  
 
Taking into consideration the fact that dHop lacking DP1 cannot support GR activity in 
yeast, though it is still capable of binding to Hsp70 and Hsp90, it was interesting to note 
that the substitution of DP2 of human Hop by DP2 from dHop also failed to support GR 
activity. However, a substitution of DP2 from dHop with DP2 from human Hop was 
shown to regain the ability to enhance GR activity in yeast (Carrigan et al., 2005). It is 
possible therefore, that the DP2 domains may be responsible for Hop’s ability to enhance 
GR activity, besides its Hsp70 binding capabilities. Carrigan et al. (2005) have thus 
proposed a novel role for Hop in GR maturation in vivo, which is independent of 
Hsp70/90 binding and showed using chimeric studies, that DP2 is critical for this “new” 
role of Hop.  
 
1.1.12 Hop Modulates Hsp70 and Hsp90 Chaperone Pathways 
Despite its designated role as an ‘adaptor’ protein, Hop has been shown to actively 
modulate the functions of both Hsp70 and Hsp90 during its interactions with these major 
heat shock proteins. The impairment of an Hsp70-dependent and Hsp90-dependent 
chaperone pathway upon deletion of the respective TPR1 and TPR2 domain of yeast Hop 
was clearly demonstrated (Song and Masison, 2005). Deletion of TPR1 did not affect 
Hsp90 dependent client protein activity, and deletion of TPR2 also had no adverse effect 
on Hsp70 dependent client protein activity. These deletions, however, impaired client 
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protein folding pathways that involved both Hsp70 and Hsp90 (Song and Masison, 2005). 
This implied Hop was a not only a concurrent but also an independent regulator of Hsp70 
and Hsp90 chaperone pathways.  
 
A number of possible modifications of Hop on the Hsp90 chaperone pathway have been 
reported. The protein levels of Hop were seen to be increased in GR-Hsp90 complexes in 
the presence of Hsp90 inhibitor, geldanamycin, compared to GR-Hsp90 complexes in the 
absence of geldanamycin (Morishima et al., 2000). This may be due to the fact that 
geldanamycin-inhibited Hsp90 is in an ADP-bound conformation, which has higher 
affinity for Hop, than the ATP-conformation (Sullivan et al., 1997; Morishima et al., 
2000). GR incubated with geldanamycin in the absence of Hop displayed little 
association with Hsp90, whereas a more stable GR-Hsp90 association was detected in the 
presence of Hop (Morishima et al., 2000). The effect of Hop on GR-Hsp90 interactions in 
the presence of geldanamycin could either be due to the stable retention of Hsp90 by 
Hop, or due to an influence that Hop may be exerting on the geldanamycin-Hsp90 
conformation such that its affinity for GR is increased (Morishima et al., 2000).  
 
Furthermore, the exclusion of Hop has shown reduced activity, but not accumulation, of 
two structurally and functionally unrelated Hsp90 client proteins, the steroid receptor GR 
and the oncogenic tyrosine kinase v-Src (Chang et al., 1997). The exclusion of Hop did 
not, however, have an effect on the activity of c-Src which is a protein closely related to 
v-Src but less dependent on Hsp90. This suggests that Hop is an important factor in 
specifically promoting the maturation of Hsp90 client proteins (Chang et al., 1997) and 
could facilitate the transfer of certain substrates from Hsp70 to Hsp90 with greater 
efficiency. This is also consistent with suggestions made by Carrigan et al. (2005) 
regarding a novel role for Hop in enhancing GR maturation.  
 
It has been suggested that Hop may change its conformation during the assembly of the 
Hsp70-Hop-Hsp90 chaperone heterocomplex, due to the fact that the affinity and 
stoichiometry of Hsp70-Hop binding is dramatically affected by subsequent binding of 
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Hsp90. Although Hsp70 binds to Hop with a relatively lower affinity than Hsp90, this 
affinity is increased five fold in the presence of Hsp90 (Hernandez et al., 2002). Hsp90 
may thus be altering the conformation of Hop to one that better accommodates 
interactions of Hop with Hsp70. Another possibility is that Hop binding to Hsp90 may 
open up a new conformation of Hsp90 that provides contact sites for Hsp70 binding 
(Murphy et al., 2001; Hernandez et al., 2002). 
 
As part of the Hsp70-Hop-Hsp90 multichaperone machinery, Hop is also involved in a 
process called “chaperone-mediated autophagy”, one that targets cytosolic proteins to the 
lysosomes for degradation in response to stress conditions such as prolonged starvation or 
serum withdrawal (Agarraberes and Dice, 2001). Protein substrates have to become 
unfolded in order to be transported into the lysosomal lumen. Hop is speculated to be part 
of the strategy employed to stabilize the lysosomal Hsp70-substrate complex on the 
lysosomal surface in such a way that it allows for the complete unfolding of the substrate 
protein before import into the lysosome (Agarraberes and Dice, 2001). 
 
Apart from modulating their chaperoning pathways, Hop has also been reported to 
individually modulate both Hsp70 and Hsp90. Yeast Hop stimulates ATP hydrolysis of 
Hsp70, enhancing its ATPase activity by a factor of 200 and is a non-competitive 
inhibitor of Hsp90’s ATPase activity (Richter et al., 2003; Wegele et al., 2003). Studies 
conducted by Wegele et al. (2003) showed that yeast Hop was capable of accelerating 
ATP hydrolysis of Hsp70 to a greater extent than any other stimulation factor including 
yeast Hsp40. Even when yeast Hop was added to a pre-formed Hsp70-Hsp40 complex, it 
was still able to activate the ATPase activity of Hsp70 and moreover, yeast Hsp40 was 
shown to be unable to replace yeast Hop in a preformed Hsp70-Hop complex. Binding of 
yeast Hop to Hsp90 and Hsp70 allowed the activation of Hsp70 ATPase and inhibition of 
Hsp90 ATPase at the same time (Wegele et al., 2003). In the human system, Hop has not 
shown any effect on Hsp70’s ATPase activity, alone or in combination with Hsp90 (Chen 
et al., 1996b). Although human Hop does not affect Hsp90’s ATPase cycle, it has shown 
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to be capable of inhibiting the client protein-stimulated ATPase activity of Hsp90 
(McLaughlin et al., 2002). 
 
The ATPase inhibition of Hsp90 by yeast Hop is achieved by bringing about a 
conformational change in Hsp90, the restriction of its N-terminal dimerization, which is 
required for ATP hydrolysis. This was confirmed by studies demonstrating a Hop binding 
site in the N-terminal region of Hsp90, in addition to the already characterized C-terminal 
peptide region that interacts with the TPR2A domain of Hop (Richter et al., 2003). This 
also suggests that through the suppression of ATP-turnover by Hsp90, Hop plays a role in 
preparing Hsp90 for fresh “loading” of substrate protein (Prodromou et al., 1999; 
Siligardi et al., 2002). Interestingly, studies on yeast Hop have also suggested that the 
DP2 domain is important for the capacity of yeast Hop to modulate Hsp90’s functions 
(Flom et al., 2006).  
 
1.1.13 Hop’s Interactions Beyond Hsp70 and Hsp90 
A number of reports on various protein-protein interactions involving Hop, and which 
may or may not involve Hsp70 and/or Hsp90, have been published; a summary of the 
network of interactions involving Hop is schematically illustrated in figure 1.3. TPR-
mediated protein interactions of Hop are not exclusive to the Hsp70/Hsp90 
multichaperone complex. Studies done with Saccharomyces cerevisiae have shown that 
in the presence of non-fermentable carbon sources like ethanol and glycerol, yeast Hop, 
in addition to other Hsp90 co-chaperones Cpr7 and Cns1, interacts with Hsp104 through 
its N-terminal TPR1 domain independently of Hsp90 (Abbas-Terki et al., 2001). Hsp104 
is a stress tolerance factor, which acts in concert with Hsp40 and Hsp70 to reactivate 
denatured proteins (Glover and Lindquist, 1998). 
 
Yeast Hop has also demonstrated direct interactions with Cdc37, a co-chaperone of 
Hsp90 (Abbas-Terki et al., 2002). Yeast Hop is not essential for growth of yeast cells at 
30oC but growth impairment can occur at higher and lower temperatures or in the 
presence of minimal media (Nicolet and Craig, 1989; Smith et al., 1993). Under normal 
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conditions however, a combination of Cdc37 and yeast Hop mutations has shown to be 
synthetically lethal to yeast implying that their interaction may contribute to the vital 
functioning of yeast (Abbas-Terki et al., 2002). Cdc37 is a molecular chaperone as well 
as co-chaperone of Hsp90 involved in the prevention of aggregation of polypeptides and 
folding of protein kinases. Thus it is possible that the interaction of yeast Hop with Cdc37 
is a crucial step in the initiation of Cdc37 into the chaperone dependent-folding pathway 
(Lee et al., 2004). The interaction between yeast Hop and Cdc37 is speculated to occur 
via both TPR1 and TPR2 domains of Hop but possibly not on the same binding sites as 
those involved in binding of Hop to both Hsp70 and Hsp90 (Abbas-Terki et al., 2002). 
These findings were consistent with other reports showing the interaction of Hop with the 
mammalian homologue of Cdc37, p50, and the authors suggested the presence of a 
complex comprising of Hsp90, Hop and p50 in which one of the Hsp90 co-factors acted 
as the central component (Harst et al., 2005).  
 
Hop was shown to stimulate the nucleotide exchange of the eukaryotic chaperonin-
containing TCP1 (CCT), also known as the TCP-1 ring complex (TriC), which is 
involved in the proper folding of actins and tubulins (Gebauer et al., 1998). This 
interaction led to the interference of CCT’s substrate-associative capabilities. CCT 
cooperates with Hsp70 in refolding of luciferase in vitro, and this phenomenon is 
proposed to occur in vivo for certain substrates after translation or after stress-induced 
damage. The interaction of Hop with CCT was mediated through its C-terminal domain, 
in contrast to its interaction with Hsp70, which is mainly through its N-terminal domain, 
and this is consistent with the observation that the presence of Hsp70 did not affect Hop-
CCT interactions (Gebauer et al., 1998). 
 
A novel role of mouse Hop, in neuroprotection, has been proposed by (Zanata et al., 
2002; Coitinho et al., 2007). Recombinant mouse Hop was found to bind to Prpc (a 
protein whose expression is crucial to the propagation of neurological disease, in 
particular, Prion disease) both in vitro and in vivo. The interaction of Prpc with mouse 
Hop was found to transduce neuroprotective signals. Using behavioral studies in rats, it 
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was also shown that the interaction of mouse Hop with Prpc enhanced short term and long 
term memory formation, and the mouse Hop peptide 230-245 which was reported to 
interact with Prpc (Zanata et al., 2002) had a potent enhancing effect on memory 
performance (Coitinho et al., 2007). A number of other molecules have shown in vitro 
association with Prpc such as Hsp60, BiP, Bcl-2 and a 37/67-kDa laminin receptor 
(Martins et al., 2001), but physiological relevance in the form of neuroprotection has only 
been attributed to the Prpc-laminin complex. The laminin receptor-binding site on the 
Prpc molecule maps to a region of amino acids that is significantly distinct from that of 
the mouse Hop-Prpc binding domain. It is suspected that mouse Hop may therefore 
participate within a Prpc-laminin complex wherein association of Prpc with both 
molecules may supply an additive effect (Zanata et al., 2002). Interestingly, the amino 
acids 230-245 of mouse Hop that contain the Prpc –binding site, overlaps with TPR2A 
domain of Hop, and are known to contain crucial residues required for Hop-Hsp90 
interaction. 
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Figure 1.3: Functions of Hop in vivo (updated and adapted from Daniel et al., 2006). Although 
free Hop exists within the cell, most of Hop is bound to Hsp90 (A). The most well known function of 
Hop is as the Hsp70-Hsp90 co-chaperone, facilitating the transfer of the client protein from Hsp70 to 
Hsp90 (B). Transfer of the client protein from Hsp70 onto Hsp90 is followed by the dissociation of 
both Hop and Hsp70 from the multichaperone complex. The client protein is refolded by Hsp90 and 
then released, thereby freeing Hsp90 (C). The Hsp70-Hop-Hsp90 multichaperone machinery is 
involved in chaperone-mediated autophagy, facilitating the degradation of unfolded polypeptides (D). 
Free Hop interacts directly with Hsp104 which may involve Hsp40 (E). Hop also interacts directly 
with TriC (F). Hop has also been shown to interact with Cdc37, an Hsp90 co-chaperone, 
independently of Hsp90 (G).  Mouse Hop interacts with client proteins like the Prpc, and this 
interaction is believed to be localized to the plasma membrane (H). Hop has been captured in the 
nucleus under G1/S arrest of the cell cycle. It is believed to translocate to the nucleus (shown in 
dotted lines) through a potential bipartite NLS (I). The major chaperone partners of Hop, Hsp70 and 
Hsp90, have also been shown to translocate to the nucleus under specific conditions. It is thus 
speculated that Hop may be involved as a scaffolding protein within the nucleus facilitating the 
assembly of the Hsp70-Hsp90 chaperone heterocomplex. Hop may also have multiple nuclear 
functions, some of which may be independent of Hsp70 and Hsp90 (J). We further speculate that Hop 
may be interacting with Hsp70 and Hsp90 at the plasma membrane (K). Although Hop has been 
shown as a dimer in this figure, the stoichiometry of Hop in many of these interactions is unknown. 
Heat shock proteins are identified by their molecular weight stated as numbers. CP stands for client 
protein.  
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1.2 Motivation for this Study and Problem Statements    
         Associated Therewith 
Subcellular localization studies done on mammalian cells showed that mouse Hop was 
localized predominantly to the cytosol with a small amount of the protein also being 
found in the nucleus (Lässle et al., 1997; Longshaw et al., 2004). A greater nuclear 
translocation of mouse Hop was seen only under conditions of G1/S arrest or when 
nuclear export of the protein was inhibited, suggesting that mouse Hop was dynamically 
shuttling between the cytosol and the nucleus and that nuclear translocation of Hop was 
cell cycle regulated (Longshaw, 2002; Longshaw et al., 2004). Some reports have also 
shown the detection of about 6% of mouse Hop to be localized to the membranes (Zanata 
et al., 2002; Coitinho et al., 2007).  
 
Two NLS sequences were identified in the central region of mouse Hop, of which the 
bipartite NLS at K222-K239 was predicted to be functional (Blatch et al., 1997); this 
putative NLS, when fused to EGFP, was shown to be capable of translocating EGFP to 
the nucleus (Longshaw, 2002; Longshaw et al., 2004). However, the functionality of the 
NLS has not yet been established within the context of the Hop protein and critical 
residues within this NLS have not yet been mapped out. Human Hop has been found in 
the golgi apparatus and small vesicles in normal cells, and nucleolar localization of 
human Hop has only thus far been described in SV40-transformed cells (Honoré et al., 
1992). The chaperone partners of Hop, Hsp90 and Hsp70, although generally cytosolic, 
have both been detected in the nucleus under certain stressful conditions (Pratt and Toft, 
1997; Nollen et al., 2001; Langer et al., 2003). Since the Hsp70/Hsp90 chaperone 
heterocomplex has thus far been shown to be cytosolic, understanding the subcellular 
localization patterns of Hop is critical to understanding the nature of its biological 
interactions, both in the context of its co-chaperone capacity, as well as within complexes 
and roles that extend beyond Hsp70 and Hsp90. 
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Hop has previously been proposed to be a phosphoprotein due to various reports showing 
the elevation of acidic isoforms of human Hop after viral transformation (Honoré et al., 
1992) and mouse Hop after heat shock (Lässle et al., 1997). In vitro experiments done on 
mouse Hop showed that it contained two phosphorylation sites for CKII and cdc2-kinase 
at S189 and T198 respectively (Longshaw et al., 2000). However, Hop has thus far not 
been shown to be phosphorylated in vivo. Interestingly, both in vitro phosphorylation 
sites are located upstream of the predicted bipartite NLS thus constituting a postulated 
CcN motif (Longshaw et al., 2000; Longshaw, 2002). Therefore, similar to the regulation 
of subcellular localization patterns of SV40 large T-ag (Jans and Hubner, 1996), previous 
studies using phosphorylation mimic-derivatives of mouse Hop suggested that 
phosphorylation by CKII and cdc2-kinase may promote the nuclear import or cytosolic 
retention of mouse Hop respectively (Longshaw et al., 2004). Thus it is postulated that 
phosphorylation of mouse Hop is a key factor in regulating the assembly of the 
Hsp70/Hsp90 chaperone heterocomplex based on its possible regulation of the 
subcellular localization of mouse Hop.   
 
Hop is generally found complexed to Hsp90 and is known to interact with Hsp70 within 
this complex (Smith et al., 1993; Chang et al., 1997; Hernandez et al., 2002). The Hop-
Hsp90 complex may thus be a prerequisite for many of its biological functions within the 
cell. It is therefore, especially interesting to note that the proposed phosphorylation sites 
(S189 and T198) are immediately upstream of Hsp90 binding TPR2A domain of Hop, 
and that the proposed bipartite NLS site (K222-K239) overlaps with TPR2A. Figure 1.4 
shows the amino acid sequence of the TPR2A domain with a flanking C-terminal helix. 
The overlapping residues of the putative bipartite NLS with the TPR2A domain are 
shown in grey. This implies that the interaction of Hop with Hsp90 as a co-chaperone 
may be regulated by phosphorylation at one or both of these sites and that Hop-Hsp90 
complex may regulate, or may be regulated by, the subcellular localization of Hop under 
stressed or unstressed conditions.  
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KKQALKEKELGNDAYKKKDFDTALKHYDKAKELDPTNMTYITNQAAVYFEKGDYNKCRELCEKAIE 
 
VGRENREDYRQIAKAYARIGNSYFKEEKYKDAIHFYNKSLAEHRTPDVLKKCQQAEKILKEQERLA 
 
 
 
 
TPR 2A-1 TPR 2A-2 
TPR 2A-3 
225 259 
300 333 * * * 353 
287 
292 
222 
Figure 1.4: Partial amino acid sequence of Hop showing the predicted bipartite NLS, the 
TPR2A domain and a flanking C-terminal helix (Adapted from Daniel et al., 2006) TPR2A 
comprises of three TPR motifs (residues are shown by a thick black overline) denoted as TPR2A-1, 
TPR2A-2 and TPR2A-3 (Scheufler et al., 2000). The proposed NLS extends from K222-K239 
(Longshaw et al., 2000; 2004). The residues against a gray background are those which form part of 
the putative NLS and which overlap with TPR2A-1 motif. The major arm of the bipartite NLS is 
denoted by an asterisk under each residue. The residues shown in bold, K229, N233 and K301 form 
part of the carboxylate clamp and have been shown to be important for Hsp90 binding (Odunuga et 
al., 2003). 
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Based on the literature that has been published thus far on Hop, a number of questions 
have arisen regarding the factors regulating Hop’s involvement as a co-chaperone in the 
Hsp70/Hsp90 chaperone heterocomplex, such as its subcellular localization and its 
phosphorylation status. How does the subcellular localization of Hop affect its functions, 
particularly as a scaffolding protein and with regards to its Hsp partners? Is the postulated 
bipartite NLS functional within mouse Hop and what conditions prompt the nuclear 
translocation of Hop? Is Hop phosphorylated in vivo? How does stress affect both the 
phosphorylation status of Hop and its subcellular localization? How does phosphorylation 
of Hop and its subcellular localization affect its interaction with Hsp90? 
 
1.3 Primary Hypothesis 
The co-chaperone Hop is phosphorylated by cell cycle kinases in vivo, and its 
phosphorylation status regulates both its subcellular localization, as well as its 
fundamental function of assembling the Hsp70/Hsp90 multichaperone heterocomplex.  
 
1.4 Secondary Hypotheses 
(i) Hop is phosphorylated in vivo under normal and heat shock conditions. 
(ii) Hop co-localizes with Hsp70 and Hsp90 under heat shock conditions and this 
co-localization is different to that observable under normal conditions.   
(iii) Hop contains a functional bipartite NLS in vivo and functionality of this NLS 
affects Hop-Hsp90 interactions. 
(iv) Phosphorylation of Hop affects its interaction with Hsp90, and this in turn 
regulates the subcellular localization of Hop.  
  
 
 
 
CHAPTER 2 
 
THE PHOSPHORYLATION STATUS OF HOP 
 
 
 
 
“The most exciting phrase to hear in science, the one that heralds new discoveries, is not  
‘Eureka!’ (‘I’ve found it!’) but rather ‘hmm… that’s funny’ ” 
- Isaac Asimov 
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2.1 INTRODUCTION 
Post-translational phosphorylation of proteins catalyzed by protein kinases often plays a 
critical role in cell signaling and therefore acts as an important ‘molecular switch’ within 
the cellular environment. Previous reports have put forward suggestive evidence that Hop 
belongs to a phosphoprotein family (Nicolet and Craig, 1989; Honoré et al., 1992; Lässle 
et al., 1997; Longshaw et al., 2000) implying that phosphorylation of Hop may act as a 
signal for some of its biological functions in vivo. An acidic isoform of the yeast homolog 
of Hop, STI1, was reported which suggested that this protein was post-translationally 
phosphorylated (Nicolet and Craig, 1989). Shifts in the isoform composition of human 
Hop to more acidic isoforms after viral transformation (Honoré et al., 1992) and similar 
changes in isoform composition of mouse Hop after heat shock for 10 minutes at 42oC 
(Lässle et al., 1997), implied that phosphorylation of a sub-population of Hop may be 
stress-induced or stress-regulated. The co-chaperone, Hop, was shown to be 
phosphorylated in vitro by cell cycle kinases, CKII and cdc2-kinase, at positions S189 
and T198, respectively (Longshaw et al., 2000). Both these phosphorylation sites were 
located upstream of a potential bipartite NLS and mimicking phosphorylation at either 
site was found to have an effect on the subcellular localization of Hop in vivo (Longshaw 
et al., 2004).  
 
The main aim of this study was to derive conclusive evidence as to the phosphorylation 
status of Hop in vivo and to determine whether an acute heat shock response could 
modify its phosphorylation status, in NIH 3T3 mouse fibroblast cells.  
 
The specific objectives of this study were to: 
1. Successfully detect an acute heat shock response in NIH 3T3 mouse fibroblast 
cells using inducible Hsp70 as a marker. 
2. Determine the phosphorylated status of Hop in vivo using 2D gel electrophoresis 
and Western analysis as tools. 
3. Compare the phosphorylated status of Hop in vivo under normal and heat shock 
conditions. 
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2.2 EXPERIMENTAL PROCEDURES 
All general laboratory materials and specialized reagents used are as listed in the 
Appendix, Section A1. The generation of recombinant antibodies against the C-terminus 
of Hop is described in Appendix Section B1. All the cells used in the studies described in 
this chapter as well as subsequent chapters were obtained from cell lines, and were either 
NIH 3T3 mouse fibroblast cells or Baby Hamster Kidney (BHK) – 21 cells. 
 
2.2.1 Tissue Culture and Heat Shock of NIH 3T3 Mouse Fibroblast Cells 
NIH 3T3 mouse fibroblast cells were maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% heat inactivated fetal calf serum, penicillin 
(100 U mL–1) and streptomycin (100 U mL–1) in a humidified atmosphere, at 37°C with 
5% CO2. An acute heat shock response was obtained by treating the cells at 80% growth 
confluence to pre-warmed DMEM and then incubating for 10 to 30 minutes at 42oC 
(Kuhl and Rensing, 2000).  
 
2.2.2 Harvesting Cells for One-Dimensional (1D) and Two-Dimensional 
(2D) Gel Electrophoresis  
Cells were harvested at 80% confluency for 1D gel electrophoresis by trypsinization 
followed by three washes with phosphate buffered saline (PBS) pH 7.4. The harvested 
cells were resuspended in minimum volume of lysis buffer (50 mM Tris-HCl, 150 mM 
NaCl, 0.02% sodium azide, 100 µg mL-1 Phenyl methyl sulphonyl fluoride (PMSF), 1 µg 
mL-1 aprotinin and 1% Triton X-100) and incubated at 4oC for 10 minutes to allow lysis 
to occur. The lysate was centrifuged at 12000 g for 30 minutes at 4oC to remove insoluble 
cell debris, and the supernatant used immediately for 1D sodium dodecyl suphate 
polyacrylamide gel electrophoresis (SDS-PAGE). This was carried out by treating the 
lysate with SDS sample denaturing and reducing buffer (62.5 mM Tris-HCl, pH 6.8, 10% 
v/v glycerol, 2% w/v SDS, 5% v/v β-mercaptoethanol, 0.05% w/v bromophenol blue) 
and boiling for 5 minutes (Laemmli, 1970).  
 
For 2D gel electrophoresis, NIH 3T3 fibroblast cells growing at 80% confluency were 
harvested by scraping in ice cold PBS. The cell pellets obtained were resuspended into 
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2D lysis buffer (40 mM Tris-HCL, 8 M Urea, 4% Triton X-100, 1 µg mL-1 aprotinin and 
100 µg mL-1 PMSF) and lysed on ice for one hour. The lysate was centrifuged at 13000 
rpm for 30 minutes on a benchtop microfuge to remove insoluble cell debris. Protein 
concentration was determined using the 2D-Quant kit as described in section 2.2.4.1 and 
the protein samples were further processed for 2D gel electrophoresis using the 2D clean-
up kit that is described in section 2.2.4.2.  
 
2.2.3 SDS-PAGE 
Discontinous SDS-PAGE analysis was carried out according to Laemmli (1970). A 
(0.1%)-SDS-(4%)-PAGE stacking gel was pre-cast on top of a (0.1%)-SDS-(12%)-PAGE 
resolving gel in a Bio-Rad Protean III electrophoresis system. Protein samples were 
added to the SDS-PAGE sample denaturing buffer described in section 2.2.2 and heated 
to 95oC for 5 minutes. The protein samples were loaded onto the gel and resolved at 200 
V for 45 minutes in SDS-PAGE running buffer (0.025 M Tris, 0.0192 M glycine, 1% 
(w/v) SDS). The gel was removed and incubated with shaking for 1 hour in coomassie 
blue stain (0.1% (w/v) coomassie brilliant blue R-250, 40% (v/v) methanol, 10% (v/v) 
glacial acetic acid) and 3 hours in destain solution (40% (v/v) methanol, 10% (v/v) 
glacial acetic acid). 
 
2.2.4 2D Gel Electrophoresis 
2.2.4.1 Protein Quantitation 
Due to the presence of reducing agents like DTT, and other 2D-specific reagents, which 
can interfere with standard protein assays such as the Bradford assay, a specific 2D-
Quant kit (Amersham Biosciences, USA) was employed to quantitatively precipitate 
sample protein from the cell lysate, while leaving behind interfering contaminants in the 
solution. The standard procedure as detailed in the manufacturer’s instructions was 
strictly adhered to for the protein quantitation analysis using this kit. The procedure 
involved the pelleting of the protein by centrifugation steps and its resuspension into an 
alkaline solution of cupric ions that bound to the polypeptide backbones of all protein 
present. The assay then made use of a colorimetric agent which, when added to the 
reaction, bound to any unreacted cupric ions. The color density was thus inversely 
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proportional to the concentration of protein in the sample. Protein concentration was 
estimated by comparison to a standard curve generated using a standard BSA solution (2 
mg/mL) provided in the kit.  
 
2.2.4.2 Protein Clean-Up 
Protein precipitation using the 2D Clean-Up kit (Amersham Biosciences, USA) was 
employed to selectively separate proteins in the cell lysate from contaminating substances 
such as detergents, salts, lipids, phenolics and nucleic acids that can interfere with 
effective IEF. Manufacturer’s instructions were followed for this procedure, using 
‘procedure A’ for sample volumes of 1-100 µL containing 100 µg of protein per sample. 
The precipitated proteins obtained were resuspended in sample rehydration buffer (9 M 
Urea, 2% Triton X-100, 2% Ampholytes, 0.002% bromophenol blue, 100 mM DTT) to a 
final concentration of 1 µg/µL, and was ready to be processed by isoelectric focusing.  
 
2.2.4.3 Isoelectric Focusing (IEF) 
Total protein obtained after the protein clean-up procedure (120 µg) was applied onto an 
immobilized pH gradient (IPG) strip within the chambers of a Zoom® IPGRunner 
Cassette and rehydrated overnight as per manufacturer’s instructions. Rehydrated IPG 
strips were focused by performing IEF in triple distilled water. The applied electric 
potential (V) was increased in a step-wise fashion as follows: 200 V (20 minutes), 450 V 
(15 minutes), 750 V (15 minutes) and 1000 V (120 minutes), with a total power of 0.1 W 
strip-1 and current, 0.05 mA strip-1.  
 
After IEF, the IPG strips were removed from the Zoom® IPGRunner cassette and 
equilibrated in SDS-Equilibration buffer (1.5 M Tris-HCL, pH 8.8, 6 M Urea, 30% 
Glycerol, 2% SDS, 0.1% w/v bromophenol blue, 10 µg/µL) for 1 hour at room 
temperature with shaking. A 0.5% agarose gel containing a molecular weight marker well 
and a well for the IPG strip, was pre-cast on top of a (0.1%)-SDS-(12%)-PAGE resolving 
gel in a Bio-Rad Protean III electrophoresis system. The equilibrated IPG strip containing 
the protein samples was then carefully loaded onto the agarose gel, and SDS-PAGE 
analysis was conducted as described in section 2.2.3. This was followed by Western 
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analysis, which is described in section 2.2.5. When IPG strips with a linear pI range were 
used, the approximate pI’s of the spots resolved by 2D gel electrophoresis were estimated 
by calculating the distance migrated by the spot as a percentage of gel length and reading 
off the pI from a graph of ‘spot position’ vs pH generated by Amersham 
(www.amershambiosciences.com; refer to Appendix A2).  
 
2.2.5 Western Analysis 
2.2.5.1 Protein Transfer/Blotting onto Nitrocellulose 
Western analysis was carried out on the resolved proteins according to Towbin et al. 
(1979). Following electrophoresis, the gel was equilibrated in ice-cold transfer buffer (25 
mM Tris, 192 mM glycine, 20% (w/v) methanol) along with a nitrocellulose membrane 
and 3MM Whatman filter paper. The pre-equilibrated SDS-PAGE gel was placed against 
the nitrocellulose membrane, sandwiched between pieces of equilibrated 3MM Whatman 
filter paper, and the proteins transferred from the gel to the membrane in a small scale 
Bio-Rad Western transfer set (Bio-Rad, UK), in chilled transfer buffer at 100 V for 1 
hour. The transfer was kept chilled by the insertion of a cooling unit containing ice and 
continuous stirring on a magnetic stirrer. To determine whether the transfer was 
successful, the nitrocellulose membrane was stained with Ponsceau stain (0.5% (w/v) 
Ponceau S, 1% (v/v) glacial acetic acid) for 1 minute. The stain was removed by rinsing 
with distilled water. 
 
2.2.5.2 Chemiluminescence-Based Immunodetection   
After Western transfer of proteins onto a nitrocellulose membrane, the membrane was 
washed twice in TBS-Tween (50 mM Tris-HCl, pH 7.5, 150 mM NaCl and 0.2% v/v 
Tween-20) and blocked overnight in blocking solution (5% w/v non-fat milk powder in 
TBS-Tween) at 4oC. Proteins were then specifically detected by incubating the membrane 
with primary antibody diluted into blocking solution for 2 hours at room temperature 
with shaking. This was followed by four washes with TBS-Tween for 15 minutes each at 
room temperature with shaking.  
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The membrane was incubated with horseradish peroxidase (HRP)-conjugated secondary 
antibody for 1 hour at room temperature with shaking, followed by four washes with 
TBS-Tween for 15 minutes each as before. The membrane was then incubated with 
luminol based detection reagents (ECL Advance Western blot detection kit) for five 
minutes, and visualized using the Bio-Rad’s VersaDocTM Model 4000 imaging system.  
 
2.2.5.3 Primary and Secondary Antibody Dilutions 
Monoclonal mouse anti-human Hsp70 (inducible) was used at a dilution of 1:5000; 
Recombinant Anti-Hop at a dilution of 3:1000; HRP-conjugated sheep anti-mouse 
secondary antibody at a dilution of 1:5000; and HRP-conjugated anti-human F(ab’)2 
secondary antibody at a dilution of 1:50000 in blocking solution. 
 
2.2.6 Analysis of the Phosphorylated State of Hop In Vivo 
In order to satisfactorily determine the phosphorylation status of Hop in vivo, NIH 3T3 
cells were either treated with phosphatase inhibitors (PI), to limit or eliminate any 
dephosphorylation of Hop, or treated with shrimp alkaline phosphatase (SAP), which 
dephosphorylated any phosphorylated isoforms of Hop. Cell lysate obtained from the 
cells treated under each of the conditions specified, were comparatively analyzed using 
2D gel electrophoresis followed by Western analysis using antibodies generated against 
Hop (final concentration 2 µg/mL) 
 
For the treatment of cells with phosphatase inhibitors, NIH 3T3 cells were incubated with 
serine/threonine phosphatase inhibitor, okadeic acid, (diluted to 30 nM in DMEM) at 
37oC for 30 minutes (Bianchini et al., 1991; Zennadi et al., 2004) prior to heat shock or 
further lysis preparation for 2D gel analysis. Tyrosine phosphatase inhibitor, sodium 
vanadate (Huyer et al., 1996) was added into the lysis buffer to a final concentration of 2 
mM and the cells were then lysed as described in section 2.2.2, in preparation of 2D gel 
electrophoresis. 
 
SAP treatment was carried out by incubating cells that were not treated with any 
phosphatase inhibitors, with 10 U SAP in lysis buffer at 4oC for 1 hour followed by 
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centrifugation at 12000 g to remove insoluble cell debris (section 2.2.2). Protein samples 
obtained from both treatments described above were submitted to 2D gel electrophoresis 
and Western analysis, and the spots corresponding to possible isoforms of Hop were 
comparatively analyzed by estimating the pI’s as described in section 2.2.4.3.  
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2.3 RESULTS 
2.3.1 Heat Shock Response was Induced at 42oC But Hop Protein Levels 
Did Not Change 
Acute heat shock conditions to temperatures between 40 and 45.5oC for less than one 
hour applied to mammalian cells are described as short-term heat shock exposure (Kuhl 
and Rensing, 2000). Hsp72 was used as a marker of the heat shock response as this 
protein is induced under heat stress (Tavaria et al., 1996; Takayama et al., 1997). Mouse 
NIH 3T3 cells were subjected to heat shock at 42oC for 10, 20 and 30 minutes and 
equivalent amounts of protein were subjected to SDS-PAGE and Western analysis for the 
detection of Hsp72 (inducible Hsp70) and for Hop. Levels of Hsp72 were shown to be 
markedly increased with an increase in the duration of heat shock, as seen in figure 2.1, 
panel B (compare lanes 2-5). Panel C of figure 2.1, lanes 2-5 showed that the levels of 
Hop did not change significantly upon heat shock for 0, 10, 20 and 30 minutes of heat 
shock. These results are representative of three independently conducted experiments. 
 
2.3.2 Acidic Isoforms of Hop Emerged After Heat Shock  
Figure 2.2 shows the comparative 2D profile of Hop after Western analysis from cells 
that were grown normally at 37oC and those that were subjected to heat shock at 42oC. 
The isoforms of Hop were resolved on a non-linear pI strip range 3-10 and all isoforms 
were seen between pI’s of approximately 6 and 6.4. Under normal conditions, a major 
(figure 2.2, 0 min; Bold large asterisk) and a minor isoform (figure 2.2, 0 min; Medium 
asterisk) were detected. After heat shock, there was a reduction in the amount of the 
major isoform and an increase in the minor isoform (figure 2.2, 30 mins). Moreover, 
there was an emergence of at least two more relatively acidic isoforms (figure 2.2, 30 
min; smaller asterisks).  The presence of a negatively charged phosphate group after 
phosphorylation of a protein allowed the inference of relatively acidic isoforms to be 
associated with phosphorylation. The non-linear nature of resolution of the strip used for 
IEF made it difficult to assign individual pI’s to each spot. The results obtained are 
representative of three independently conducted experiments. 
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Figure 2.1: Heat shock response was induced at 42°C but the protein levels of Hop were not 
changed by the heat shock response. A: Mouse NIH 3T3 cells were subjected to varying durations 
of heat shock at 42°C and total protein was subsequently harvested and quantified. A: Total protein 
lysates (30 ~g) were resolved by SOS-PAGE and stained with Coomassie Blue (Lane 1: molecular 
mass markers; Lane 2: 0 min heat shock; Lane 3: 10 mins heat shock; Lane 4: 20 mins heat shock; 
Lane 5: 30 mins heat shock). B: Western analysis was performed using antibodies generated toward 
the inducible Hsp70 to detect increasing levels of inducible Hsp70 with heat shock. C: Antibodies 
generated toward the C-terminus of Hop were used to detect whether there was any change in the 
steady state levels of Hop during the duration of the heat shock treatment. The protein levels of Hop 
did not change signficantly between the various durations of heat shock applied. This figure 
represents the results obtained from three experiments conducted independently. 
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Figure 2.2: Acidic isoforms of Hop emerged after heat shock. Mouse NIH 3T3 cells were 
subjected to 0 and 30 minutes of heat shock at 42oC and total protein was subsequently harvested. 
Total protein (120 µg) was resolved by 2D gel electrophoresis (isoelectric focussing and SDS-PAGE 
steps indicated) using a non-linear pI strip range of 3-10 followed by Western blot analysis for the 
detection of Hop. The major isoform obtained under normal conditions is indicated by the bold 
asterisk and the minor isoform, by a medium asterisk. Two other isoforms representing relatively 
acidic isoforms, which emerged after heat shock treatment are also indicated by smaller asterisks. All 
isoforms were identified within a pI range of 6-6.4, however individual pI’s were not assigned to any 
one isoform due to difficulties arising from the non-linear nature of the pI strip used. This figure 
represents the results obtained from three independent experiments. 
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2.3.3 Hop was Phosphorylated In Vivo at 37oC 
An analysis of the phosphorylated state of Hop in vivo was conducted by a more rigorous 
determination of the isoform profile of Hop in the presence of PI and after SAP 
treatment. Furthermore, the isoforms of Hop were separated with greater resolution on a 
linear pI strip range of 4-7 (figure 2.3). For lysates treated with PI and no SAP added, 
Hop was found to exist not only as a major and minor isoform, but also as three more 
relatively acidic isoforms (figure 2.3; upper panel). The major isoform with a calculated 
pI of approximately 6.1 was labeled ‘0’ and the minor isoform found at pI of 
approximately 6.0 was labeled ‘+1’. A third isoform, approaching a pI of 6.0 and merging 
with isoform +1 was labeled ‘+2’. The two other relatively more acidic isoforms at pIs 
less than 5.9 were designated by asterisks and were not assigned approximate pI’s. 
Treatment of the cell lysate with SAP caused a considerable reduction in isoforms +1 and 
+2 (figure 2.3; lower panel) suggesting that they were dephosphorylated by SAP 
treatment. These results provided evidence of in vivo phosphorylation of at least two 
subpopulations of Hop under normal conditions. The most acidic isoform obtained under 
normal conditions (designated by an asterisk) disappeared after SAP treatment, indicating 
that this isoform may correspond to a minor phosphorylated isoform of Hop. A prominent 
isoform, designated ‘+3’ was detected after SAP treatment at an approximate pI of 5.9, 
and this isoform was not prominent in lysate obtained from normally grown cells that 
were treated with PI (figure 2.3; upper panel). The results are representative of at least 
two independent experiments. 
 
2.3.4 Hop was Phosphorylated Differently In Vivo at 42oC Versus 37oC 
The isoform composition of Hop after 30 minutes of heat shock (figure 2.4; upper panel) 
differed from that of normal conditions in that there was a reduction in the amount of the 
major isoform 0. There was also an increase of a number of minor acidic isoforms, the 
most prominent of which had an approximate pI of 5.9 and was designated ‘+3’. This 
isoform was also seen in the SAP treated normal lysate (figure 2.3, lower panel). All the 
other minor isoforms that increased after heat shock were not designated approximated 
pI’s, and were indicated by asterisks. However, it was noted that these isoforms were 
found at pI’s of 5.9 or lower. Treatment of the heat shocked cell lysate with SAP yielded 
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an isoform profile for Hop (Figure 2.4; lower panel) which included a slight increase of 
the previously major isoform 0, and the complete absence of isoform +2. Isoform +3 
showed a considerable reduction after treatment with SAP. The results obtained are 
representative of at least two independent experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2: The Phosphorylation Status of Hop 
 
 56 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-
6.
0
-
6.
1
-
5.
9
37 ºC + PI
37 ºC - PI + SAP-
6.
0
-
5.
9
+1 0* +2
+1 0+3
-
6.
1
*
**
SDS-PAGE
IEF
-
6.
0
-
5.
9
-
6.
1
-
6.
0
-
6.
1
-
5.
9
-
6.
0
-
5.
9
-
6.
1
-
6.
0
-
6.
1
-
5.
9
-
6.
0
-
5.
9
-
6.
1
-
6.
0
-
5.
9
-
6.
1
Figure 2.3: Hop was phosphorylated in vivo at 37oC: Mouse NIH 3T3 total protein lysate (120 µg) 
was resolved by 2D-gel electrophoresis, followed by Western analysis for the detection of Hop. The 
isoelectric focusing (IEF) and SDS-PAGE steps are shown.  The upper panel shows the Western of 
lysates prepared from cells that were grown under 37oC and treated with phosphatase inhibitors (37oC 
+ PI); the lower panel shows the Westerns of lysates prepared from cells that were also grown at 
37oC and treated with shrimp alkaline phosphatase (SAP) but not treated with PI (37oC – PI + SAP). 
Approximate pI’s for the prominent isoforms were estimated and are indicated at the top of each 
panel. The position of the isoforms with assigned pI’s did not always coincide due to technical 
discrepancies such as slight changes in gel size. The major isoform under normal conditions, with an 
approximate pI of 6.1 was arbitrarily given the label ‘0’. Any isoform that was found to be more 
acidic than ‘0’ was labeled with increasing positive numbers. Additional isoforms which were not 
assigned a pI value were labeled with an asterisk. The figure presented represents the results obtained 
from at least two independently conducted experiments.  
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Figure 2.4: Hop was phosphorylated differently in vivo at 42oC versus 37oC: Mouse NIH 3T3 
total protein lysate (120 µg) obtained from cells that were heat shocked at 42oC for 30 minutes were 
resolved by 2D-gel electrophoresis, followed by Western analysis for the detection of Hop. The 
isoelectric focusing (IEF) and SDS-PAGE steps are shown.  The upper panel shows the Western of 
lysates prepared from cells that were grown under 42oC and treated with phosphatase inhibitors (42oC 
+ PI); the lower panel shows the Westerns of lysates prepared from cells that were also grown at 
42oC and treated with shrimp alkaline phosphatase (SAP) but not treated with PI (42oC – PI + SAP). 
Approximate pI’s for the prominent isoforms were estimated and are indicated at the top of each 
panel. The position of the isoforms with assigned pI’s did not always coincide due to technical 
discrepancies such as slight changes in gel size. The major isoform under normal conditions, with an 
approximate pI of 6.1 was arbitrarily given the label ‘0’. Any isoform that was found to be more 
acidic than ‘0’ was labeled with increasing positive numbers. Additional isoforms which were not 
assigned a pI value were labeled with an asterisk. The figure presented represents the results obtained 
from at least two independently conducted experiments. 
Chapter 2: The Phosphorylation Status of Hop 
 
 
58 
2.4 DISCUSSION 
The separation of the isoforms of mouse Hop on a non-linear pI strip of 3-10 (figure 2.4) 
showed the presence of two isoforms under normal conditions, with an increase in acidic 
isoforms after heat shock for 30 minutes. These results were comparable to other studies 
that showed that mouse Hop migrated as a major and minor, relatively more acidic, 
isoform (Lässle et al., 1997; Zanata et al., 2002). Upon heat shock for ten minutes, there 
was a significant decrease in the major isoform and an increase in both the numbers of 
acidic isoforms and their amount (Lässle et al., 1997).   
 
Earlier studies on mouse Hop (Lässle et al., 1997) were conducted using a cell lysate that 
was treated with a tyrosine phosphatase inhibitor (sodium vanadate). The initial isoform 
analysis reported by the present study (figure 2.2) was, however, conducted on a cell 
lysate that was not treated with any phosphatase inhibitors, and was nevertheless 
comparable with results published by Lässle et al. (1997). Therefore, in light of the 
present study, the findings of Lässle et al. (1997) can be re-interpreted as suggestive of 
phosphorylation of Hop at sites other than tyrosine. This is consistent with later findings 
that suggested phosphorylation at serine and threonines (Longshaw et al., 2000; 
Longshaw et al., 2004). However, on the basis of these results, further strategies were 
employed to directly test the presence of phosphorylated isoforms of Hop. Mouse 
fibroblast cells were either treated with phosphatase inhibitors, which included the 
tyrosine phosphatase inhibitor, sodium vanadate, as well as the serine/threonine 
phosphatase inhibitor, okadeic acid, or the cells were treated with SAP, a protein 
phosphatase. Lysates obtained from each treatment were resolved by 2D gel 
electrophoresis, using a pI strip of 4-7 for better resolution, followed by Western analysis 
for the detection of Hop.  
 
The results obtained showed that under normal conditions, not only did Hop exist as a 
major (0) and minor isoform (+1), but also as three more relatively acidic isoforms 
(figure 2.3; upper panel). Treatment of the cell lysate with SAP in the absence of PI 
(figure 2.3; lower panel), showed a considerable decrease in isoform +1 and +2. These 
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results provided, for the first time, evidence of in vivo phosphorylation of at least two 
subpopulations of Hop under normal conditions.  
 
Heat shock is also known to exert both inhibitory and activating effects on various 
kinases and phosphatases, thus influencing the phosphorylation status of certain proteins 
(Duncan and Hershey, 1989; Bagi and Hidvegi, 1990; Somero, 1995). Since Hop was 
shown to be phosphorylated under normal conditions, it was of interest to analyze the 
phosphorylated status of Hop when the cell was heat shocked. Analysis by 2D showed 
that the isoform composition of Hop under acute heat shock conditions (figure 2.6; upper 
panel) differed from that of normal conditions in that there was a reduction in the amount 
of the major isoform ‘0’. This was consistent with data published by Lässle et al. (1997). 
Moreover, a number of minor acidic isoforms were observed to be present after heat 
shock, of which +3 at pI 5.9 was the most distinctive. Treatment of heat shocked cell 
lysate with SAP yielded an isoform profile for Hop (figure 2.4; lower panel) which 
included a slight increase in the levels of the previously major isoform 0, and the 
complete disappearance of isoform +2. Interestingly, isoform +3 showed a considerable 
decrease after treatment with SAP.  It was debatable as to whether all the minor isoforms 
appearing after heat shock and designated by asterisks were generated by 
phosphorylation, since some of them were still observable when normal cell lysate was 
treated with SAP. Therefore, although heat shock may lead to a number of modifications 
of Hop in mammalian cells, the data presented here implies that differential 
phosphorylation of Hop as one of these modifications.  
 
The phosphorylation of Hop as a result of heat shock may differ within the mammalian 
and yeast system. Early studies carried out on yeast Hop (Nicolet and Craig, 1989) 
reported two major and two minor isoforms of the protein with pI’s ranging from 5.75 to 
6.05, implying differential phosphorylation of yeast Hop in vivo. However, there was no 
apparent change in the isoform composition of yeast Hop after heat stress (Nicolet and 
Craig, 1989), suggesting that the heat shock conditions used did not change the 
phosphorylation state of Hop in the yeast system. The present study has shown that 
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mouse Hop is indeed phosphorylated in vivo under normal conditions, and differentially 
phosphorylated under acute heat stress (42oC for 30 minutes).  
 
It is likely, based on the presence of okadeic acid in the experimental conditions, that 
under normal conditions, phosphorylation of Hop may be attributable to phosphorylation 
at the serine or threonine residues. Hop contains six possible sites within its amino acid 
sequence, which may be phosphorylated by CK II and two possible sites which may be 
phosphorylated by cdc2-kinase (Blatch et al., 1997). It has been established that Hop is 
indeed phosphorylated in vitro by CKII at Serine 189, as well as by cdc2-kinase at 
Threonine 198 (Longshaw et al., 2000). 
 
Heat shock is known to induce the activation of mitogen-activated protein (MAP) kinases 
(Rouse et al., 1994; Chen et al., 1995). The possibility that Hop may be phosphorylated 
by stress-related kinases has been previously investigated and Hop was found to have a 
potential phosphorylation site for MAPKAP kinase 2 and two potential sites for S6 
kinases within its amino acid sequence (Lässle et al., 1997). Although in vitro analysis 
showed that none of the GST-Hop fusion proteins examined were phosphorylated by any 
of these kinases, when possible folding artifacts of the fusion proteins are taken into 
consideration, these results do not completely rule out the possibility that Hop may also 
be phosphorylated by a stress kinase pathway in vivo (Lässle et al., 1997).  
 
Another major signaling event that the heat shock response induces is the transcriptional 
induction of heat shock proteins (Duncan and Hershey, 1989; Lee et al., 2005). However, 
after submitting mouse fibroblast cells to heat shock at 42oC for 30 minutes, no increase 
of Hop was observed at the protein level (figure 2.3). Other reports have shown that heat 
shock as well as viral transformation in mammalian cells, caused an increase in mRNA 
levels of mouse and human Hop respectively, and although human Hop was upregulated 
after viral transformation (Honoré et al., 1992), there was no change in the expression 
levels of Hop in mouse cells after heat shock (Lässle et al., 1997). In contrast to the 
mouse homolog, the parasitic (Leishmania major) and the plant homolog of Hop have 
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been shown to be stress-inducible both at the genetic level, as well as at the protein level 
(Webb et al., 1997; Zhang et al., 2003).  
 
Hop’s differential phosphorylation under normal and stress conditions could have various 
implications with regards to its function, particularly in terms of its scaffolding properties 
within the Hsp70-Hsp90 chaperone heterocomplex. Previous studies on the in vitro 
phosphorylation of Hop by cell cycle kinases suggested that the phosphorylation of Hop 
may play a part in regulating its subcellular localization (Longshaw et al., 2000; 
Longshaw et al., 2004). It is thus likely that the differential phosphorylation patterns 
exhibited by Hop may be better understood within the context of the subcellular 
localization patterns that it presents, and that a functional significance of Hop’s 
phosphorylation may lie in the regulation of its subcellular localization. 
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“It is a good morning exercise for a research scientist to  
discard a pet hypothesis every day before breakfast.” 
- Konrad Lorenz (Pioneer of Ethology) 
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3.1 INTRODUCTION 
The various functions of Hop, within as well as outside the realm of an Hsp70-Hsp90 co-
chaperone, are largely dependent on its subcellular localization. Early studies reported the 
occurrence of human Hop in the Golgi apparatus and small vesicles in normal cells, 
whereas a nucleolar localization of Hop was seen in SV40-transformed cells (Honoré et 
al., 1992). In mouse fibroblast cells grown under normal conditions, the localization of 
Hop was reported to be predominantly cytoplasmic, with a low incidence of Hop being 
identified in the nucleus (Lässle et al., 1997; Longshaw et al., 2004). However, when 
these cells were arrested in the G1/S phase, or treated with Leptomycin B, a Streptomyces 
metabolite which inhibits the CRM1 dependent nuclear export of proteins (Kudo et al., 
1999), a predominantly nuclear accumulation of Hop was reported (Longshaw et al., 
2004).  
 
This implied that Hop was constantly shuttling between the nucleus and cytosol, but the 
export of Hop from the nucleus was occurring at a faster rate than its import (Longshaw 
et al., 2004).  A bipartite NLS was proposed (Longshaw, 2002), which when fused to 
EGFP (enhanced green fluorescent protein) resulted in the localization of EGFP to the 
nucleus (Longshaw et al., 2004), suggesting that this NLS was indeed functional. Other 
studies using immunoprecipitation techniques with membrane fractions from mouse brain 
tissue have shown that at least a portion of the Hop population is localized at the cell 
surface, where it interacts with Prpc (a protein whose expression is crucial to the 
propagation of neurological disease, in particular, Prion disease) both in vitro and in vivo 
(Zanata et al., 2002).  
 
Previous work reported that the nuclear translocation of Hop was cell cycle regulated 
since arresting the cells in G1/S phase showed increased nuclear translocation (Longshaw 
et al., 2004). Stress conditions like heat stress are known to cause arrest of the cell in the 
G1/S phase of the cell cycle (Kuhl and Rensing, 2000). Thus, one of the main objectives 
of this study was to compare the subcellular localization patterns of Hop under normal 
growth conditions (37oC), acute heat shock conditions (42oC for 30 minutes) and 
hydroxyurea treatment which arrests the cells in the G1/S phase (Longshaw et al., 2004).  
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A second objective was to study the functionality of the previously proposed bipartite 
NLS (K222 - K239) in vivo. Other studies on bipartite NLSs have shown that usually the 
major arm of a bipartite NLS is critical for functionality in vivo due to its ability to bind 
to the major binding site on importin-α (Conti et al., 1998; Conti and Kuriyan, 2000; 
Fontes et al., 2000; Friedrich et al., 2006). Moreover, when the major binding site on 
importin-α is not involved in interactions with NLSs, the IBB domain is found to occupy 
this binding site thereby inhibiting nuclear transport of any importin-α complex (Catimel 
et al., 2001). Based on this, the residues of the major arm of the proposed NLS were 
predicted to be critical for functionality of the NLS activity in vivo. It was thus of interest 
to mutate the residues within the putative NLS that were predicted to be important for 
NLS functionality, and test the functionality of this NLS by studying the subcellular 
localization patterns of the NLS-mutant proteins under normal conditions, heat shock and 
hydroxyurea treatment. In light of the partnership of Hop with Hsp70 and Hsp90, an 
investigation into the subcellular localization of both these major heat shock proteins was 
also warranted in order to understand the broader context of the subcellular localization 
of Hop. Thus it was also of interest to compare the subcellular localization of Hop with 
that of Hsp70 and Hsp90 under normal and heat shocked conditions.  
 
The specific objectives of this study were to: 
1. Successfully generate Hop-EGFP and its mutational constructs, Hop-K239A-
EGFP and Hop-K237/238/239A-EGFP. 
2. Transiently transfect mammalian cells with Hop-EGFP and its derivative 
constructs, Hop-K239A-EGFP and Hop-K237/238/239A-EGFP, and study the 
subcellular localization patterns of these constructs under normal conditions, 
acute heat shock conditions (42oC for 30 minutes) and after treatment of the cells 
with 10 mM hydroxyurea to induce G1/S arrest of cells.   
3. Biochemically fractionate mammalian cells into its various subcellular 
compartments, and perform Western analysis detection of Hop, Hsp70, Hsp90 
and β-actin (a cytosolic marker protein). 
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3.2 EXPERIMENTAL PROCEDURES 
 
3.2.1 The Subcellular Localization of Hop-EGFP and Derivatives of the 
Putative NLS Under Normal Conditions, Heat Shock and G1/S 
Arrest, Using Confocal Fluorescence Microscopy  
3.2.1.1 Generation and Analysis of Plasmid Constructs Encoding Hop-EGFP 
and its Mutant Derivatives  
The Hop-EGFP plasmid construct and its mutants Hop-K239A-EGFP and Hop-
K237/238/239A-EGFP were generated from pSK-mSTI1-EGFP. pSK-mSTI1-EGFP 
contains cDNA encoding the full-length protein mSTI1 (mouse homolog of Hop) fused at 
its C-terminal with EGFP (Longshaw, 2002; Longshaw et al., 2004). All mutations were 
carried out by site-directed mutagenesis using a double-stranded whole plasmid linear 
amplification procedure (Appendix A8). For screening purposes, silent mutations were 
engineered to create restriction sites except where the desired codon change(s) 
automatically generated restriction sites. The specific mutagenic primers are listed in 
Section C of the Appendix.  
 
After mutagenesis, 1 µL of the mutated DNA was used to transform E.coli XLI blue 
cells. Modified plasmids were isolated from E.coli harboring them using the Qiagen 
miniprep kit. All plasmid constructs and their mutations were confirmed both by 
restriction enzyme analysis (Appendix A9) and by DNA sequencing (Appendix A11) 
according to plasmid maps generated by Vector NTI Advance TM 10 (Invitrogen 
Corporation, USA). The large size of pB-mSTI1-EGFP (17.39 kbp) made it difficult to 
manipulate. Hence all mutations within Hop were conducted on the pSK-mSTI1-EGFP 
plasmid and then the mSTI1-EGFP encoding fragment from pSK-mSTI1-EGFP, both 
mutated and wild type, was further subcloned into pBCMGSNeo (Karasuyama and 
Melchers, 1988) XhoI/NotI sites to produce pB-mSTI1-EGFP as previously described 
(Longshaw, 2002; Longshaw et al., 2004). Plasmid DNA restriction analyses were 
visualized by 0.8% agarose gel electrophoresis as described in Appendix A10. 
Unfortunately the pBCMGSNeo plasmid as supplied was not fully sequenced by 
Karasuyama and Melchers (1988), and therefore all cloning work was carried out with 
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reference to an approximated restriction map (figure 3.3 A). The inserts of the plasmids 
used in this study were, however, confirmed as correct by sequencing as described in 
Appendix A11. All plasmid constructs listed retain their original cloning nomenclature, 
which refers to mSTI1 (mouse homolog of Hop). However to avoid confusion, the 
proteins they encode have been labeled mouse Hop.  
 
3.2.1.2 The Subcellular Localization of Hop-EGFP and Its Mutant 
Derivatives Under Various Treatments by Confocal Laser Scanning 
Fluorescence Microscopy 
3.2.1.2.1 Tissue Culture and Heat Shock of BHK-21 Cells 
BHK-21 cells were used for all subcellular localization studies due to the ease of transient 
transfections of relatively large plasmids, as compared to NIH 3T3 mouse fibroblast cells. 
The BHK-21 cells were maintained in DMEM supplemented with 10% heat inactivated 
fetal calf serum, penicillin (100 U mL–1) and streptomycin (100 U mL–1) in a humidified 
atmosphere, at 37°C with 5% CO2. An acute heat shock response was obtained by 
treating the cells at 80% growth confluence to pre-warmed DMEM and then incubating 
for 30 minutes at 42oC (Kuhl and Rensing, 2000).  
 
3.2.1.2.2 Transient Transfection of BHK-21 Cells and Preparation of Cells For 
Confocal Microscopy 
BHK-21 cells were transiently transfected with pB-mSTI1-EGFP and its mutant 
derivatives. Transient transfections were carried out using IBAfect, a polycationic 
transfection reagent based on liposome technology, in combination with MA Lipofection 
Enhancer (IBA, Germany). The MA Lipofection Enhancer is based on a technique that 
associates plasmid DNA to magnetic nanoparticles. Exploiting magnetic force with the 
help of a magnet plate allows for the rapid and efficient delivery of the full nucleic acid 
dose into the target cells.  
 
BHK-21 cells were grown to 60% confluency on 13 mm cover slips in 24 well plates. 
Plasmid DNA (1 µg) was incubated with IBAfect (3 µL) in serum-free DMEM at room 
temperature for 20 minutes. This was followed by the addition of MA Lipofection 
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Enhancer (1 µL), mixed well by pipetting up and down, and incubated at room 
temperature for 15 minutes. The DNA-IBAfect-MA Lipofection Enhancer mixture was 
added to the cells and mixed well by pipetting. The 24 well plate was placed on a 24 well 
plate-magnet for 15 minutes at room temperature. The cells were then incubated at 37oC 
for 48 hours, before further treatments. Acute heat shock conditions were achieved for 30 
minutes as described in section 3.2.1.2.1. Arrest of cells in the G1/S phase was achieved 
by treating transfected cells with 10 mM hydroxyurea (Longshaw et al., 2004). Cells 
were fixed in 4% paraformaldehyde for 10 minutes and nuclei stained with 2 mg mL–1 4’, 
6-diamidino-2-phenylindole (DAPI; Sigma) in PBS.  
 
3.2.1.2.3 Confocal Laser Scanning Fluorescence Microscopy 
Slides were mounted in fluorescent mounting solution (DAKO). Cells expressing Hop-
EGFP or its derivative EGFP-conjugated proteins were viewed and captured using the 
Zeiss LSM 510 Meta confocal microscope (40 x oil immersion objective) and LSM 510 
software (Zeiss). A FITC/EGFP filter with an excitation wavelength of 488 nm and an 
emission wavelength within the range of 505-550 nm was used to visualize the EGFP 
fluorescence (green) and in a separate channel, a DAPI filter with an excitation 
wavelength of 405 nm and an emission wavelength within the range of 420-480 nm was 
used to visualize DAPI-stained nuclei (blue). For quantification purposes, cells were 
divided into three categories: cells showing (i) predominantly cytoplasmic fluorescence, 
(ii) cytoplasmic and nuclear fluorescence and (iii) predominantly nuclear fluorescence. 
Average values were taken from six different fields and the error bars represent standard 
deviations. 
 
3.2.2 The Subcellular Localization of Hop, Hsp70 and Hsp90 Under 
Normal   and Heat Shock Conditions Using Biochemical Fractionation  
Whole BHK-21 cells were fractionated into cytoplasmic, nuclear, membrane and 
cytoskeletal fractions using the ProteoExtract® Subcellular Proteome Extraction Kit (S-
PEK, Calbiochem) (Sabio et al., 2005). This method takes advantage of different 
solubility of the various subcellular compartments in four specific buffers resulting in the 
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sequential extraction of subcellular proteomes, which are in the native and functional 
state.  
 
BHK-21 cells were grown to 80% confluence as described in 3.2.1.2.1 in T 75 cm tissue 
culture flasks and either directly subjected to biochemical fractionation, or heat shocked 
before being biochemically fractionated by S-PEK according to the supplier’s 
specifications. Each appropriate extraction reagent for the extraction of a specific 
subcellular proteome (in the order of decreasing complexity, i.e. cytosolic, membranous, 
nuclear and cytoskeletal), along with a protease inhibitor cocktail, as provided in the kit, 
was added directly into the tissue culture flask, without the need for cell removal, and 
incubated with agitation under the conditions described.  In the case of nuclear extraction 
of proteins, Benzonase ® (DNase/RNase) provided by the kit was also added into the 
extraction buffer.  
 
Proteins obtained from each fraction were resolved using SDS-PAGE and then subjected 
to Western analysis, probing for β-actin (monoclonal anti-mouse β-actin at a final 
dilution of 1:4000), Hsp72/73 (monoclonal mouse anti-human Hsp72/73 which detects 
both the inducible and the constitutive Hsp70; final dilution: 1:5000), Hsp90 (monoclonal 
rat anti-human Hsp90; final dilution: 1:5000) and Hop (dilution: 3:1000). The secondary 
antibodies used were HRP-conjugated sheep anti-mouse and HRP-conjugated goat anti-
rat IgM at final dilutions of 1:5000. The analysis was conducted on total protein obtained 
from equivalent number of cells. 
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3.3 RESULTS 
3.3.1 pB-mSTI1-EGFP and its Derivative Constructs Were Successfully 
Generated 
The pSK-mSTI1-EGFP plasmid shown in figure 3.1 A (Longshaw, 2002; Longshaw et 
al., 2004) was screened by restriction endonucleases digestion and the resultant DNA 
fragments were resolved by 0.8% agarose gel electrophoresis as shown in figure 3.1 B. 
Lane 2 shows the uncut parent plasmid, which resolved into a higher mobility fragment 
that corresponds to the supercoiled DNA and a lower mobility fragment which is the 
nicked DNA. Digestion of pSK-mSTI1-EGFP with Not I and Xho I separately linearized 
the plasmid and produced an expected fragment of 5296 bp (lanes 3 and 4 respectively) 
compared to the double digestion of pSK-mSTI1-EGFP with Not I and Xho I together, 
which produced the two expected 2918 and 2378 bp fragments (lane 5).  
 
Site-directed mutagenesis was carried out on pSK-mSTI1-EGFP to produce pSK-mSTI1-
K239A-EGFP (figure 3.2 A) and pSK-mSTI1-K237/238/239A-EGFP (figure 3.2 B). An 
Nsi I digestion site was engineered onto the plasmid along with the above-mentioned 
mutations, in order to facilitate restriction endonuclease digestion. Figure 3.2 C shows the 
digestion of the various pSK-mSTI1-EGFP constructs with Nsi I. Lane 2 corresponds to 
uncut parental plasmid, which has resolved into the expected supercoiled DNA fragment 
of higher mobility and the nicked DNA fragment of lower mobility. Treatment of the 
parental plasmid with Nsi I did not digest the plasmid and produced the fragments 
comparable to the uncut plasmid (lane 3). The pSK-mSTI1-K239A-EGFP plasmid was 
linearized by Nsi I into the expected 5296 bp band (lane 5), which can be compared to the 
uncut plasmid (lane 4). The presence of a higher mobility band and a lower mobility band 
in lane 5 corresponds to the presence of supercoiled and nicked DNA respectively and 
shows that the plasmid was partially digested. Similarly, digestion of pSK-mSTI1-
K237/238/239-EGFP with NsiI resulted in an expected fragment of 5296 bp (lane 7) 
when compared to the uncut plasmid (lane 6). The presence of supercoiled and nicked 
DNA was also detected after digestion of the plasmid with Nsi I (lane 7) indicating partial 
digestion. All mutations were furthermore confirmed by sequencing.  
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Following successful mutagenesis and confirmation of the mutagenic constructs obtained, 
the mSTI1-EGFP encoding fragment from pSK-mSTI1-EGFP, both mutated and wild 
type, were subcloned into pBCMGSNeo (Karasuyama and Melchers, 1988) XhoI/NotI 
sites to produce pB-mSTI1-EGFP as described previously (Longshaw et al., 2004) and 
shown in figure 3.3 A. The successful ligation reactions were tested by restriction 
endonuclease digestion using Hind III as shown in figure 3.3 B. Lanes 2, 4 and 6 show 
the resolution of uncut plasmids (pB-mSTI1-EGFP, pB-mSTI1-K239A-EGFP and pB-
mSTI1-K237/238/239A-EGFP) into supercoiled and nicked DNA. The digestion of all 
three plasmids resulted in the expected fragments of approximate sizes 7700, 5000, 3790 
and 902 bp (lanes 3, 5 and 7) indicating that the coding regions for mSTI1-EGFP, 
mSTI1-K239A-EGFP and mSTI1-K237/238/239A-EGFP were successfully ligated into 
the pB vector. The mutations were confirmed by sequencing. 
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Figure 3.1: The identity of pSK-mSTIl-EGFP was restriction analyzed with Not I and 
Xho I. pSK-mSTIl-EGFP (A) was digested with restriction endonucleases and the digested 
fragments were further resolved on a 0.8% agarose gel (B). B: Lane 1: Lambda markers 
digested with Pst I; Lane 2: Undigested pSK-mSTII-EGFP; Lane 3: pSK-mSTII-EGFP 
linearized by Not I; Lane 4: pSK-mSTII-EGFP linearized by Xho I; Lane 5: pSK-mSTIl-EGFP 
doubly digested with Not I and Xho I to release two expected fragments at 2918 and 2378 bp. 
Sizes of each DNA marker in fragment in basepairs (bp) are annotated on the left and expected 
sizes of the fragments obtained after each digest are annotated on the right (bp). Nicked (N) and 
supercoiled (S) DNA fragments are also indicated on the right hand side of the gel. 
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Figure 3.2 Codon changes for the K239A and K237/238/239A substitutions were successfully 
engineered in pSK-mSTI1-EGFP. Successful mutations engineered in pSK-mSTI1-EGFP to produce 
the constructs pSK-mSTI1-EGFP (K239A) (A) and pSK-mSTI1-EGFP (K237/238/239A) (B) were 
analyzed by restriction enzyme digest, followed by resolution of all digested fragments on a 0.8% 
agarose gel (C). (C) Lane 1: Lambda markers digested with Pst I; Lane 2: Undigested pSK-mSTI1-
EGFP; Lane 3: pSK-mSTI1-EGFP treated with Nsi I but undigested; Lane 4: pSK-mSTI1-K239A-
EGFP uncut; Lane 5: pSK-mSTI1-K239A-EGFP linearized by Nsi I. Lane 6: pSK-mSTI1-
K237/238/239A-EGFP uncut; Lane 7: pSK-mSTI1-K237/238/239A-EGFP linearized by Nsi I. Sizes of 
each DNA marker fragment in basepairs (bp) are annotated on the left and expected sizes of the 
fragments obtained after each digest (bp) are annotated on the right. The linearized fragment was seen 
at the expected size of 5296 bp for all mutated constructs digested with Nsi I. Nicked (N) and 
supercoiled (S) DNA fragments are annotated on the right hand side of the gel.  
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Figure 3.3: The coding regions for mSTI1-EGFP, mSTI1-K239A-EGFP and mSTI1-
K237/238/239A-EGFP were successfully ligated into the pBCMGSneo (pB) vector. After 
mutagenesis in pSK-mSTI1-EGFP was conducted and confirmed using restriction endonuclease 
analysis and sequencing, both mutated and unmutated mSTI1-EGFP fragments were released from 
the pSK vector and ligated into the pB vector using the XhoI/NotI restriction sites (A). The pB vector 
and the ligated products were digested with Hind III and all digested fragments were analyzed on 
0.8% agarose gel (B). B: Lane 1: Lambda markers digested by Pst I; Lane 2: pB-mSTI1-EGFP uncut; 
Lane 3: pB-mSTI1-EGFP digested by Hind III; Lane 4: pB-mSTI1-K239A-EGFP uncut; Lane 5: pB-
mSTI1-K239A-EGFP digested by Hind III Lane 6: pB-mSTI1-K237/238/239A-EGFP uncut; Lane 7: 
pB-mSTI1-K237/238/239A-EGFP digested by Hind III. Sizes of each DNA marker fragment in 
basepairs (bp) are annotated on the left and expected sizes of the fragments obtained after each digest 
(bp) are annotated on the right. Hind III digested all successfully ligated constructs into four 
fragments of expected sizes, 7700, 5000, 3790 and 902 bp. 
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3.3.2 Hop-EGFP and its Derivative Constructs were Predominantly 
Localized to the Cytosol Under Normal Conditions. 
The subcellular distribution pattern of exogenous mouse Hop in BHK-21 cells using a 
Hop-EGFP fusion protein showed that under normal conditions Hop-EGFP localized 
predominantly to the cytosol of most cells with very little nuclear localization (figure 3.4, 
top panel). Quantitative analysis of the cells showed that Hop was predominantly 
localized to the cytosol in more than 90% of the cells and that Hop localized equivalently 
to both the cytosol and the nucleus in less than 10% of the cells (figure 3.5). The cells 
were transfected with pB-EGFP alone as a control (data not shown), and EGFP was seen 
to be distributed evenly throughout the nuclear and cytosolic compartments in all the 
cells and under all the conditions tested (Longshaw, 2002; Longshaw et al., 2004).  
 
Both NLS mutants, Hop-K239A-EGFP and Hop-K237/238/239A-EGFP also showed a 
predominantly cytosolic localization under normal conditions (figure 3.4, middle and 
bottom panels). However, quantitative analysis of the cells displayed a decrease in the 
total percentages of cells that showed mutated Hop localizing predominantly to the 
cytosol when compared to unmodified Hop (figure 3.5). Furthermore, Hop-K239A-EGFP 
and Hop-K237/238/239A-EGFP showed increased incidences of localization to both the  
cytosol and nucleus (> 20% and > 40% respectively) compared to unmodified Hop-EGFP 
(figure 3.5).  
 
 Hop-EGFP and its Derivative Proteins Localized to the Nucleus Under Heat 
Shock 
When the cells were subjected to heat shock at 42oC for 30 minutes, Hop-EGFP showed 
increased nuclear, but not nucleolar, localization (figure 3.6, top panel) compared to 
normal conditions. More than 70% of the cells displayed both cytosolic and nuclear 
localization, with around 10% percentage of the cells showing a predominantly nuclear 
localization of Hop (figure 3.6).  
 
Hop-K239A-EGFP and Hop-K237/238/239A-EGFP also showed increased incidences of 
nuclear localization under heat shock conditions, with a similar number of cells showing 
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both cytosolic and nuclear localization of the mutants (figure 3.5). Both Hop-EGFP 
mutant derivatives showed a slightly greater incidence of predominantly nuclear 
localization compared to unmodified Hop-EGFP after heat shock. Interestingly, Hop-
K237/238/239A-EGFP did not display any incidences of predominantly cytosolic 
localization, whereas Hop-K239A-EGFP and Hop-EGFP showed < 20 % incidence of 
this localization pattern after heat shock. Like Hop-EGFP, both Hop-NLS mutants did not 
show any nucleolar localization.  
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Figure 3.4: Hop-EGFP and its NLS mutants localized predominantly to the cytosol 
under normal conditions. BHK-21 cells were transiently transfected with plasmids 
expressing Hop-EGFP and its NLS mutant derivatives (Hop-K239A-EGFP and Hop-
K237/238/239A-EGFP). Scale bars, 10 µM were automatically calculated and inserted 
into the figures using the LSM 510 software (Zeiss). The EGFP (green) and DAPI-
stained nuclei (blue) were visualized with two separate channels using a FITC/EGFP and 
DAPI filter respectively.  
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Figure 3.5: Hop-EGFP and its derivatives were predominantly cytosolic under 
normal conditions but translocated to the nucleus under heat shock conditions. 
BHK-21 cells were transiently transfected with plasmids expressing Hop-EGFP, Hop-
K239A-EGFP and Hop-K237/238/239A-EGFP and then treated normally (37oC) or heat 
shocked for 30 minutes (42oC). Cells showing predominantly cytosolic fluorescence 
(black bars), cytosolic and nuclear fluorescence (grey bars) and predominantly nuclear 
fluorescence (white bars) were quantitated. Average values were taken six different fields 
(30-40 transfected cells per field); these results are representative of three independent 
transfections for each plasmid construct and for each treatment. The error bars represent 
standard deviations. 
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Figure 3.6: Hop-EGFP and its NLS derivatives localized to the nucleus during heat 
shock. BHK-21 cells were transiently transfected with plasmids expressing Hop-EGFP 
and its NLS mutant derivatives (Hop-K239A-EGFP and Hop-K237/238/239A-EGFP), 
and then subjected to heat shock at 42oC for 30 minutes. Scale bars, 10 µM were 
automatically calculated and inserted into the figures using the LSM 510 software 
(Zeiss). The EGFP (green) and DAPI-stained nuclei (blue) were visualized with two 
separate channels using a FITC/EGFP and DAPI filter respectively. 
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3.3.4 Hop-EGFP and its NLS Mutants Showed Increased Incidence of 
Nuclear Localization Under Conditions of G1/S Arrest 
As shown in figure 3.7, Hop-EGFP showed an increased incidence of nuclear but not 
nucleolar localization when the cells were treated with hydroxyurea, which arrested the 
cells in the G1/S phase. This finding was consistent with previous studies (Longshaw, 
2002; Longshaw et al., 2004). However, mutating the major arm of the putative NLS of 
Hop did not affect its localization patterns. Both Hop-K239A-EGFP and Hop-
K237/238/239A-EGFP showed a similar localization pattern to unmodified Hop-EGFP 
when the cell was arrested in the G1/S phase of the cell cycle.  
 
 
3.3.5 β-actin Localizes Predominantly to the Cytosol Under Normal and 
Heat Shock Conditions 
Biochemical fractionation of BHK-21 cells that were grown at 37oC (normal conditions) 
and that were heat shocked at 42oC for 30 minutes were analyzed by SDS-PAGE and 
Western detection for β-actin (figure 3.8). β-actin is a protein found predominantly in the 
cytosol, membranous and cytoskeletal fractions of the cell. It is not found in the nucleus 
under normal conditions (Wada et al., 1998). This protein was thus used as a marker of 
the various fractions obtained biochemically, particularly to distinguish between nuclear 
and non-nuclear fractions. As expected, β-actin was found predominantly in the cytosolic 
and membranous fractions under normal and heat shock conditions. A small fraction of 
β-actin was detected in the cytoskeletal fractions particularly after heat shock. β-actin 
was not found in the nuclear extracts of normally treated cells (figure 3.8, first panel) as 
was expected, suggesting that the nuclear fractions obtained by biochemical fractionation 
techniques employed was relatively free of contamination by cytosolic proteins. 
However, a slight increase of β-actin was seen in heat shocked nuclear extracts, but this 
was not unexpected as β-actin has been reported to translocate to the nucleus during heat 
shock (Iida et al., 1992; Wada et al., 1998). This result, therefore, also confirmed that the 
nuclear fractions were indeed obtained from heat-shocked cells. 
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Figure 3.7: Hop-EGFP and its NLS mutants localize to the nucleus when the cells 
are treated with hydroxyurea. BHK-21 cells were transiently transfected with plasmids 
expressing Hop-EGFP and its NLS mutant derivatives (Hop-K239A-EGFP and Hop-
K237/238/239A-EGFP), and treated with hydroxyurea (10 mM) for 5 hours. Scale bars, 
10 µM were automatically calculated and inserted into the figures using the LSM 510 
software (Zeiss). The EGFP (green) and DAPI-stained nuclei (blue) were visualized with 
two separate channels using a FITC/EGFP and DAPI filter respectively. 
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3.3.6 Hsp70 Translocated to the Nucleus After Heat Shock 
Hsp70 is a predominantly cytosolic protein that has been found to translocate to the 
nucleus after heat shock (Chu et al., 2001; Nollen et al., 2001; Diehl et al., 2003). Using 
Western analysis to detect Hsp70 in the biochemically isolated fractions of BHK-21 cells 
grown normally, as well as heat shocked, it was shown that Hsp70 was predominantly 
localized to the cytosol with a fraction of Hsp70 localizing to the membranes (figure 3.2, 
second panel). After heat shock, there was a distinct presence of Hsp70 in the nuclear 
fractions when compared to the nuclear fraction obtained from cells that were not heat 
shocked. This validated the presence of a nuclear extract having been successfully 
isolated by biochemical fractionation. Hsp70 was also detected in the cytoskeletal 
fraction after heat shock but not in the cytoskeletal fraction obtained from non-heat 
shocked cells (figure 3.8, second panel).  
 
3.3.7 Endogenous Hop Co-fractionated With Hsp70 and Hsp90 to the 
Cytosol, Membranes and Cytoskeletal Fractions Under Normal 
Conditions and After Heat Shock 
Biochemical fractionation of the cells followed by Western analysis of Hsp70, Hsp90 and 
Hop showed that all three proteins co-fractionated to the cytosolic fractions under normal 
and heat shocked conditions (figure 3.8, panels 2, 3 and 4). The predominant presence of 
endogenous Hop (as opposed to exogenous Hop, see section 3.3.2) in the cytosol was 
confirmatory of the confocal microscopic data described in section 3.3.2. There was an 
induction in the amount of Hsp70 found in all heat-shocked fractions compared to 
normal, attributable to the presence of inducible Hsp70 (Hsp72).  
 
Figure 3.8 (panel 4) showed that Hop also localized to the membranes under normal 
conditions, and there was an increased amount of Hop in the membrane fraction after 
heat shock. Furthermore, Hsp70 and Hsp90 were localized to the membrane fraction 
under normal conditions, with an increased translocation of these proteins to the 
membranes after heat shock (figure 3.8, panels 2 and 3).  
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Figure 3.8: Biochemical fractionation analysis of Hop, Hsp70 and Hsp90 under 
normal conditions and heat shock conditions. Western blot analysis using antibodies 
for the detection of β-actin (cytoplasmic and membrane marker), Hsp72/73, Hsp90 and 
Hop, after the biochemical fractionation of BHK-21 whole cell lysates obtained from 
cells grown at 37oC (normal conditions) and cells incubated for 30 minutes at 42oC (heat 
shock). C: cytosolic fraction, M: membranous fraction, N: nuclear fraction, CS: 
cytoskeletal fraction. Subcellular fractions were prepared from whole cell lysates using 
equivalent number of cells for each treatment. The results presented are representative of 
three independent experiments.   
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Hop was detected in the cytoskeletal fractions of cells obtained from normally grown 
cells as well as cells that were heat shocked (figure 3.8, panel 4). Hsp70 and Hsp90, 
though absent in the normal cytoskeletal fractions, co-fractionated along with Hop in the 
heat shocked cytoskeletal fractions (figure 3.8, panels 2 and 3). 
 
3.3.8 Endogenous Hop Co-fractionated With Hsp70 But Not Hsp90 in Heat 
Shocked Nuclear Fractions 
A slight presence of endogenous Hop was detected in the nuclear fraction of heat shocked 
cell lysate, but this was absent in the lysate obtained from cells that were not heat-
shocked (figure 3.8, panel 4). Hop was seen to co-fractionate with Hsp70, but not Hsp90 
in heat shocked nuclear fractions (figure 3.8, panels 2 and 3).  
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3.4 DISCUSSION 
Previous investigations into the subcellular localization of mouse Hop showed a 
generally cytosolic accumulation of the protein, with a small proportion of Hop in the 
nucleus (Lässle et al., 1997; Longshaw et al., 2004). The results of this study performed 
with BHK-21 cells grown under normal conditions agree with the above mentioned 
reports that the majority of cells showed a predominantly cytosolic localization of 
exogenous mouse Hop with a small percentage of nuclear Hop also being detected (figure 
3.3, panel 1 and 3.5). Furthermore, detection of endogenous Hop in BHK-21 cells after 
biochemical fractionation predominantly in the cytosolic fraction, confirmed this finding 
(figure 3.2, panel 4).  
 
Endogenous Hop was also detected in the membranous fraction of BHK-21 cells grown 
under normal conditions (figure 3.8, fourth panel). In the fractionation experiments 
conducted for this study, the membrane fraction would have contained membranes from 
various cellular compartments, i.e. both inter and intra-cellular membranes. Although it is 
likely that membraneous Hop may correspond to Hop localizing at the cell surface, based 
on the previous reports of Hop-Prpc interaction (Zanata et al., 2002), we cannot exclude 
the possibility of Hop localizing to other membraneous structures such as lysosomal 
membranes (Agarraberes et al., 2001) within the cell.  The mechanism of Hop’s 
translocation to the membrane is unknown as no transmembrane domain or signal peptide 
for membrane transport has been identified within the amino acid sequence of Hop 
(Lässle et al., 1997; Zanata et al., 2002). It was proposed by Zanata et al. (2002), 
however, that Hop may participate in a protein complex that is taken into the cell 
membrane or that it may be secreted by a pathway that is distinct from the classical route 
through the ER and Golgi apparatus as described by Muesch et al. (1990). Although 
mouse Hop has not yet been shown to localize to the Golgi apparatus, human Hop has 
been detected in the Golgi apparatus and small vesicles (Honoré et al., 1992).  
 
Short-term heat shock in mammalian cells can cause the transient arrest of the cell cycle 
at the G1/S phase by suppressing the hyperphosphorylation of retinoblastoma protein 
(pRb) which is required to release transcription factor E2F in order for the cell to enter 
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into the S phase (Khandijan, 1995). The arrest of mouse fibroblast cells in the G1/S phase 
has previously shown to cause an increased nuclear localization of Hop (Longshaw et al., 
2004). As for mouse cells, this study showed the nuclear localization of Hop under G1/S 
arrest in hamster cells. Furthermore, this study showed for the first time in a mammalian 
system, that a significantly higher nuclear (but not nucleolar) localization of Hop 
occurred under heat shock (figures 3.4 and 3.5). This suggests that the heat shock 
conditions used in this study promoted G1/S arrest of the cells and thus, that Hop 
localization and function is probably stress regulated on a primary level and cell cycle 
regulated on a secondary level.   
 
Although the confocal microscopic data (figure 3.4 and 3.5) showed a higher incidence of 
nuclear localization of Hop under heat shocked conditions, the detection of endogenous 
Hop in the nuclear fractions of heat shocked BHK-21 cells was very slight (figure 3.2, 
fourth panel). This may be attributed to the invasive nature of the biochemical 
fractionation procedure, which rendered it more difficult to capture Hop in the nucleus 
under heat shock. It may also be indicative of the dynamic nature of Hop’s nuclear 
translocation, which is consistent with the observations published by Longshaw et al. 
(2004). In presenting this data, it is acknowledged that although Hsp70 localizing to heat 
shocked nucleus provided evidence of a nuclear fraction being successfully isolated from 
heat shocked cells, this is not sufficient to prove the presence of nuclear proteins under 
normal conditions.  
 
The SDS-PAGE profile of the biochemically fractionated cells showed the presence of 
lower molecular weight proteins in both nuclear fractions (data not shown), which may 
correspond to the presence of histones. However, detection by Western analysis of the 
presence of a nuclear marker control such as histone, which is localized in the nucleus of 
cells under normal conditions, would have been essential in confirming the presence of 
nuclear proteins. It is therefore arguable that the low levels of Hop and Hsp70, and the 
absence of Hsp90 in heat-shocked fractions may be due to the sub-optimal recovery of 
nuclear proteins. Had a histone marker been successfully employed, the comparison of 
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nuclear histone levels to histones in total lysate would have allowed the efficiency of 
nuclear protein recovery to be assessed. 
 
Residues within the major arm of the proposed NLS in mouse Hop were mutated and 
functionality of the NLS in vivo was analyzed by studying the subcellular localization 
patterns of the derivative mutant proteins, Hop-K239A-EGFP and Hop-K237/238/239A-
EGFP. Both Hop mutants displayed a predominantly cytosolic localization under normal 
conditions (figure 3.3 middle and lower panels), but showed significantly higher 
incidences of nuclear localization than unmutated Hop-EGFP (figure 3.5). Under heat-
shocked conditions, both mutants showed a higher incidence of nuclear localization, 
similar to unmutated Hop; interestingly however, a greater percentage of cells showed 
‘predominantly nuclear’ localization of Hop-K237/238/239A-EGFP than that of Hop-
EGFP after heat shock (figure 3.5).  
 
Since mutation of the major arm of the proposed NLS did not obstruct nuclear 
localization of Hop, it was concluded that unlike previously reported classical bipartite 
NLSs, residues of the major arm of the proposed NLS of Hop were not directly involved 
in translocation of Hop into the nucleus. However, since these residues are part of the 
major arm of a bipartite NLS which has been shown to be capable of translocating EGFP 
to the nucleus on its own (Longshaw et al., 2004) one cannot exclude an indirect effect of 
these proposed residues on nuclear translocation of Hop. Moreover, such an indirect 
effect on NLS functionality would be consistent when considering the increased nuclear 
translocation of the Hop-NLS mutants versus unmodified Hop under heat shock and G1/S 
arrest. 
 
Hsp70 and Hsp90 were both shown to co-fractionate with Hop in the cytosolic fractions 
(figure 3.2, panels 2, 3 and 4) as was expected. Previous reports have described the 
interactions of Hop with Hsp70 and Hsp90 to form the multichaperone heterocomplex 
within the cytosol (Chen and Smith, 1998; Pratt and Toft, 2003; Pratt et al., 2004b). It 
was also expected that both Hsp70 and Hsp90 would co-fractionate with Hop in the 
nucleus after heat shock, since it is already established that both these major heat shock 
Chapter 3: The Subcellular Localization of Hop 
 
 
87 
proteins translocate to the nucleus under heat stress (Biggiogera et al., 1996; Bharadwaj 
et al., 1999; Chu et al., 2001; Nollen et al., 2001; Langer et al., 2003). Moreover, 
previous work done in a haploid amphibious system (Xenopus oocytes) showed that 
invertebrate Hop co-localized with Hsp70 and Hsp90 in the nucleus before and after heat 
shock for 1 hour (Bharadwaj et al., 1999). The present study however, using biochemical 
fractionation as a tool, showed that only Hsp70 co-fractionated with Hop and not Hsp90.  
The movement of Hsp90 into the nucleus may be of a similar nature to that of Hop since 
very little Hop was captured in the heat shocked nuclear fractions obtained by 
biochemical fractionation. Thus the absence of Hsp90 in the heat shocked nuclear 
fractions of the cells may be due to the inefficiency of this procedure to reflect such a 
dynamic transition, rather than a true reflection of the localization patterns of Hsp90 
under heat shock. The significance of Hop moving into the nucleus may lie in the likely 
participation of Hop in complexes with nuclear Hsp70 and Hsp90. Hop was proposed to 
be involved in the Hsp70-Hsp90 heterocomplex required for the folding of the heat shock 
transcription factor 1 (HSF1) which is an entirely nuclear protein (Bharadwaj et al., 
1999).  Hop may also be recruited to the nucleus for functions that are completely 
independent of Hsp70 and/or Hsp90.  
 
Under the heat shock conditions used, there was a significant increase in the amount of 
Hop in the membrane fraction (figure 3.8) indicating that the heat shock response may 
increase the recruitment of Hop to membranous structures. Hsp70 and Hsp90 were both 
found to co-fractionate with Hop in the membrane fractions, and as in the case of Hop, 
the heat shock response also increased the recruitment of Hsp90 to the membranes. This 
implied that Hop might be involved in client protein transfer from Hsp70 to Hsp90 even 
within membranes. In both the mammalian and the yeast system, it is known that the 
majority of Hop is found bound to Hsp90 (Smith et al., 1993; Chang et al., 1997; 
Prodromou et al., 1999).  Thus the co-increase in amounts of Hsp90 and Hop in the 
membrane fraction may be further indication of Hop-Hsp90 complexes within the 
membrane, and these may or may not be independent of Hsp70 functions. However, the 
possibility of membrane-associated Hop and Hsp90 occurring in separate membrane 
complexes cannot be excluded.  
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Endogenous Hop was also detected in the membranous fraction of BHK-21 cells grown 
under normal conditions (figure 3.8, fourth panel), a finding which is consistent with 
reports of the interaction of Hop with Prpc at the cell membrane (Zanata et al., 2002). T 
 
A further sub-population of Hop was identified in the cytoskeletal fraction of cell lysate 
under normal and heat shock conditions with no comparative difference in levels detected 
(figure 3.8). No specific cytoskeletal role for Hop has yet been elucidated, apart from its 
proposed interactions with eukaryotic chaperonin-containing TCP1 (CCT), also known as 
the TCP-1 ring complex (TriC), which may be involved in the proper folding of actins 
and tubulins (Gebauer et al., 1998). Although neither Hsp70 nor Hsp90 were detected in 
the cytoskeletal fractions under normal conditions, there was a definite presence of both 
these chaperones in the cytoskeletal fractions after heat shock. Hsp70 is also known to 
interact with CCT during the refolding of luciferease in vitro, and this phenomenon is 
proposed to occur in vivo for certain substrates after translation or after stress-induced 
damage (Gebauer et al., 1998). Early reports showed the co-localization of Hsp90 
immunofluorescence with the cytoskeleton (Fostinis et al., 1992; Czar et al., 1996) and 
possible association with tubulins (Sanchez et al., 1988). It is thus possible that Hsp70, 
Hsp90 and Hop are together involved in the chaperoning assembly of various cytoskeletal 
structures.  
  
The co-fractionation of Hop with Hsp90 in the cytosol, membranes, cytoskeleton and 
possibly nucleus under various conditions was particularly interesting due to previous 
reports on the majority of cellular Hop being found in complexes with Hsp90 (Smith et 
al., 1993; Chang et al., 1997; Prodromou et al., 1999). Moreover, the residues of the 
proposed NLS of mouse Hop were seen to overlap with residues which have already been 
shown to be critical for Hop-Hsp90 interaction (Scheufler et al., 2000; Odunuga et al., 
2003; Longshaw et al., 2004). Other studies showed that phosphorylation sites on mouse 
Hop at the serine and threonine residues (S189 and T198 respectively) may play a part in 
regulating the subcellular localization of Hop (Longshaw et al., 2000; Longshaw et al., 
2004). It is possible thus, that the differentially phosphorylated isoforms of Hop may be 
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localized to different subcellular compartments of the cell. Taking the results from the 
previous and the present chapter together, it is proposed that phosphorylation of Hop and 
Hop-Hsp90 interactions may be mechanistically involved in regulating the subcellular 
localization of Hop.   
 
  
 
 
 
CHAPTER 4 
ROLE OF THE PUTATIVE NLS AND IN VITRO 
PHOSPHORYLATION SITES OF HOP IN HOP-HSP90 
BINDING 
 
 
 
 
“Insanity: doing the same thing over and over again and expecting different results.” 
- Albert Einstein 
 
 
 
 
 
 
 
 
 
Chapter 4: Role of the putative NLS and in vitro phosphorylation sites of Hop in Hop-Hsp90 binding 
 
 
91 
4.1 INTRODUCTION 
The majority of cellular Hop is found in a stable complex with Hsp90 in both yeast and 
mammalian systems, as shown by in vitro and in vivo experimentation (Smith et al., 
1993; Chang et al., 1997; Prodromou et al., 1999). Hop exists as a dimer in solution 
(Prodromou et al., 1999; van der Spuy et al., 2001) and associates with Hsp90 in a dimer-
dimer interaction (Prodromou et al., 1999; Hernandez et al., 2002). It has been 
established that it is the central TPR2A domain of Hop which is involved in mediating 
interactions with the TPR acceptor site on Hsp90, found in the C-terminal region and 
comprising of an EEVD motif (Chen et al., 1996b; Brinker et al., 2002; Odunuga et al., 
2003). However it is also proposed that there may be networks of interactions between 
Hop and Hsp90 besides those mediated by the TPR domains of Hop, which allow for its 
functionality as a scaffolding protein (Odunuga et al., 2003; Flom et al., 2006; Flom et 
al., 2007).  
 
A direct interaction between Hop and the ATP-binding site in the N-terminal domain of 
Hsp90 has been suggested based on studies that showed a weakened binding of Hop to 
Hsp90 when part of the N-terminal ATP-binding domain of Hsp90 was deleted (Chen et 
al., 1998). In addition, yeast Hop was shown to inhibit the ATPase activity of Hsp90 in 
vitro, as well as displace geldanamycin, which binds to the ATP-binding site of Hsp90 in 
the N-terminus (Prodromou et al., 1999). Based on in vitro biochemical studies, a change 
in the conformation of Hop and/or Hsp90 during its interaction has been speculated 
(Prodromou et al., 1999). Changes in the structural conformation of Hop when bound to 
Hsp90 are not unexpected, since it is known that binding of Hop to Hsp90 reduces the 
number of Hsp70 binding sites on the Hop dimer from two sites to one site, but at the 
same time, increases the affinity of Hsp70-Hop binding five fold (Hernandez et al., 
2002). Hsp90 may alter the conformation of Hop to one that better accommodates Hsp70, 
or Hop-Hsp90 binding may open up a new conformation of Hsp90 which provides 
contact sites for Hsp70 binding (Murphy et al., 2001; Hernandez et al., 2002).  
 
Although a bipartite NLS was proposed in mouse Hop, which on its own has been shown 
to be functional (Longshaw et al., 2004), results of the previous chapter showed that 
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predicted residues within the major arm of this putative NLS were not directly involved 
in translocation of Hop into the nucleus. These residues of the major arm of the putative 
bipartite NLS of Hop overlap with the TPR2A domain which modulates interactions 
between Hop and the ‘EEVD’ motif of Hsp90 (as shown in figure 1.4). Residues within 
the spacer region of the NLS (N233, K229 and K301), which also overlap with TPR2A, 
have already been shown to be crucial for Hop-Hsp90 interactions (Scheufler et al., 2000; 
Odunuga et al., 2003). It was thus speculated that the residues, which formed part of the 
major arm of the putative NLS, were involved in Hop-Hsp90 interaction, and in this way, 
the nuclear localization of Hop was affected by Hop-Hsp90 interaction. 
 
The results obtained from chapter 2 showed that Hop was phosphorylated in vivo. 
Previous work has detailed two in vitro phosphorylation sites for CKII and cdc2 kinase 
on mouse Hop, which were identified at S189 and T198, respectively. These were found 
upstream of the putative NLS and evidence was presented that suggested that 
phosphorylation at either of these sites could affect the subcellular localization of Hop 
(Longshaw et al., 2000; Longshaw et al., 2004). S189 and T198 are found immediately 
upstream of the TPR2A domain of mouse Hop. The main objective of this study was to 
test the hypothesis that phosphorylation of Hop might play a significant role in the 
binding of Hop to Hsp90, and Hop-Hsp90 binding may be mechanistically involved in 
regulating the subcellular localization of Hop.  
 
The specific objectives of this study were to:  
1. Generate GST-Hop and its mutational constructs, GST-Hop-K239A, GST-Hop-
K237/238/239A, GST-Hop-S189E and GST-Hop-T198E. 
2. Purify GST-Hop and its derivative proteins for SPR and co-precipitation studies. 
3. Determine any possible interactions of the major arm of the proposed NLS with 
Hsp90. 
4. Determine whether phosphorylation of Hop at the S189 or T198 position affects 
its interactions with Hsp90.   
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4.2 EXPERIMENTAL PROCEDURES 
4.2.1 Generation and Analysis of Plasmid Constructs Encoding GST-Hop 
and its Derivative Proteins 
The GST-Hop protein and its various derivatives were generated from the plasmid 
pGEX3X2000, which contains the cDNA encoding the full-length protein mSTI1 fused 
to the C-terminus of glutatione-S-transferase (GST-Hop). All mutations were carried out 
by site-directed mutagenesis using a double-stranded whole plasmid linear amplification 
procedure (Appendix A8). For screening purposes, silent mutations were engineered to 
create restriction sites except where the desired codon change(s) automatically generated 
restriction sites. The specific mutagenic primers are listed in Section C of the Appendix. 
All plasmid constructs and their mutations were confirmed both by restriction enzyme 
analysis (Appendix A9) and by DNA sequencing (Appendix A11).   
 
4.2.2 Expression and Purification of GST-Tagged Proteins 
pGEX3X2000-derived plasmid constructs were transformed into E.coli XL1 Blue cells 
(Appendix A4) and expressed and purified using the protocol detailed in Appendix 
Section A6.  
 
4.2.3 Surface Plasmon Resonance Spectroscopy (SPR) Analysis 
Surface plasmon resonance (SPR) studies were performed using a Biacore X apparatus 
(BIACORE, Sweden) to measure the interactions of GST-Hop and its various mutant 
derivatives with Hsp90 in real-time. SPR refers to the angle with which an incident beam 
of light strikes a metal surface. Interactions between biomolecules on this metal surface 
cause corresponding changes in the angle and intensity of the reflected light, and this is 
used to detect any such molecular interaction that occurs on the metal surface. The 
running buffer for SPR (10 mM Hepes containing 140 mM KCl and 0.001% Tween) 
analysis was filter-sterilized and degassed before use. The Biacore X apparatus was 
primed with the running buffer using the standard priming protocol, which involved the 
washing and equilibration of the Biacore chip (Sensor chip CM5) and valves within the 
instrument with running buffer at room temperature.  A mixture of N-hydroxy-
succinimide and 1-ethyl-3 –[3-dimethylaminopropyl] carbodiimide (NHS/EDC) was 
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injected into the first flow cell to activate the surface of the chip by modification of the 
carboxymethyl groups to N-hydroxysuccinimide esters.  
 
Purified Hsp90 (40 µL of 60 µg/mL stock solution) was immobilized onto the activated 
carboxymethylated dextran surface of the chip by amine coupling (the N-
hydroxysuccinimide esters reacted spontaneously with the amines on the Hsp90 to form 
covalent links) by injection into the first flow cell only. The second flow cell was used as 
a control for non-specific binding to the chip, and therefore no Hsp90 was immobilized 
on it. Approximately 9165 response units (RU) of Hsp90 were immobilized onto the first 
flow cell of the chip. Any unreacted N-hydroxysuccinimide esters and unbound Hsp90 
was deactivated and washed out by injecting ethanolamine hydrochloride (40 µL) into 
both flow cells.  
 
The purified GST-Hop proteins were dialyzed to exchange the elution buffer containing 
Tris-HCL for the SPR running buffer before conducting the SPR analysis. Increasing 
concentrations (0.2 µM, 1 µM and 5 µM) of various GST-Hop constructs were passed 
over the immobilized Hsp90 at a continuous flow rate of 10 µL minute-1 and the 
associated kinetics were recorded. GST (0.2 µM, 1 µM and 5 µM) was also passed 
through both cells and any non-specific binding to Hsp90 and/or the chip was monitored. 
Regeneration of the chip in between each consecutive protein concentration or protein 
construct was achieved by passing 10 mM HCl on the chip at a flow rate of 10 µL 
minute-1. All experiments were performed at room temperature.  
 
The data was analyzed using the BIAevaluation software version 3.0. Binding curves 
were generated by plotting response units (RU) versus time (seconds) and then fitted onto 
the Langmuir binding model. This was used to determine the apparent dissociation 
constants (KD values), which were taken as apparent affinities of binding. 
 
4.2.4 GST-Co-Precipitation Assays 
In separate 1 mL reactions, GST-Hop fusion proteins (GST alone was used as a negative 
control, and GST-C334 which contained the C-terminal TPR domains essential for Hop-
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Hsp90 binding was used as the positive control) were coupled to glutathione-agarose 
beads to a final concentration of 0.3 µM (note that a final volume of 1 mL was sufficient 
to dilute out the presence of reduced glutathione). Binding to the beads was allowed to 
occur for 1 hour at 4°C, after which unbound fusion protein was removed by washing 
three times in ice-cold PBS. Hsp90 binding assays were carried out using purified Hsp90 
(Söti et al., 1998), which was added to a final concentration of 0.2 µM. After incubation 
for 3 hours at 4°C, the beads were collected and washed extensively in ice-cold PBS to 
remove nonspecifically bound extract proteins.  
 
The bound proteins were solubilized in SDS sample buffer (70 µL) and resolved using 
SDS-PAGE. Chemiluminescence-based Western analysis (see section 2.2.5 and 2.2.6) 
was used to detect the co-precipitation of Hsp90 (monoclonal rat anti-human Hsp90 at a 
final dilution of 1:5000 was used as the primary antibody, and an HRP-conjugated goat 
anti-rat IgM was used as the secondary antibody at a final dilution of 1:5000) with the 
various GST-Hop fusion proteins.  
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4.3 RESULTS 
4.3.1 pGEX3X2000 and its Derivatives Were Successfully Generated 
Site-directed mutagenesis was used to generate the following modified plasmids: 
pGEX3X2000(K239A), pGEX3X2000(K237/238/239A) as shown in figure 4.1 A and B 
respectively. Treatment of the parent plasmid pGEX3X2000 (figure 4.1 C) with Hind III 
produced a linearized fragment of approximately 7017 as was expected (figure 4.1 D, 
lane 2 and E, lane 4). Partial digestion of the DNA was seen in figure 4.1 D, lane 4. An 
Nsi I restriction endonuclease site was engineered into the codon changes associated with 
the K239A and K237/238/239A substitutions, such that treatment of pGEX3X2000 
(unmodified plasmid) with Nsi I did not fragment the plasmid, as shown in lane 3 of both 
figure 4.1 D and E. However, treatment of pGEX3X2000 (K239A) and pGEX3X2000 
(K237/238/239A) with Nsi I yielded linearized fragments of expected size 7017 bp in 
figure 4.1 D lane 5 and figure 4.1 E lane 6 respectively. Controls showing undigested 
pGEX3X2000 (K239A) and pGEX3X2000 (K237/238/239A) were shown in lanes 4 of 
figure 4.1 D and 5 of figure 4.1 E respectively.  
 
Phosphorylation mimics were also constructed by generating the following plasmids: 
pGEX3X2000(S189E) (figure 4.2 A) and pGEX3X2000(T198E) (figure 4.2 B), which 
were analyzed by restriction endonuclease digestion as shown in figure 4.2 D and E.  
Treatment of the parent plasmid pGEX3X2000 (figure 4.2 C) with Hind III produced a 
linearized fragment of approximately 7017 as was expected (figure 4.2 D, lane 4). The 
codon change for the S189E substitution was engineered onto the parent plasmid with an 
Acc I restriction site that was not present on the parent plasmid. Hence pGEX3X2000 
treated with Acc I did not produce any digested fragments (figure 4.2 D, lane 3). 
However, treatment of pGEX3X2000 (S189E) with Acc I linearized the plasmid into the 
expected sized fragment of 7017 bp (figure 4.2 D, lane 6). Uncut controls of 
pGEX3X2000 and pGEX3X2000 (S189E) are shown in lanes 2 and 5 of figure 4.2 D. 
The T198E substitution was engineered on the parent plasmid such that an additional Eag 
I site was included after modification. Thus pGEX3X2000 was linearized by treatment 
with Eag I (figure 4.2 E, lane 3) whereas pGEX3X2000 (T198E) treated with Eag I was 
digested into two fragments of expected sizes, 5564 and 1453 bp (figure 4.2 E, lane 6). 
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The uncut controls of both parent and modified plasmids are shown in lanes 2 and 4 of 
figure 4.2 E). All plasmids were further confirmed by sequencing analysis. 
 
4.3.2 GST-Hop and its Derivative Proteins Were Successfully Expressed 
and Purified 
GST-Hop and its derivative proteins were heterologously over-produced in E. coli XLI 
Blue cells carrying the respective pGEX3X2000 plasmid or its derived constructs, as 
shown in figure 4.3. The proteins were then purified by S-hexyl glutathione agarose 
affinity chromatography after optimally expressing them by 5 hours of IPTG induction. 
The majority of the protein was recovered in the soluble fractions after clarification of the 
cell extracts. Aliquots of the purified proteins were resolved by SDS-PAGE to confirm 
the enrichment of the eluent with GST-Hop or its derivative proteins according to van der 
Spuy et al. (2000). 
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Figure 4.1 pGEX3X2000 and its NLS-mutated derivatives were successfully generated. Site-
directed mutagenesis was used to generate the following modified plasm ids: (A) 
pGEX3X2000(K239A), (B) pGEX3X2000(K2371238/239A) from the parent plasmid (C) 
pGEX3X2000. The mutations were analyzed by restriction endonucleases and the resultant fragments 
were resolved on a 0.8% agarose gel (D and E). Sizes of each DNA marker fragment in basepairs 
(bp) are annotated on the left and expected sizes of the fragments obtained after each digest (bp) are 
annotated on the right. Nicked (N) and supercoiled (S) DNA fragments are annotated on the right 
hand side of the gel. (D) pGEX3X2000 (K239A) was analyzed by digestion with Nsi I. Lane 1: 
Lambda markers digested with Pst I; Lane 2: pGEX3X2000 linearized with Hind III; Lane 3: 
pGEX3X2000 treated with Nsi I but uncut; Lane 4: pGEX3X2000 (K239A) undigested; Lane 5: 
pGEX3X2000 (K239A) linearized with Nsi I. (E) pGEX3X2000 (K237/238/239A) was analyzed 
with Nsi I. Lane 1: Lambda markers digested with Pst I; Lane 2: Uncut pGEX3X2000; Lane 3: 
pGEX3X2000 treated with Nsi I but uncut; Lane 4: pGEX3X2000 linearized with Hind III; Lane 5: 
pGEX3X2000 (K237/238/239A) undigested; Lane 6: pGEX3X2000 (K237/238/239A) linearized 
with Nsi I. 
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Figure 4.2: Phosphorylation mimic constructs pGEX3X2000 (S189E) and pGEX3X2000 
(T198E) were successfully generated and confirmed using restriction endonuclease analysis. 
Site-directed mutagenesis was used to generate the following modified plasmids: (A) 
pGEX3X2000(S189E), (B) pGEX3X2000(T198E) from the parent plasmid, (C) pGEX3X2000. The 
mutations were analyzed by restriction endonucleases and the resultant fragments were resolved on a 
0.8 % agarose gel. Sizes of each DNA marker fragment in basepairs (bp) are annotated on the left and 
expected sizes of the fragments obtained after each digest (bp) are annotated on the right. Nicked (N) 
and supercoiled (S) DNA fragments are annotated on the right hand side of the gel (D) pGEX3X2000 
(S189E) was analyzed by digestion with Acc I. Lane 1: Lambda markers digested with Pst I; Lane 2: 
pGEX3X2000 uncut; Lane 3: pGEX3X2000 treated with Acc I but uncut; Lane 4: pGEX3X2000 
linearized with Hind III at the expected fragment size of 7017 bp; 5: pGEX3X2000 (S189E) uncut; 6:  
pGEX3X2000 (S189E) linearized with Acc I (7017 bp). (E) pGEX3X2000 (T198E) was analyzed 
with Eag I. Lane 1: Lambda markers digested with Pst I; Lane 2: Uncut pGEX3X2000; Lane 3: 
pGEX3X2000 linearized with Eag I (7017 bp); Lane 4: pGEX3X2000 (T198E) undigested; Lane 6: 
pGEX3X2000 (T198E) fragmented with Eag I into two bands of expected sizes, 5564 and 1453 bp.  
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Figure 4.3 GST-Hop and its derivative proteins were successfully expressed and purified. All 
GST-Hop proteins were heterologously over-produced in E. coli XLI Blue cells carrying the 
respective pGEX3X2000 plasmid or its derived constructs and further analyzed by SDS-PAGE. Lane 
1: Molecular mass markers; Lane 2: GST; Lane 3: GST-Hop; Lane 4: GST-C334; Lane 5: GST-Hop-
K239A; Lane 6: GST-Hop-K237/238/239A; Lane 7: GST-Hop-S189E; Lane 8: GST-Hop-T198E. 10 
µL of the eluent containing varying concentrations of total protein was loaded in each lane.  
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4.3.3 The Interaction of GST-Hop and Derivative Proteins With Hsp90 
Using SPR Analysis 
SPR analysis was used to monitor the biomolecular interactions of GST-Hop and various 
derivatives of this protein with Hsp90. Concentration-dependent SPR signals (0.2, 1 and 
5 µM) were recorded for specific protein interactions. Apparent dissociation constants 
(KD values) were determined and taken as apparent affinities of binding. The binding 
curves of three concentrations of GST-Hop to immobilized Hsp90 showed a dose-
dependent binding pattern as seen in figure 4.4 A. The binding of the phosphorylation 
mimics, GST-Hop-S189E and GST-Hop-T198E to immobilized Hsp90 also showed 
similar dose-dependent patterns (figure 4.4 D and E) in contrast to the NLS mutants, 
GST-Hop-K239A and GST-Hop-K237/238/239A (figure 4.4 B and C), which showed 
similar binding patterns to Hsp90 as that of the negative control, GST (figure 4.5 A). The 
KD of binding of the full-length unmodified Hop (GST-Hop) to immobilized Hsp90 was 
calculated to be 1.4 µM. This value correlates with KD values reported in the literature 
(Brinker et al., 2002; Odunuga et al., 2003). KD values for GST-Hop-K239A and GST-
Hop-K237/238/239A could not be calculated due to the low levels of interaction with 
Hsp90. The KD of binding of GST-Hop-S189E with Hsp90 was calculated to be 1 µM 
and that of GST-Hop-T198E with Hsp90, 2.5 µM. GST-Hop-T198E showed reduced 
binding to Hsp90 compared to the unmodified protein, GST-Hop (figure 4.5 B). These 
experiments have been repeated independently by immobilizing the GST-Hop constructs 
on a sensor chip and passing purified Hsp90. Similar results were obtained (data not 
shown). 
 
4.3.4 The Interaction of GST-Hop Derivative Proteins With Hsp90 Using 
GST-Co-Precipitation Assays 
GST-co-precipitation assays using equivalent concentrations (0.3 µM) of GST-fusion 
proteins (confirmed by Coomassie staining; data not shown) were carried out to confirm 
the results obtained using SPR analysis. The results showed that all mutant derivatives of 
GST-Hop, GST- Hop-T198E, GST-Hop-K239A and GST-Hop-K237/238/239A, showed 
minimal and possibly non-specific binding to purified Hsp90, compared to the positive 
control, GST-C334 and the negative control, GST.  
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Figure 4.4: Surface plasmon resonance (SPR) spectroscopy was used to determine the apparent 
affinity of GST-Hop and its derivative proteins for purified Hsp90. Approximately 9165 response 
units (RU) of Hsp90 was immobilized on a sensor chip, and three varying concentrations of each 
GST-Hop protein (purple: 5 µM, light blue: 1 µM and dark blue: 0.2 µM) was passed over the chip at 
a continuous flow rate of 10 µL/minute. The response units obtained were plotted against time (in 
seconds) to obtain the binding response curves. A: GST-Hop-Hsp90 binding; B: GST-Hop-K239A-
Hsp90 binding; C: GST-Hop-K237/238/239A-Hsp90 binding; D: GST-Hop-S189E-Hsp90 binding; 
E:  GST-Hop-T198E-Hsp90 binding.  
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Figure 4.5 Mutations in the major arm of the NLS abrogated Hop-Hsp90 binding whereas cdc2-
kinase phosphorylation of Hop may disrupt binding of Hop to Hsp90. A summary of the relative 
binding response curves of GST-Hop and its derivative proteins (1 µM) with purified Hsp90 generated by 
surface plasmon resonance (SPR) spectroscopy. Color codes are indicated to the right and the left of each 
graph. A: GST-Hop and the NLS mutants (GST-Hop-K239A and GST-Hop-K237/238/239A) with Hsp90. 
GST alone was used as the negative control. Relative binding curves shown by both NLS mutants were 
comparable to GST and thus showed negative binding to Hsp90. B: GST-Hop and the phosphorylation 
mimics (GST-Hop-S189E and GST-Hop-T198E) with Hsp90. GST-Hop-S189E showed a similar binding 
response pattern to Hsp90 as did unmodified GST-Hop. However, GST-Hop-T198E showed comparatively 
reduced binding to Hsp90. GST was used as the negative control.   
Chapter 4: Role of the putative NLS and in vitro phosphorylation sites of Hop in Hop-Hsp90 binding 
 
 
 104 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1        2           3            4        5 
Hsp90 
Figure 4.6: Interaction of GST-Hop derivative proteins with purified Hsp90. Co-precipitation 
assays were used to confirm the extent of interaction between various GST-Hop derivatives (0.3 µM) 
and purified Hsp90 (0.2 µM). GST-Hop proteins that were previously coupled to glutathione agarose 
beads were incubated with purified Hsp90 for three hours at 4oC. After extensive washes to remove 
unbound proteins, the bound proteins were solubilized in SDS sample buffer and resolved by SDS-
PAGE. Western analysis was carried out to detect the co-precipitation of Hsp90 with the GST-Hop 
proteins by using an antibody specific for Hsp90 α and β. Lane 1: GST-C334 (positive control); Lane 
2: GST (negative control); Lane 3: GST-Hop-K239A; Lane 4: GST-Hop-K237/238/239A; Lane 5: 
GST-Hop-T198E. This figure is representative of two independently conducted experiments.  
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4.4 DISCUSSION 
Residues, K237, K238 and K239, which constitute the major arm of the proposed 
bipartite NLS, were shown to be critical for Hop-Hsp90 interactions by SPR and GST-co-
precipitation studies. Mutation of these amino acid residues abrogated binding to Hsp90, 
and the results were comparable to that of the negative control, GST (figure 4.5 A). Three 
different concentrations of each mutant were passed over immobilized Hsp90 on a chip, 
in order to calculate the mutant/Hsp90 affinity constants. However, since binding of the 
mutant Hop proteins to Hsp90 were below detection, it was impossible to calculate KD 
values (figure 4.4 B and C). The effects of phosphorylation at two sites previously 
described, S189 and T198 (Longshaw et al., 2004), on Hop-Hsp90 interactions were also 
investigated. SPR analysis of the phosphorylation mimics, GST-Hop-S189E and GST-
Hop-T198E with Hsp90 showed that mimicking phosphorylation at position S189 did not 
alter Hop-Hsp90 interactions (figure 4.5 B) and showed similar affinity values to 
unmodified Hop (figure 4.4 D compared to A). GST-Hop-T198E on the other hand, 
showed a diminished affinity for Hsp90 compared to that of unmodified Hop (figure 4.5 
B). GST-co-precipitation assays confirmed the low affinity binding of GST-Hop-T198E 
to Hsp90 (figure 4.6), with similar levels of Hsp90 co-precipitating for this GST-Hop 
mutant as was observed for the negative control, GST.  
  
Interestingly SPR analysis showed partial disruption of Hsp90-GST-Hop-T198E 
interactions whereas the co-precipitation analysis suggested that mimicking 
phosphorylation at T198 completely abolished interactions of Hop with Hsp90. This may 
reflect the transient nature of interactions between Hsp90 and the phosphorylated mimic 
of Hop, since the SPR technique can generally detect weak protein-protein interactions 
which are not always detectable using GST-co-precipitation analysis. It must also be 
noted that the KD values were calculated by artificially fitting the binding response curves 
obtained onto a Langmuir binding curve, and is therefore not exact, but rather an apparent 
value reflecting the affinity between the two proteins. Moreover, a number of differences 
in technicalities between the two methods may have given rise to slight differences in 
results obtained. In the SPR studies conducted, Hsp90 was immobilized on the surface of 
a chip and GST-Hop proteins were passed over it, whereas in the co-precipitation 
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analysis, although GST was bound to the matrix, neither Hop nor Hsp90 was 
immobilized. Immobilization of Hsp90 may have allowed for stronger interactions with 
GST-Hop-T198E, thereby portraying a less realistic illustration of its interactions with 
GST-Hop-T198E. The SPR analysis cannot be completely disregarded on the basis of 
this however, since binding of Hop to Hsp90 showed results comparable to previously 
published work in which Hsp90 was not immobilized (Brinker et al., 2002; Odunuga et 
al., 2003). Moreover, the experiments conducted by immobilizing Hsp90 were repeated 
using immobilized anti-GST, followed by GST-Hop binding, and then passing Hsp90 
over the immobilized GST-Hop. Similar trends were obtained (data not shown).  
 
Taking into consideration the results from the previous chapter together with the present 
chapter, disruption of Hop-Hsp90 binding accounted for increased incidences of nuclear 
localization of Hop. These data suggested that the major arm of the proposed NLS of Hop 
contributed to the network of interactions between Hop and Hsp90, and that these 
interactions may modulate the subcellular localization of Hop by sequestering Hop in the 
cytosol. A three dimensional (3D) representation of the structure of the TPR2A domain 
of Hop, shown in space fill with the NLS residues that were mutated, illustrates the 
proximity of these NLS residues to the methionine of the Hsp90 peptide (figure 4.7). It is 
therefore proposed that one or more of the NLS residues are involved in direct 
interactions with Hsp90.  
 
Mimicking phosphorylation at T198, a site that was earlier shown to be phosphorylated 
by cdc2-kinase in vitro, appeared to disrupt Hop-Hsp90 interaction. Previously, 
immunoprecipitation assays using Hop-T198E-EGFP and NIH 3T3 cell lysate showed 
that Hsp90 co-immunoprecipitated with the phosphorylation mimic in mouse fibroblast 
lysate (Longshaw et al., 2004). This could be attributed to the dimerization of Hop 
(Prodromou et al., 1999; Carrigan et al., 2004) in vivo, resulting in the binding of mutated 
Hop with endogenous unmutated Hop within the cell lysate and thereby masking the 
functional effects of the mutations on Hop. In the present study conducted, no cell lysate 
was introduced into the SPR analysis system and the GST-co-precipitation assay, thereby 
eliminating the possibility of GST-Hop interacting with endogenous Hop.  
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Figure 4.7:  Ribbon representation of the structure of TPR2A of Hop and the C-terminal 
TPR acceptor motif of Hsp90. The structure of the TPR2A (green) of human Hop with the C-
terminal MEEVD motif of Hsp90 shown in red (1ELR; Scheufler et al., 2000). The space filled 
residues in green, K237, K238 and K239 form the major arm of the predicted NLS, and these are 
shown relative to the space filled residue in red, methionine, which forms part of the pentapeptide 
MEEVD of Hsp90. This figure was generated using Pymol Molecular Graphics Software 
(http://pymol.sourceforge.net). 
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A predicted homology model of Hop showing the positions of the phosphorylation sites 
T198 and S189 in conjunction with the first motif of TPR2A domain of Hop depicted the 
positioning of T198 directly opposite K229 (Longshaw, 2002). Phosphorylation at T198 
would induce a negative charge to this residue and this may result in weak ionic 
interactions with a positively charged K229, which in turn, may partially disrupt the 
binding of Hop to Hsp90. The partial disruption of Hop-Hsp90 binding, upon mimicking 
phosphorylation at T198, is indicative of a possible role of phosphorylation in regulating 
Hop-Hsp90 interactions. 
 
Previous studies mapped out residues in TPR2A domain of Hop, K229, N233, N264, 
K301 and R305, which form a carboxylate clamp with the MEEVD motif of the TPR 
acceptor site of Hsp90 (Scheufler et al., 2000; Odunuga et al., 2003). Interestingly, the 
phosphorylation site T198, falls outside of the TPR2A domain. A number of other 
residues have been identified in Hop which are not part of the TPR2A domain but which 
are necessary for Hop-Hsp90 interaction (Flom et al., 2006; Flom et al., 2007). 
Moreover, although the MEEVD sequence of Hsp90 is mainly involved in interaction 
with Hop (Chen et al., 1998), there are multiple binding sites within Hsp90 that are 
necessary for Hop interaction and which are not necessarily part of the MEEVD motif. 
For example, mutations of residues Glu-651 and Asp-653 in Hsp90 not only decreased 
the extent of Hop binding, but also diminished chaperone activity of Hsp90 (Ramsey et 
al., 2000). There are a host of other co-chaperones other than Hop that interact with 
Hsp90 through their TPR domains; mutation of the above mentioned residues in Hsp90 
did not appear to affect their interactions with Hsp90 (Ramsey et al., 2000). The simplest 
conclusion would be that the TPR domain interactions between Hsp90 and Hop serve as a 
targeting site, and that the differences in biological significance of interactions between 
the TPR containing co-chaperone, Hop, with Hsp90 may lie within the sites of interaction 
that are outside the TPR domains.  
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5.1 CHAPTER 2 
2D gel electrophoretic analysis of 120 µg protein of total cell lysate resolved on a non-
linear pI strip of 3-10 confirmed the presence of a major and minor isoform of Hop under 
normal conditions. However, the addition of tyrosine and serine/threonine phosphatase 
inhibitors to the cell lysate, and resolution of the isoforms on a pI strip range of 4-7 
showed that apart from the two isoforms detected initially, there were at least three more 
relatively acidic isoforms. Dephosphorylation of the cell lysate with SAP showed a 
considerable decrease in levels of two of the relatively more acidic isoforms, thereby 
providing evidence of in vivo phosphorylation of at least two subpopulations of Hop 
under normal conditions. Heat shock caused a decrease in the amounts of the major 
isoform and the presence of a number of minor acidic isoforms. Dephosphorylation of the 
heat shocked lysate caused various changes to the isoform composition, with a particular 
decrease in amounts of one of the minor acidic isoforms, which were present after the 
heat shock exposure. This data was suggestive of phosphorylation being a modification 
of Hop under normal conditions, and that Hop was differently phosphorylated after heat 
stress.  
 
5.2 CHAPTER 3 
Previous literature has shown a varied subcellular localization pattern for the various 
homologues of Hop under different conditions. A mouse Hop-EGFP protein construct 
was predominantly cytosolic under normal conditions but showed higher nuclear, but not 
nucleolar, localization when the cells were subjected to heat stress. The arrest of the cells 
in the G1/S transition showed a higher incidence of nuclear accumulation of Hop-EGFP, 
confirming that Hop indeed translocates to the nucleus under G1/S phase arrest. Since 
heat stress is known to cause cell cycle arrest in the G1/S phase (Khandijan, 1995; Kuhl 
and Rensing, 2000) it was concluded that Hop’s nuclear localization was possibly 
primarily regulated by heat stress and secondarily regulated by the cell cycle events.   
 
Biochemical fractionation of the cells confirmed the cytosolic localization of endogenous 
Hop, but also showed that Hop localized to the membranes and to a smaller extent, the 
cytoskeletal fractions, under normal and heat shocked conditions. The presence of 
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endogenous Hop in the nucleus under heat-shocked conditions was detected using the in 
vitro fractionation method and suggested that the nuclear translocation of Hop was of a 
highly dynamic nature and could not be captured with this invasive technique.  
 
Mutation of the residues, K237, K238 and K239, which formed the major arm of the 
putative NLS, did not disrupt the nuclear localization of Hop under heat shock or G1/S 
arrest. Thus unlike classical bipartite NLS’s, the major arm of this NLS did not contribute 
directly to its nuclear translocatory function but may have an alternative regulatory role 
in Hop localization. 
 
Biochemical fractionation of the cells also showed that Hsp70 but not Hsp90 co-
fractionated with Hop to the nucleus under heat stress. Mammalian Hsp90 is known to 
translocate dynamically to the nucleus under heat stress, and it was concluded that this 
method of fractionation was not sufficient to detect Hsp90 in the nucleus and more 
conclusive in vivo techniques would have to be used to confirm this result. Both heat 
shock proteins were shown to localize with Hop in the membranes and cytoskeletal 
fractions of the cells after heat shock.  
 
5.3 CHAPTER 4 
GST-Hop and its various derivatives were successfully constructed and their interactions 
with Hsp90 analyzed using SPR analysis and GST-co-precipitation studies. GST-Hop-
K239A and GST-Hop-K237/238/239A did not bind to Hsp90 and were comparable to the 
negative control, indicating that these residues found within the putative NLS were 
critical for Hop-Hsp90 binding. Mimicking phosphorylation at S189 did not alter Hop-
Hsp90 interactions, but a phosphorylation mimic at T198 showed partial disruption of 
Hop-Hsp90 binding. This suggested that phosphorylation of Hop by cdc2-kinase could 
possibly disrupt this complex formation.  
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5.4 DISCUSSION 
This study of mammalian Hop has shown, for the first time that Hop is a phosphoprotein 
in vivo and that one of the modifications that Hop undergoes when the cell is stressed 
may be phosphorylation. Work done in BHK-21 cells showed that exogenous and 
endogenous Hop was primarily localized to the cytosol and membranes under normal 
conditions. However, under heat stress and/or conditions that may lead to the arrest of the 
cell in the G1/S transitory phase of the cell cycle, mouse Hop-EGFP was localized to the 
nucleus. This supports previously published reports of mouse Hop translocating to the 
nucleus of NIH 3T3 mouse fibroblast cells under conditions of G1/S arrest (Longshaw et 
al., 2004) and provides novel evidence of the subcellular localization of Hop possibly 
being primarily regulated by stress events.  
 
A bipartite NLS within the amino acid sequence of mouse Hop was earlier shown to be 
functional when fused to EGFP by successfully translocating EGFP into the nucleus 
(Longshaw et al., 2004). When the localization of Hop-EGFP NLS mutants was assessed, 
contrary to expectations, there was an increased incidence of nuclear localization of the 
NLS mutants. This suggested that the residues of the major arm of this putative NLS 
were not directly responsible for nuclear translocation of Hop. However mutation of the 
NLS in Hop abrogated binding of Hop to Hsp90, as was shown by the in vitro studies 
conducted. A ribbon representation of the 3D structure of TPR2A domain of Hop in 
association with the Hsp90 pentapeptide shown in figure 4.7 demonstrated the proximity 
of the residues of the major arm of the NLS to methionine of Hsp90. This shows the 
potential of Hop-Hsp90 interactions in regulating the localization of Hop. Hop-Hsp90 
binding may act as a cytosolic retention factor for Hop. Based on the results from this 
study, as well as what is currently known about Hop’s subcellular localization 
particularly in terms of its nucleocytosolic shuttling capabilities, and its functions within 
the cell, we propose a model shown in figure 5.1. Various aspects of this model are 
further discussed in this section. 
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Figure 5.1: Predicted model for Hop's interaction as an Hsp70-Hsp90 co-chaperone. Hop 
exists on its own or in complex with Hsp90, in the cytosol under normal conditions. This may be 
regulated by phosphorylation (a). Interaction of Hop with Hsp90 is known to facilitate a number of 
other interactions, of which the most well established one is the interaction of Hop-Hsp90 complex 
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(Figure 5.1 contd) 
with Hsp70 in order to facilitate substrate transfer from Hsp70 to Hsp90 (b). This multichaperone 
complex then dissociates, freeing its various components. Hop is known to trans locate to the nucleus 
(c) under stress conditions and its nuclear localization mechanism may be regulated by 
phosphorylation by CKII and cdc2 kinase. It is already known that both Hsp70 and Hsp90 translocate 
to the nucleus under heat shock (f and g respectively). Hop may also be capable of moving into the 
nucleus in concert with Hsp90 (d) as a complex (arrows shown in dotted lines) using its putative NLS 
(222-239), or through the functioning of multiple NLSs. Within the nucleus Hop may have a number 
of functions , of which we propose that it is capable of its basic function of interacting with Hsp70 
and/or Hsp90 to form nuclear complexes (e). 
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The possibility that binding of Hop to Hsp90 may serve to sequester Hop in the cytosol 
(figure 5.1) is consistent with the finding that the majority of Hop under normal 
conditions is cytosolic and complexed to Hsp90 (Smith et al., 1993; Chang et al., 1997; 
Prodromou et al., 1999). Ligand-Hsp90 interactions sequestering the ligand within the 
cytosol has previously been reported in the case of the GR which when bound to Hsp90 
restricted its localization to the cytosol (Guiochon-Mantel et al., 1996). A protein-protein 
interaction regulating the subcellular localization of one or both partners is also seen in 
the case of ICAP-1 (integrin cytoplasmic domain-associated protein 1), a protein 
involved in cell proliferation processes and possessing a functional NLS. The cytosolic 
retention of ICAP-1, which shuttles between the nucleus and the cytoplasm, was shown 
to be through the specific interaction of this protein with β-1 integrin (Fournier et al., 
2005).  
 
In the case of Hop, however, we suggest that not only does binding of Hop to Hsp90 
regulate its cytosolic retention, but also that the Hop-Hsp90 interaction could involve 
residues of the proposed bipartite NLS of Hop. Therefore, within the bipartite NLS, the 
minor arm could be the functional nuclear localization signal, whereas the major arm, in 
binding to Hsp90, promotes cytosolic retention of Hop-Hsp90 under normal conditions. 
Despite the apparent logic of this suggested mechanism of cytosolic retention by NLS-
protein interaction, surprisingly few reports of such interactions are available. Li et al.  
(1999) showed that the breast cancer-associated protein, BCRA1, which is previously 
described in section 1.1.3, is sequestered in the cytosol by binding of its NLS to a 
cytosolic retention protein, BRAP2 (BCRA1-associated protein 2). The BRCA1 protein 
is a nucleo-cytosolic shuttling protein that is ordinarily targeted to the nuclei by two 
functional NLS motifs, which bind to importin α. Its exclusive retention in the cytosol or 
the nucleus has been observed in many breast cancer cell lines; however this was 
suggested to be due to problems in its nucleo-cytosolic transport regulation rather than 
due to mutations within BRCA1 (Chen et al., 1996a; Li et al., 1999; Fabbro et al., 2002).  
 
The cytosolic retention protein BRAP2 showed a higher affinity for NLS motifs of 
BRCA1 than does importin-α. It was speculated that phosphorylation of BRCA1 may 
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serve to dissociate it from the BRCA1-BRAP2 complex, and allow for binding to 
importin-α and consequent nuclear translocation. Interestingly, BRAP2 also recognized 
the NLS motifs of SV40 large T-ag and the bipartite NLS found in mitosin. The role of 
BRAP2 was suggested to be exclusive to regulation of nuclear transport of a number of 
shuttling proteins by serving as a cytosolic retention protein (Li et al., 1999). This was 
confirmed more recently by reports showing the interaction of BRAP2 with the NLS of 
cell cycle inhibitory protein p21 during monocyte differentiation, causing the cytosolic 
arrest of p21 (Asada et al., 2004). p21 expressed in the cytosol is known to inhibit 
apoptosis as well as promote the assembly and nuclear translocation of cyclinD/Cdk4 
complexes (LaBaer et al., 1997; Asada et al., 1999). Thus its interaction with BRAP2 
appears to be a mode of regulation of its nucleo-cytosolic trafficking.  
 
Reports showing the interaction of the prion protein PrPc with Hop mapped out residues 
on TPR2A of Hop to be crucial for this interaction (Coitinho et al., 2007). Since a 
number of residues on TPR2A are also crucial for Hop-Hsp90 interactions, it is possible 
that PrPc may compete with Hsp90 for binding to Hop. Wild-type PrPc is not detected in 
the cytosol and is localized predominantly on cell surfaces or synaptosomal fractions 
(Martins et al., 2001; Zanata et al., 2002). Since a portion of Hop has been shown to be 
localized at the cell membranes, it is also possible that Prpc-Hop binding through residues 
within the TPR2A of Hop which may include those found in the NLS region, could allow 
for the retention of a subpopulation of Hop at the plasma membrane.  
 
A second potential NLS in mouse Hop was detected downstream (amino acids 337-351), 
shown in figure 5.2, which appeared to be ‘buried’ within the protein conformation 
(Blatch et al., 1997). The possibility exists that both NLSs are functional in vivo. It is 
already known that multiple copies of an NLS are more efficient than single copies, for 
example, the maize R protein requires two of three NLS-functioning sequences to be 
nuclear (Shieh et al., 1993). Also, in the case of the APC protein, two monopartite NLSs 
were identified. Although either NLS was found to be sufficient to function on its own, 
optimal nuclear import of APC required both NLS functioning (Zhang et al., 2000).  
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Figure 5.2: Minor arm of the putative NLS acts as a Monopartite NLS with a second possible 
NLS downstream? A ribbon representation of the structure of TPR2A (green) of human Hop with 
the C-terminal MEEVD motif of Hsp90 shown in red (1ELR; Scheufler et al., 2000). The minor arm 
of the predicted bipartite NLS (residues K222 and K223, shown in blue) may be responsible for the 
functionality of the NLS, with the major arm acting as a cytosolic retention factor by interacting with 
Hsp90. There also exists the possibility of a second NLS found downstream of the first NLS, also 
shown in blue (residues 337-351), which could be acting in concert with the predicted bipartite NLS. 
Residues shown in gold are those that form part of the carboxylate clamp of Hop, which is important 
for interaction with Hsp90 (Odunuga et al., 2003). This figure was generated using Pymol Molecular 
Graphics Software (http://pymol.sourceforge.net). 
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If both NLSs found in mouse Hop are indeed functional, mutation of the major arm of the 
first NLS could result in a modification of the structure of Hop such that the second NLS 
may be better positioned and exposed to importin binding, facilitating more efficient 
nuclear localization than that obtained for unmutated Hop.   
 
Hsp90 is cytosolic under normal conditions but has been shown to translocate to the 
nucleus as shown in figure 5.1g (Perdew et al., 1993), and has also been implicated in the 
dynamic nuclear trafficking of SR and p53 (Pratt, 1997; Galigniana et al., 2004). Hsp90 
translocates into the nucleus under heat shock and although a number of potential NLS’s 
have been identified within its amino acid sequence, none of them have been shown to be 
functional in vivo (Biggiogera et al., 1996; Bharadwaj et al., 1999; Langer et al., 2003). It 
has been proposed, however, that certain conditions, which alter the conformation of 
Hsp90, may allow for the presentation of its NLSs such that they become functional 
(Langer et al., 2003). The interaction of Hop with Hsp90 is one in which the 
conformation of one or both partners is altered (Prodromou et al., 1999; Murphy et al., 
2001; Hernandez et al., 2002).  
 
Thus although the Hop-Hsp90 complex is cytosolic under normal conditions, it is 
tempting to speculate that a sub-population of Hop and Hsp90 may be directed to the 
nucleus as a complex under heat stress, either by the combined effort of NLSs found 
within both proteins, or by Hsp90 ‘piggy-backing’ on Hop (figure 5.1d). However, this 
does not exclude the translocation of a population of Hop into the nucleus on its own 
(figure 5.1c). This is inferred by the finding that mutations in Hop that were seen to 
disrupt Hop-Hsp90 binding in vitro, were also seen to promote the nuclear translocation 
of Hop in vivo.   
 
The nuclear translocation of both Hop, and Hsp90 have been described as dynamic 
(Langer et al., 2003; Longshaw et al., 2004) and it was proposed that Hop was constantly 
shuttling between the nucleus and the cytosol but that the nuclear export of Hop occurred 
at a faster rate than its nuclear import (Longshaw et al., 2004). The results of the in vitro 
fractionation studies supports this theory because of the difficulty in detecting Hop in the 
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nuclear extracts of heat stressed cells, despite the evident detection of its nuclear 
localization under heat stress and cell cycle arrest, using confocal microscopic analysis. 
Moreover Hsp90, which is known to translocate to the nucleus under stressful conditions 
like heat shock (Perdew et al., 1993; Biggiogera et al., 1996; Bharadwaj et al., 1999; 
Langer et al., 2003) was not detected in the heat shocked nuclear fractions obtained by 
biochemical fractionation (chapter 3). Thus, although this method was sufficient to detect 
the nuclear localization of proteins such as Hsp70 after heat shock, the time delays 
involved in various steps of fractionation were not necessarily conducive to detecting the 
subcellular localization of dynamically shuttling proteins.  
 
Hop was found to co-fractionate with Hsp70 in the nucleus after heat shock; this was not 
unexpected, as Hsp70 has been shown to migrate to the nucleus and the nucleolus, 
particularly during stress (figure 5.1f), where it is involved in stress-related 
cytoprotection (Bharadwaj et al., 1999; Nollen et al., 2001). Hsp70 not only participated 
in the holding and refolding of heat unfolded nuclear proteins, but also stimulated the 
translocation of unfolded proteins into the nucleolus during stress. Storage of these 
unfolded proteins in the nucleolus during stress was associated with preventing random 
aggregation with other nuclear proteins and temporarily halting protein synthesis by 
interfering with the assembly of ribosomes (Nollen et al., 2001).   
 
The detection of Hop in the nucleus under stress conditions allows for various 
speculations on its possible roles within the nucleus, particularly with regards to its 
scaffolding properties as an Hsp70-Hsp90 co-chaperone. It is already known that Hsp70 
is involved in the import of various proteins into the nucleus such as the SV 40 large T-ag 
and nucleoplasmin (Tsukahara and Maru, 2004), as well as being involved in the 
regulation of the activity of certain nuclear DNA-binding transcription factors (Diehl et 
al., 2003). Thus, the question arises as to whether Hop forms heterocomplexes with 
Hsp70 and Hsp90 in the nucleus under stressed conditions as it does in the cytosol (figure 
5.1e). A role for nuclear Hop together with Hsp70 was previously proposed in 
maintaining a transcriptionally potent form of the OCA-S complex, a multicomponent 
transcription activator complex in the S phase (Zheng et al., 2003). 
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Various studies suggest that the regulation of HSF under stress and non-stress conditions 
is mediated by constituents of the Hsp70-Hsp90 multichaperone heterocomplex in a 
similar manner to that of SR complexes (Nair et al., 1996; Bharadwaj et al., 1999). 
Reconstitution experiments in a cell-free system showed that Hop, in addition to Hsp90, 
Hsp70, FKBP51, FKBP52, CyP40 and p23, were capable of forming a heterocomplex 
with HSF (Nair et al., 1996). In an amphibious system (Xenopus oocytes) where HSF is 
an entirely nuclear protein, a role for Hop along with Hsp70 and Hsp90 was proposed in 
the disassembly of the HSF homotrimer within the nucleus (Bharadwaj et al., 1999).  
 
 The possibility of Hop translocating into the nucleus as a complex with Hsp90 implies 
that there may be specific functions for this complex within the nucleus. Hop may be 
involved in Hsp90 complexes that have been shown to stably associate and participate in 
the chaperoning of telomerase complexes (Forsythe et al., 2001). Hop, in both the yeast 
and mammalian system, has been detected within protein complexes involving Hsp90 
and Ssl2, a DNA helicase required for transcription and DNA repair. These results have 
suggested roles for Hop and Hsp90 in mediating the function of Ssl2, and in so doing, 
ultimately being involved in DNA repair and transcription (Flom et al., 2005). However, 
it must be noted that yeast Hop does not appear to have an NLS, and has thus far, not 
been shown to localize to the nucleus.  
 
Hop, Hsp70 and Hsp90 were also found to co-fractionate in the membranes under normal 
and stress conditions, and in the cytoskeleton under heat shocked conditions. This implies 
that Hop interacts as a scaffolding protein with both these major heat shock proteins, not 
only in the cytosol, and possibly nucleus, but also in the membranous and cytoskeletal 
structures of the cell. Further studies in the form of live cell imaging of various 
fluorophore-tagged proteins (i.e. Hop and it’s chaperone partners, Hsp70 and 90) and 
using techniques such as FRAP (Fluorescence Recovery After Photobleaching) and 
FRET (Fluorescence Resonance Energy Transfer) would be required to characterize such 
interactions within these cellular compartments. The function(s) of the possible 
membranous and cytoskeletal Hsp70-Hop-Hsp90 heterocomplexes may not be restricted 
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to those conventionally known of, because of the variation in types of proteins and their 
roles within the various compartments of the cell.  
 
Although this study showed direct evidence of the differential phosphorylation of Hop, 
the residues at which it is phosphorylated have only been mapped in vitro (Longshaw et 
al., 2000). Future studies using antibodies that are developed against phosphorylated 
residues of Hop, such as S189 and T198 (Longshaw et al., 2000) have to be conducted to 
further charecterize the phosphorylation of Hop in vivo. It was postulated that the 
phosphorylation of Hop may regulate its subcellular localization (Longshaw et al., 2000; 
Longshaw et al., 2004) and this hypothesis is supported by this study. The various 
isoforms of Hop seen in the 2D gel electrophoretic study and the change in isoform 
profile after dephosphorylation, confirmed the presence of differentially phosphorylated 
isoforms of Hop under normal as well as stressed conditions; each of these isoforms may 
be differentially localized within the cell. We propose that the major isoform of Hop 
under normal conditions was cytosolic, and that the majority of this isoform was 
complexed to Hsp90 (figure 5.1).  
 
The treatment of mouse fibroblast cells with a CKII inhibitor caused a cytosolic 
distribution of Hop similar to normal conditions. Moreover, a CKII-phosphorylation 
mimic of Hop showed increased incidences of nuclear localization compared to the 
unmodified Hop (Longshaw et al., 2004). Mimicking phosphorylation at the in vitro 
CKII phosphorylation site of Hop had no significant effect on Hop-Hsp90 binding 
implying that phosphorylation of Hop by CKII did not disrupt Hop-Hsp90 interaction. 
Interestingly Hsp90 also associates with CKII and not only enhances its kinase activity 
(Miyata and Yahara, 1992) but is itself phosphorylated by this kinase (Lees-Miller and 
Anderson, 1989). Thus CKII phosphorylation may regulate the nuclear import of Hop, 
whether it is on its own, or in complex with Hsp90 (figure 5.1c,d).  
 
The inhibition of cdc2-kinase in mouse fibroblast cells resulted in a marked nuclear 
accumulation of Hop (Longshaw et al., 2004). In this study, a cdc2-kinase 
phosphorylation mimic of Hop disrupted Hop-Hsp90 interactions in vitro and implied 
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that phosphorylation of Hop by cdc2-kinase was unfavourable for Hop-Hsp90 
interactions in vivo. We speculate that the regulation of the complexation state of Hop 
within the cytosol may be carried out by cdc2-kinase phosphorylation (figure 5.1a). A 
Hop isoform phosphorylated at T198 by cdc2-kinase in vivo may not be associated with 
Hsp90, and be involved in various cytosolic functions that do not involve Hsp90, such as 
Hop-Hsp104 interactions (Abbas-Terki et al., 2001), and the interaction of Hop with 
TRiC which is involved in folding of actins and tubulins (Gebauer et al., 1998).  
 
Dephosphorylation of free Hop at T198 and its subsequent phosphorylation by CKII at 
S189, may enable it to move into the nucleus with or without Hsp90. This may not be the 
only mode of regulation of nuclear translocation. Based on the data presented in this 
study however, we propose that one of the mechanisms that regulates Hop’s interactions 
with Hsp90 and its subcellular localization, both as free Hop and the Hop-Hsp90 
complex, is phosphorylation. Phosphorylation-dephosphorylation events have also been 
implicated in SR-Hsp90 interactions and subcellular trafficking, with studies suggesting 
that under normal physiological conditions a dephosphorylation event, particularly 
relating to serine/threonine phosphorylation sites, may be required for the loss of high 
affinity binding to Hsp90 (Galigniana et al., 1999).  
 
Phosphorylation-dependent subcellular localization of heat shock proteins is not 
uncommon. Hsp25, a small heat shock protein induced by various kinds of cell stress 
conditions, was shown to be phosphorylated by MAPK and ERK signal transduction 
pathways in hippocampal HiB5 cells during heat shock. Although a population of 
phosphorylated Hsp25 remained in the cytosol, a large portion of the phosphorylated 
Hsp25 translocated into the nucleus where it was implicated in various thermoprotective 
roles (Geum et al., 2002). Interestingly, the bacterial homolog of Hsp70, DnaK, showed a 
decrease in electrophoretic mobility and isoelectric point, upon heat shock at 42oC for 30 
minutes. This heat-induced modification was attributed to phosphorylation, and the 
phosphorylated form of DnaK was shown to possess an enhanced affinity for unfolded 
proteins (Sherman and Goldberg, 1993). Although it is known that Hsp70 translocates to 
the nucleus under heat shock, it is not yet known whether phosphorylation of Hsp70 
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plays a functional role in its subcellular localization. Thus it is tempting to speculate that 
heat-induced phosphorylation may be a general mechanism in regulation of the 
subcellular localization, and consequently, function of heat shock proteins and/or their 
co-chaperones. 
 
Further research in this field is necessary to elucidate the mechanism by which Hop 
translocates to the nucleus, specifically with regard to its NLS. Guidelines to establishing 
whether a putative NLS is truly functional in vivo are reviewed by Lange et al. (2007).  
Four main specifications have been elaborated, namely: 
(a). The proposed NLS sequence must be shown to be sufficient to target an unrelated 
protein into the nucleus. 
(b) The transport of the protein into the nucleus must be shown to be dramatically 
hindered upon modification or deletion of the proposed NLS. 
(c) The putative NLS must be shown to directly interact with its putative import receptor.  
(d) Disabling the proposed nuclear import pathway in vivo must be shown to disrupt the 
nuclear import of the protein carrying the proposed NLS. 
 
Thus far, the proposed NLS of Hop has been shown to be functional only with respect to 
the first specification mentioned (Longshaw et al., 2004). Although the transport of the 
protein into the nucleus was shown to be enhanced upon mutation of the major arm of the 
proposed NLS this appeared to be an indirect effect. The results of this study appear to be 
pointing at the minor arm of the putative NLS as being directly responsible for its nuclear 
translocation. However, this has to be established by mutation or deletion of these 
residues and analyzing the subcellular localization of such modified Hop proteins.  
 
The proposed bipartite NLS of Hop has not yet been analyzed with respect to its 
interactions with any nuclear transport machinery, in particular, importin-α and β. 
Several isoforms of importin-α have been described in eukaroytes, including importin-
α1/Rch1, importin-α5/hSRP1, importin-α3/Qip, importin-α4/hSRP1, importin-α6 and 
importin-α7. There are 14 putative members of the importin-β family in the yeast system 
and possibly more than 22 in the mammalian system (Köhler et al., 1999; Ström and 
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Weis, 2001). Previously bipartite NLS sequences have shown to bind to both the major 
and the minor binding site on importin-α, with the major binding site of importin-α 
recognizing the major arm of the NLS and the minor binding site of importin-α 
recognizing the minor arm of the NLS (Conti et al., 1998; Kobe, 1999; Fontes et al., 
2000; Fontes et al., 2005; Lange et al., 2007). Binding of the NLS to the major binding 
site of importin-α appears to be more physiologically relevant to nuclear transport than 
its minor binding site and furthermore, the auto-inhibitory domain on importin-α is found 
on its major NLS-binding site (Conti et al., 1998; Conti and Kuriyan, 2000; Fanara et al., 
2000; Catimel et al., 2001).  
 
Therefore the possibility of the minor arm and not the major arm, of this putative NLS, 
acting as the functional nuclear localization signal is interesting in the context of how it 
interacts with importin-α and needs to be investigated further. Moreover, the results of 
this study raise questions as to whether the second NLS found downstream of the first 
NLS is involved in nuclear translocation, either on its own, or in concert with the first 
NLS. Treating cells with a nuclear export inhibitor such as leptomycin B (Longshaw et 
al., 2004) and analyzing the subcellular localization of various NLS mutants of Hop after 
different time intervals could prove to be a useful kinetic study in determining the nature 
of its NLS’s and subsequently, its nuclear localization. The inhibition of export of mouse 
Hop-EGFP by leptomycin B (Longshaw et al., 2004) suggested a CRM-1 export pathway 
mediated by a nuclear export signal (NES). The NES may be working together with the 
cytosolic retention factor (Hop-Hsp90 interactions) in regulating the export of Hop from 
the nucleus, and its characterization may prove to be vital in further understanding the 
dynamics of Hop’s subcellular localization.  
 
Traditionally, the function of Hop has been restricted to that of Hsp70-Hsp90 scaffolding 
protein, but various studies now indicate that Hop plays a greater role within this system, 
as a modulator of their chaperone activities and is even involved in their protein folding 
pathways. Moreover, other research has also shown that Hop interacts with a variety of 
other proteins that may or may not be linked with Hsp70 or Hsp90. The work presented 
here may be regarded as novel data demonstrating the phosphorylation status of Hop, its 
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subcellular localization patterns under stressful conditions, and its mechanism of 
interaction with Hsp90 as well as the possibility of all three aspects of Hop being 
mechanistically linked. The presence of the various isoforms of Hop including a number 
of differentially phosphorylated isoforms, and its varied subcellular localization patterns 
are an indication of the complex roles that Hop plays in numerous systems and under a 
variety of cellular conditions. Understanding these processes would help to elucidate the 
integral aspects of chaperone-mediated processes within the cell, particularly with 
regards to the assembly of the Hsp70-Hsp90 heterochaperone complex. 
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APPENDIX 
 
 
A1 Special Reagents and Chemicals 
 
Reagent Supplier 
24 Magnet Plate IBA BioTAGnology, Germany (Cat. No. 7-
2006-000) 
2D Clean-Up Kit Amersham Biosciences, USA (Cat. No. 80-
6484-51) 
2D Quant Kit Amersham Biosciences, USA (Cat. No. 80-
6483-56) 
Agarose Sigma, USA 
All reagents such as Ethanol, Methanol, 
Acetic acid 
Chemistry Stores, Rhodes University 
Aprotinin Sigma, USA 
BHK-21 (Baby Hamster Kidney) cells Dr. Martin Ryan, University of St. 
Andrews, Scotland 
BigDye V3.1 ABI, USA  
Bradford Reagent Sigma-Aldrich Inc, USA  
Bradford Reagent Sigma Aldrich, USA  
Carbon dioxide Afrox, South Africa 
DakoCytomation Fluorescent mounting 
medium 
DakoCytomation, Denmark  
Deoxyribonuclease I (Rnase free) Fermentas Life Sciences, USA (Cat. No. 
EN0521) 
Dithiothreitol (DTT) Amersham Biosciences, USA  
DNA Clean and Concentrator-5 Zymo research, USA  
Dulbecco’s Modified Eagle Medium 
(DMEM) 
Cambrex; USA 
Eag I Amersham Pharmacia Biotech 
ECL Advance western blotting detection 
kit 
Amersham Biosciences, UK  
ECL anti-mouse IgG1 horseradish 
peroxidase-linked species specific whole 
antibody (from sheep) 
Amersham Biosciences, UK  
Fetal calf serum Highveld Biologicals PTY LTD. South 
Africa 
Glutathione agarose Sigma-Aldrich Inc, USA  
High-range rainbow molecular weight Amersham Biosciences, UK  
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markers 
Hind III Amersham Pharmacia Biotech 
Hybond-C extra supported nitrocellulose 
membrane 
Amersham International, UK 
IBAfect IBA BioTAGnology, Germany (Cat. No. 7-
2005-020) 
IPTG Promega Corporation, USA  
MA Lipofection Enhancer IBA BioTAGnology, Germany (Cat. No. 7-
2003-020) 
Mouse monoclonal anti-Hsp70 StressGen, Canada  
Mouse monoclonal anti-Hsp72/73 StressGen, Canada 
Mouse monoclonal anti-β-actin Sigma, USA 
N-hydroxy-succinimide and 1-ethyl-3 –[3-
dimethylaminopropyl] carbodiimide 
(NHS/EDC) 
BIACORE, Sweden  
NIH 3T3 mouse fibroblast cells Highveld Biologicals PTY LTD. South 
Africa 
Not I Amersham Pharmacia Biotech, USA 
Nsi I New England BioLabs Inc., UK  
Okadeic acid Sigma, USA 
Penicillin/Streptomycin Highveld Biologicals PTY LTD. South 
Africa 
Peroxidase-conjugated AffiniPure F(ab’)2 
fragment goat anti-human IgG1 Fragment 
 
Jackson ImmunoResearch Laboratories 
INC. USA (Cat. No. 109-036-097) 
ProteoExtract® Subcellular Proteome 
Extraction Kit (S-PEK) 
Calbiochem, USA 
QIAprep Spin Miniprep kit  Qiagen, USA  
Quickchange Site-Directed Mutagenesis kit Stratagene, USA  
Rat Liver Hsp90 Purified by Csaba Soti (Hungary) 
Rat monoclonal anti-Hsp90 Sigma, USA 
Recombinant antibodies against Hop 
 
Morphosys® (Antibodies by Design) 
Germany. Final concentration used: 2 
ug/mL 
Sensor Chip CM5 (Research Grade) BIACORE, Sweden 
Shrimp alkaline phosphatase (SAP)  
Sodium orthovanadate Sigma, USA 
Supercompetent E. coli JM109 cells Promega Corporation, USA  
Supercompetent E. coli XL1Blue cells Promega Corporation, USA  
T4 DNA Ligase Promega Corporation, USA  
Urea Amersham Biosciences, USA  
Xho I Amersham Pharmacia Biotech, USA 
Zoom® Carrier Ampholytes 3-10 Invitrogen Life technologies, UK (Cat. No. 
ZM0021)  
Zoom® Carrier Ampholytes 4-7 Invitrogen Life technologies, UK (Cat. No. 
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ZM0022) 
Zoom® IPGRunner Cassette Invitrogen Life technologies, UK (Cat. No. 
ZM0003) 
Zoom® Strip pH 3-10NL Invitrogen Life technologies, UK (Cat. No. 
ZM0011) 
Zoom® Strip pH 4-7 Invitrogen Life technologies, UK (Cat. No. 
ZM0012) 
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A2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix A2: Technical data obtained from Amersham at www.amershambiosciences.com. 
When IPG strips with a linear pI range were used, the approximate pI’s of the spots resolved by 
2D gel electrophoresis were estimated by calculating the distance migrated by the spot as a 
percentage of gel length and reading off the pI from a graph of pH vs percentage of gel length 
generated by Amersham. 
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A3 Preparation of Supercompetent Cells 
 
A colony of E.coli cells was selected from a 2 x Yeast-Trpytone (YT) agar plate (1.6 g 
tryptone, 1 g yeast, 1.5 g agar, 0.5 g NaCl in 100 mL deionized water, prepared and 
sterilized before use) and used to inoculate 25 mL of 2 x YT broth (1.6 g tryptone, 1 g 
yeast, 0.5 g NaCl in 100 mL deionized water, prepared and sterilized before use). The 
culture was allowed to grow overnight at 37oC. The following day, the culture was 
diluted in fresh 250 mL of 2 x YT broth in a ration of 1:10 and allowed to grow for three 
hours until the culture reached log phase (A600 = 0.3-0.6). The cells were collected by 
centrifugation at 5000 g for 15 minutes at 4oC in sterile centrifuge tubes. The cell pellet 
was then resuspended in 25 mL of ice-cold MgCl2 (0.1 M) and left to stand in ice for 20 
minutes. The cell suspension was centrifuged as before and pellet resuspended in in 12.5 
mL of ice-cold CaCl2 (0.1 M). The suspensions were incubated on ice for 2 hours and the 
cells were again collected by centrifugation as before and cel pellet was resuspended in 
2.5 mL CaCl2. 100 µL of cell suspension was mixed with equal volume of sterile 30% 
glycerol, and stored at –80oC for future use.   
 
 
A4 Transformation of Supercompetent Cells 
 
Separate aliquots of supercompetent E.coli cells (100 µL) were incubated with aliquots of 
ligation products or appropriate plasmids (2 µL of 50 ng/µL) or sterile deionized triple-
distilled water (2 µL) as a negative transformation control. The reactions were incubated 
on ice for 30 minutes. Each transformation reaction was then heat pulsed for 30 seconds 
at 42oC in a dry heating block, and then placed on ice for 2 minutes. Sterile 2 x YT broth 
(800 µL of 1.6% tryptone, 1 % yeast extract, 0.5% NaCl) preheated to 42oC was added to 
each transformation reaction, before incubation at 37 oC for 1-3 hours with shaking. The 
transformation reactions were then centrifuged at 5000 g for 1 minute, the supernatent 
partially removed (800 µL) and the cell pellets resuspended in the remaining supernatent 
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(100 µL) and plated out onto sterile 2 x YT agar plates containing 0.1 mg/mL ampicillin. 
The plates were then incubated at 37 oC for 16 hours.  
 
 
A5 Induction Studies 
 
A colony of E.coli cells successfully transformed with the desired plasmid, was selected 
from a 2 x YT agar plate and used to inoculate 25 mL of 2 x YT broth containing 0.1 
mg/mL ampicillin, with shaking, overnight at 37oC. Overnight cultures were then diluted 
1:10 into sterile 2 x YT broth (225 mL) containing 0.1 mg/mL ampicillin and incubated 
at 37oC with shaking until mid-log phase was reached (A600=0.6-1). The cultures were 
then induced with the addition of isopropyl-1-thio-β-D-galactopyranoside (IPTG; final 
concentration of 1 mM) and allowed to grow for another five hours. Samples (1 mL) 
were taken hourly before induction, as well as for the five hours after induction. Each 1 
mL sample was centrifuged at 13000 rpm on a benchtop centrifuge for 1 minute, and 
resuspended in 150 uL of PBS for every 0.5 absorbance unit at A600.  The samples were 
then treated with SDS-PAGE sample loading buffer and resolved by SDS-PAGE for 
visual anaysis.  
 
 
 
A6 Expression and Purification of GST-Tagged Proteins 
 
Exponentially growing E.coli cells carrying pGEX3X derived plasmid constructs were 
induced for 5 – 6 hours at 37°C with 1 mM IPTG. The cells were harvested by 
centrifuging at 3000 g for 10 minutes and resuspending the pellet in one-hundredth-
culture volume of ice-cold phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 
4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.3) containing PMSF (1 mM). This was 
followed by lysis of the cells by sonicating at 60 Amps for 30 seconds thrice, on ice. The 
lysis procedure was further enhanced by incubating the sonicate with Triton X-100 to 1% 
Appendix 
 
 
145
final concentration and incubating at room temperature with gentle agitation for 30 
minutes. The extracts were clarified by centrifugation at 12000 g for 30 minutes at 4°C.  
 
Lyophilized glutathione agarose powder was allowed to swell in deionized water at a 
dilution of 2 mL / 10 mg overnight (4oC). Aliquots of clarified cell extracts were added to 
50 % (w/v) slurry of glutathione-agarose beads (250 µL for extracts obtained from an 
initial culture volume of 250 mL) previously equilibrated with PBS. Binding was allowed 
to occur for 1 hour at 4°C with gentle inversion. The beads were washed extensively with 
ice-cold PBS and then the bound GST fusion proteins were eluted by adding appropriate 
volume of the elution buffer (10 mM reduced glutathione in 50 mM Tris-HCl, pH 8.0). 
Eluted GST fusion proteins were analyzed by SDS-PAGE. Both unmodified GST-Hop 
and its mutant proteins were expressed and purified to typical yields of 1-3 mg/mL. 
 
 
A7 Bradfords Assay 
 
A 96-well plate was used to contain the various protein samples diluted to 10 µL in each 
well. Bradfords reagent (200 µL) was added to the samples and allowed to stand for 5 
minutes at room temperature. Absorbance values at A595 were then monitored and read 
against a standard curve constructed from known dilutions of BSA (2 mg/mL stock 
solution).  
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A8 Site Directed Mutagenesis 
 
All mutations were carried out by site-directed mutagenesis using a double-stranded 
whole plasmid linear amplification procedure (QuikChange mutagenesis kit; Stratagene). 
The following reagents were set up in 0.2 mL PCR tubes: 
 
Control Reaction 
Reagent        Volume (µL) 
Sterile deionized water      39.5 
10 x Reaction buffer       5 
pWhitescript 4.5 kb control plasmid (5 ng/µL)   2 
Oligonucleotide primer  #1 (125 ng/µL)    1.25 
Oligonucleotide primer  #2 (125 ng/µL    1.25 
DNTP mix        1 
Total Volume        50 
 
 
Test Reaction 
Reagent        Volume (µL) 
Sterile deionized water      39.5 
10 x Reaction buffer       5 
Template DNA (100 ng/µL)       1 
Forward primer (125 ng/µL)      1 
Reverse primer (125 ng/µL)      1 
DNTP mix        1 
Total volume        50 
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PfuTurbo DNA polymerase (1 µL) was added to final volumes of control and test 
reactions and submitted to the following cycling parameters for site directed mutagenesis: 
 
Segment No. of cycles Temperature (oC) Time  
1 1 95 30 seconds 
95 30 seconds 
52 1 minute 
2 12-18 
68 1 minute / kb of plasmid length 
 
After cycling, the reaction was allowed to cool down on ice before 1 µL of Dpn I 
restriction enzyme (10 U) was added to each reaction tube to digest any contaminating 
parental plasmid DNA. The mixture was incubated at 37oC for 2 hours and final products 
analyzed on a 0.8% agarose gel using 10 µL of each mutagenesis product.  
 
A9 Restriction Endonuclease Digestion of Double-Stranded 
DNA 
 
For each single and double digestion reactions, the following protocol was used: 
 
Reagents        Volume (µL) 
Sterile de-ionized water      16 
10 x Restriction buffer      2 
ds DNA (100-500 ng)       2 
 
The addition of 2 U of restriction endonuclease started the reaction. The mixture was 
incubated for 2 hours or more at the recommended temperature for the enzyme and the 
reaction was stopped by the addition of 4 µL of 6 x DNA gel loading buffer (0.25% 
bromophenol blue and 30% glycerol). For double digestion, restriction endonuclease 
enzyme that required low ionic strength buffer or low temperature was first used to digest 
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the DNA before adding high ionic strength buffer, or incubating at higher temperature. 
All DNA digests were resolved by agarose gel electrophoresis.  
 
 
 
 
A10 Agarose Gel Electrophoresis 
 
A 0.8% agarose gel was prepared in Tris-Borate-EDTA buffer (TBE: 0.045 M Tris, 0.045 
M Borate, 0.001 M EDTA, pH 8.3) buffer to a total volume of 100 mL and containing 5 
µL of 10 mg/mL stock solution of ethidium bromide. The agarose gel was cast and then 
lowered onto an electrophoretic tank. TBE buffer was added to a depth of about 3 mm 
above the gel. The DNA sample (20 µL) was added to agarose gel loading buffer (5 µL 
of 30% glycerol v/v, 0.25% w/v bromophenol blue). All air bubbles trapped in the wells 
were carefully removed before loading the DNA samples with a pipetteman. Pst I-
digested lamda DNA was resolved as a molecular marker. The leads were set such that 
the negatively charged DNA would move towards the anode. A voltage of 100 V was 
applied and the samples were allowed to migrate to 75% of the length of the gel. The 
DNA was visualized and photographed under ultraviolet (UV) light using the Bio-Rad’s 
VersaDocTM Model 4000 imaging system.  
 
 
A11 DNA Sequencing 
 
DNA sequencing was performed using the ABI 3100 Genetic Analyser with a capillary 
electrophoresis based system. DNA samples were prepared using the QIAprep Spin 
Miniprep kit, and then resuspended in sterilized ultra-pure water to reduce salt 
contamination that may interefere with the sequencing procedure. The reactions for 
thermocycling were conducted by preparing 250-500 ng of DNA mixed with 3.2 pmol of 
primer. The total volume of DNA and primer was made up to 12 µL using sterile triple 
distilled water. To this mixture, 8 µL of BigDye V3.1 was added prior to the 
amplification.  
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The amplification was carried out as follows:  
Rapid thermal ramp to 96oC, the temperature was held at 96oC for 10 seconds, followed 
by thermal ramp at 50oC and this temperature was held for 5 seconds. This was followed 
by a rapid thermal ramp to 60oC, which was maintained for 4 minutes. This amplification 
was repeated 30 times. The temperature was dropped rapidly to 4oC and the product held 
at this temperature for collection.  
 
The product was then cleaned using the DNA Clean and Concentrator-5 columns 
according to the manufacturer’s instructions (Zymo Research, California, USA). The 
product was vacuum dried and submitted to the Rhodes University DNA Sequencing 
Unit for electrophoresing. 
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B1 Generation of a Recombinant Antibody against GST-C334 
(C-Terminus of Hop) 
 
B1.1 Purification of GST-fusion protein GST-C334 
A plasmid encoding the GST fusion of the N-terminal truncated (amino acid residues 1-
208) mouse Hop protein (GST-C334) (Odunuga et al., 2003), pGEX3X1400 was 
transformed into supercompetent E. coli XL1Blue cells (Appendix A3 and A4). GST-
C334 was overproduced in E.coli XL1Blue (pGEX3X1400) by induction with IPTG 
(Appendix A5) and was purified by Glutathione (GSH) – Agarose affinity 
chromatography (Appendix A6). 
 
Protein concentrations were estimated using a standard Bradford’s protein analysis 
(Appendix A7) with a standard curve generated from known concentrations of a stock 
solution of bovine serum albumin (BSA; 2 µg/µL). 1 mg of total purified GST-C334 was 
lyophilized and sent to Morphosys-Antibodies by Design (Germany), for generation of 
recombinant antibodies using this protein as a target. 
  
B1.2 Generation of recombinant antibodies 
Purified GST-C334 was lyophilized and sent to MorphoSys Antibodies by Design 
(Germany) to custom design a human recombinant mini-antibody fragment purified from 
E.coli specific for C-terminus of mouse Hop.  Purified and lyophilised bivalent antibodies 
of the above-mentioned properties, and in addition, carrying a C-terminal myc / 6xHis 
combination were obtained. Sterile triple distilled water was used to reconstitute the 
lyophilised preparation (final concentration of 0.71 mg/mL), aliquoted into smaller 
volumes and stored at –80oC. The antibodies received were tested against NIH 3T3 
mouse fibroblast cell lysate, purified GST-C334 (positive control) and E.coli XL1Blue 
cell lysate (negative control). 
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B1.3  Recombinant antibody against C-terminus of Hop was generated and 
successfully tested 
GST-C334 was induced and purified (figure B 1) as the target for the process of 
‘panning’ so as to enrich for binding antibodies within a pre-existing library of antibody 
genes. Successful antibody samples were isolated, by plating out the bacteria harbouring 
the specific antibody genes. Purified antibody samples were received and tested by 
Western blot analysis. The antibody sample that showed the best results were used for all 
further work conducted. Western analysis of the purified bivalent mini-antibodies 
received, showed a positive detection in NIH 3T3 mouse fibroblast lysate (figure B 1, 
lane 2), purified GST-C334 (figure B 1, lane 4). The negative control did not exhibit any 
detection, as was expected (figure B 1 lane 3). 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure B 1: Antibody generated toward the C-terminus of Hop successfully 
detected Hop in positive controls. Western detection of Hop using primary antibodies 
directed against C-terminus of Hop (lower panel, and indicated by an arrow) with the 
SDS-PAGE profile shown in the upper panel. Lane 1: Molecular weight markers; Lane 2: 
NIH 3T3 mouse fibroblast cell lysate; Lane 3: Cell lysate obtained from E.col XL1 Blue; 
Lane 4: purified GST-C334.  
 
 
 
1      2      3    
66 kDa GST-C334 
Western Detection 
Appendix 
 
 
152
 
C  Oligonucleotide Primers 
 
 
Name Sequence 
mSTI1K239A (Fwd 
primer) 
5’ - GAG CTG GGA AAT GAT GCA TAC AAG AAG 
GCA GAT TTT GAC AAG – 3’ 
mSTI1K239A (Rev 
primer) 
5’ - CTT GTC AAA ATC TGC CTT CTT GTA TGC ATC 
ATT TCC CAG CTC – 3’ 
mSTI1K237/238/239A 
( Fwd primer) 
5’ – CTG GGA AAT GAT GCA TAC GCA GCG GCA 
GAT TTT GAC AAG – 3’ 
 
mSTI1K237/238/239A 
(Rev primer) 
5’ – CCT GTC AAA ATC TGC CGC TGC GTA TGC 
ATC ATT TCC CAG – 3’ 
mSTI1S189E (Fwd 
primer) 
5’ – CCT CCT TGG GGT AGA CCT GGG CGA AAT 
GGA TGA AG – 3’ 
mSTI1S189E (Rev. 
primer) 
5’ – CTT CAT CCA TTT CGC CCA GGT CTA CCC CAA 
GGA GG – 3’ 
mSTI1T198E (Fwd 
primer) 
5’ – GAG GAA GAG GCG GCC GAA CCC CCA CCC 
CCA C – 3’ 
mSTI1T198E (Rev. 
primer) 
5’ – GTG GGG GTC GGG GTT CGG CCG CCT CTT 
CCT C – 3’ 
3M SEQ FWD 
(sequencing primer) 
5’ - CCT AAT CTA TAC CAA AAG TTG – 3’ 
 
3M SEQ REV 
(sequencing primer) 
5’ – GAA TTT TCT CTG CCT GC – 3’ 
 
 
 
